# Sprint 7.15 Phase 0 — Pipeline Diagnostic Labeling

## What this is

You're hand-labeling 75 FinanceBench questions across **5 fields** so we can measure each pipeline component against your ground truth.

| Field | What stage it diagnoses |
|---|---|
| INTENT | Router — does it correctly classify the question type? |
| COMPLEXITY | Router — does it correctly route to simple-retrieval vs research-agent? |
| TARGET_COMPANY / TARGET_YEAR | Entity extractor — does it pick the right company + fiscal year? |
| EXPECTED_SUB_QUERIES | Decomposer — can the system meaningfully break the question apart? |
| HALLU_GROUNDED | Hallucination-checker — does its existing verdict match yours? |

## Composition

- **48 still-failing cases** (priority — surfaces which stage breaks on each)
- **27 passing cases** (stratified across question types — clean PASS baselines)
- Total: 75, shuffled so failing/passing don't cluster

## Quick reference card — the labels you fill per record

```
**INTENT:**                 retrieval | clarification | out_of_scope
**COMPLEXITY:**             simple_lookup | research_required
**TARGET_COMPANY:**         OK   (or override with correct slug)
**TARGET_YEAR:**            OK   (or override with correct year)
**EXPECTED_SUB_QUERIES:**   N/A  (or 2-5 numbered sub-queries if COMPLEXITY=research_required)
**HALLU_GROUNDED:**         Y | N | PARTIAL
**NOTES:**                  (optional)
```

---

## Field-by-field rules (everything self-contained — no need to open source code)

### 1. INTENT — `retrieval` / `clarification` / `out_of_scope`

| Value | Meaning | Example FB questions |
|---|---|---|
| `retrieval` | Substantive question answerable from financial documents (10-K, 10-Q, invoices, expense policies). **~95% of FB questions are this.** | "What was Apple's FY2023 revenue?" / "Does Adobe have improving FCF conversion?" / "Compare 3M segments." |
| `clarification` | Vague greeting / "what can you do" / under-specified | "Hi" / "Tell me about finance" / "What can you help with?" |
| `out_of_scope` | Unrelated to finance | "What's the weather?" / Code questions / Recipes |

For FB questions you'll mostly type `retrieval`. Speed through this field.

### 2. COMPLEXITY — `simple_lookup` / `research_required`

**Definition (the rule the router itself uses):**

#### `simple_lookup` — single-fact retrieval

The answer is a specific number, name, date, segment, or short phrase that lives in ONE section of ONE document. Yes/no questions about company-level facts ARE simple_lookup, even when a one-line explanation accompanies the answer.

Examples that are `simple_lookup`:
- "What was Apple's FY2023 total revenue?"
- "What was 3M's FY2018 capital expenditure?"
- "Does 3M maintain a stable trend of dividend distribution?"
- "Is 3M a capital-intensive business?"
- "Is Apple's debt rating investment grade?"
- "Who is the auditor for the 2022 10-K?"
- "What is the meal per diem in San Francisco?"

#### `research_required` — multi-step

Choose this ONLY if the query has **at least one** of these explicit triggers:

1. **Explicit formula or ratio** — the question defines or names a calculation:
   - "Compute days payable outstanding (DPO) defined as 365 × avg AP / COGS"
   - "Fixed asset turnover ratio defined as revenue / average PP&E"
   - "Operating cash flow ratio = X / Y"

2. **Qualifier word** that changes what counts as a correct answer:
   - "exclude" / "excluding" / "organic" / "if we exclude" / "adjusted"

3. **Comparison** across years / segments / companies:
   - "Compare X vs Y" / "compared to" / "X vs Y" / "year-over-year direction"
   - "Is FY2022 better than FY2021?"

4. **Decomposition language** — requires management's stated drivers:
   - "What drove..." / "drivers of..." / "primarily due to..." / "explain why..."

5. **Applicability judgment** — questions that ask whether the metric even applies:
   - "If [metric] is not relevant, state that and explain why"
   - "Is the quick ratio the right metric for this business?"

6. **2+ DISTINCT financial quantities from DIFFERENT document sections** — the answer requires combining inputs from multiple parts of the doc:
   - Revenue (income statement) AND PP&E (balance sheet) for a turnover ratio
   - Cash from operations (cash flow statement) AND current liabilities (balance sheet) for op CF ratio
   - Net income (income statement) AND dividends paid (cash flow statement) for retention ratio
   - Multi-year inputs (e.g., FY2017 inventory + FY2018 inventory for an average)

Examples that are `research_required`:
- "What drove operating margin change FY22 vs FY21 for 3M?" — decomposition trigger
- "If we exclude M&A, which segment dragged 3M's growth?" — qualifier trigger
- "Compute days payable outstanding for Pepsico in FY2022" — explicit formula
- "What is the FY2017 operating cash flow ratio for Adobe?" — needs cash flow + balance sheet
- "What is the FY2019 cash conversion cycle (DIO + DSO − DPO) for General Mills?" — explicit formula + multiple inputs

#### Tiebreaker rule

**When uncertain, prefer `simple_lookup`.** The agent (research) path is slower (~90s vs ~20s) and can REGRESS simple lookups by adding unnecessary disclaimers. Only choose `research_required` when at least one trigger above is **clearly** present.

### 3. TARGET_COMPANY — verify the auto-prefilled slug

The auto-prefilled value comes from FinanceBench's own `company` field, mapped to the system's canonical slug (e.g., "3M" → `3m`, "Apple Inc." → `apple`). **In almost every case it's correct.**

- If auto-prefilled value matches the question's company → type `OK`
- If wrong (e.g., a question about "AmEx" but auto-prefilled `american_express`) → override with the correct slug

### 4. TARGET_YEAR — verify the auto-prefilled year

The auto-prefilled year comes from regex on the `doc_name` field. **Almost always correct.**

- If correct → type `OK`
- If wrong (e.g., 10-Q for Q2 of fiscal 2023 but question asks about Q1) → override with the correct year

Edge cases to watch:
- 10-Q filings — fiscal year vs calendar year can differ (e.g., Ulta's "fiscal 2022" = 12 months ending Jan 2023)
- Multi-year questions ("what was the FY2017-FY2019 average...") — pick the LATEST year of the question; that's what entity extraction targets

### 5. EXPECTED_SUB_QUERIES — only fill if COMPLEXITY = `research_required`

If COMPLEXITY = `simple_lookup`, just leave the line as `N/A`. Skip.

If COMPLEXITY = `research_required`, write 2–5 sub-queries that, combined, would cover the original question. **Each sub-query must make sense on its own** (independently retrievable). Format as a numbered list.

#### Worked examples

**Q**: "What is the FY2017 operating cash flow ratio for Adobe? (defined as cash from operations / total current liabilities)"
```
1. Adobe FY2017 cash from operations
2. Adobe FY2017 total current liabilities
```

**Q**: "What is the FY2019 cash conversion cycle for General Mills? CCC = DIO + DSO − DPO. DIO = 365 × avg inventory / COGS. DSO = 365 × avg AR / Revenue. DPO = 365 × avg AP / (COGS + change in inventory)."
```
1. General Mills FY2019 inventory and FY2018 inventory
2. General Mills FY2019 accounts receivable and FY2018 accounts receivable
3. General Mills FY2019 accounts payable and FY2018 accounts payable
4. General Mills FY2019 COGS
5. General Mills FY2019 revenue
```

**Q**: "What drove operating margin change for 3M in FY2022?"
```
1. 3M FY2022 operating margin
2. 3M FY2021 operating margin (for comparison)
3. Drivers and one-off charges affecting 3M FY2022 operating margin (litigation, impairment, restructuring)
```

**Q**: "If we exclude the Combat Arms Earplugs litigation, which 3M segment dragged growth in FY2022?"
```
1. 3M FY2022 segment growth rates
2. 3M FY2022 Combat Arms Earplugs litigation impact by segment
```

**Rules for good sub-queries:**
- Each one should be a single-source retrieval (one section of one document)
- Together they should cover ALL inputs needed for the answer
- Don't repeat the original question verbatim — break it apart
- 2-5 sub-queries is the norm; more than 5 means you're over-fragmenting

### 6. HALLU_GROUNDED — `Y` / `N` / `PARTIAL`

This judges whether the V1 system's answer is **faithful to the retrieved chunks** (not whether it's correct against the gold answer). The retrieved chunks shown below are the ones the system actually saw.

| Value | When to use |
|---|---|
| `Y` | All claims in the system's answer are supported by the retrieved chunks. If the system refused ("I don't have enough information"), that's still `Y` — it didn't fabricate. |
| `N` | The system made up numbers, cited fake sources, or asserted facts not present in the chunks. Pure hallucination. |
| `PARTIAL` | Some claims are grounded in the chunks; some are made up or asserted without support. |

#### Worked examples

**System answer**: "Apple FY2023 revenue was $383.3 billion, calculated as the sum of product sales ($298.1B) and services revenue ($85.2B) [Source: 10K Page 25]."
**Retrieved chunks**: Page 25 chunk shows: "Net sales: $383,285M. Products: $298,085M. Services: $85,200M."
→ **`Y` (grounded)** — all numbers and the source citation match the chunk.

**System answer**: "Apple FY2023 revenue was $383.3 billion driven by 12% iPhone growth [Source: 10K Page 25]."
**Retrieved chunks**: Page 25 has the revenue figure but says nothing about iPhone growth %.
→ **`PARTIAL`** — revenue claim grounded; iPhone-growth claim not in the chunk.

**System answer**: "Pfizer's Upjohn separation involved $700M in costs, 90% incurred through Q2 2023 [Source: 10-Q Page 41]."
**Retrieved chunks**: Page 41 shows exactly that text.
→ **`Y` (grounded)**.

**System answer**: "I don't have enough information in the retrieved chunks to compute this ratio."
**Retrieved chunks**: Cash flow statement chunks but no balance sheet chunks.
→ **`Y` (grounded)** — refusal IS grounded; system honestly described what it could/couldn't see.

**System answer**: "Coca-Cola's FY2022 dividend payout ratio is 0.55, calculated as $7,617M / $13,945M."
**Retrieved chunks**: Page 67 shows net income = $9,542M (not $13,945M).
→ **`N` (not grounded)** — the system fabricated the $13,945M denominator; the chunk shows a different number.

**Important**: this is judging GROUNDEDNESS in the retrieved chunks shown, NOT whether the system's final answer matches the gold answer. A correct answer can still be ungrounded (if the system happened to know it from training data rather than the chunks). An incorrect answer can be grounded (if the chunks themselves had wrong/incomplete data).

---

## How to label

For each record, find the placeholders and replace them inline:

```
**INTENT:** `__REPLACE__`         →  type retrieval / clarification / out_of_scope
**COMPLEXITY:** `__REPLACE__`     →  type simple_lookup / research_required
**TARGET_COMPANY:** `OK ...`      →  type OK or your override
**TARGET_YEAR:** `OK ...`         →  type OK or your override
**EXPECTED_SUB_QUERIES:**         →  N/A or a numbered list (if research_required)
**HALLU_GROUNDED:** `__REPLACE__` →  type Y / N / PARTIAL
**NOTES:**                        →  optional
```

When done, save the file (.md). I'll parse it back to JSONL.

## Time estimate

| Step | Per Q | Total for 75 |
|---|---|---|
| INTENT | ~5 sec | ~6 min |
| COMPLEXITY | ~30-45 sec | ~30-50 min |
| TARGET company + year (verify) | ~10 sec | ~12 min |
| EXPECTED_SUB_QUERIES (only ~30 complex Qs) | ~1-2 min × 30 | ~30-60 min |
| HALLU_GROUNDED | ~1 min | ~75 min |
| **Total** | | **~3 hours** |

You can do it in chunks — the parser handles partial files gracefully.

---


# Sprint 7.15 Phase 0 — Pipeline Diagnostic Labeling

_Total: 75 records. Estimated time: ~3 hours._

---
## Record 1 of 75  —  `diag_001`  **[FAILING]**  audit=PARTIAL_ANSWER

**fb_id:** `financebench_id_00070`
**company:** American Water Works
**doc:** AMERICANWATERWORKS_2022_10K
**question_type:** domain-relevant

### Question

Does American Water Works have positive working capital based on FY2022 data? If working capital is not a useful or relevant metric for this company, then please state that and explain why.

### Gold answer

> No, American Water Works had negative working capital of -$1561M in FY 2022.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## American Water Works – FY2022 Working Capital Analysis

### What the Data Shows

**Total Current Assets (FY2022): $1,250 million** [Source: AMERICANWATERWORKS_2022_10K.pdf, Page 81]

The retrieved balance sheet provides only the **assets side**; total current liabilities for FY2022 were **not retrieved**, so the arithmetic cannot be completed with certainty.

---

### Why Working Capital Is Not a Meaningful Metric Here

More importantly, even if the exact figure were calculable, **working capital is not a useful standalone metric for American Water Works** for the following structural reasons:

1. **Regulated utility business model**: American Water Works is a rate-regulated water and wastewater utility. Its revenues are set by regulators and collected continuously from ratepayers — there is no traditional operating liquidity cycle (inventory → sales → receivables) that working capital is designed to measure.

2. **Capital structure reliance on long-term debt**: Utilities fund operations and capital expenditures primarily through long-term debt issuances and commercial paper/credit facilities, not through working capital management. Current liabilities routinely include large sh

[... truncated, total 2615 chars]
```

### V1 retrieved chunks (top 2 of 2 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 81] Table of Contents
American Water Works Company, Inc. and Subsidiary Companies
Consolidated Balance Sheets
(In millions, except share and per share data)
December 31, 2022 December 31, 2021
ASSETS
Property, plant and equipment $ 29,736 $ 27,413
Accumulated depreciation (6,513) (6,329)
Property, plant and equipment, net 23,223 21,084
Current assets:
Cash and cash equivalents 85 116
Restricted funds 32 20
Accounts receivable, net of allowance for uncollectible accounts of $60 and $75, respectively 334 271
Income tax receivable 114 4
Unbilled revenues 275 248
Materials and supplies 98 57
Assets held for sale — 683
Other 312 155
Total current assets 1,250 1,554
Regulatory and other long-term assets:
Regulatory assets 990 1,051
```

**Chunk 2:**
```
[10K | Page 82] American Water Works Company, Inc American Water Works Company, Inc and Subsidiary CompaniesConsolidated Balance Sheets(In millions, except share and per share data)December 31, 2020 December 31, 2019 ASSETSProperty, plant and equipment$ 25,614 $23,941 Accumulated depreciation(5,904) (5,709) Property, plant and equipment, net19,710 18,232 Current assets: Cash and cash equivalents547 60 Restricted funds29 31 Accounts receivable, net of allowance for uncollectible accounts of $60 and $41, respectively321 294 Unbilled revenues206 172 Materials and supplies47 44 Assets held for sale629 566 Other127 118 Total current assets1,906 1,285 Regulatory and other long-term assets: Regulatory assets1,127 1,128 Operating lease right-of-use assets95 103 Goodwill1,504 1,501 Postretirement b...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `american_water_works`  (display: American Water Works)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=american_water_works; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. American Water Works FY2022 total current assets.
2. American Water Works FY2022 total current liabilities.
3. Whether working capital is a relevant liquidity metric for a regulated water utility.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Grounded for current assets and missing liabilities; business-model relevance discussion is not supported by retrieved chunks.

---
## Record 2 of 75  —  `diag_002`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_00521`
**company:** Ulta Beauty
**doc:** ULTABEAUTY_2023_10K
**question_type:** domain-relevant

### Question

What are major acquisitions that Ulta Beauty has done in FY2023 and FY2022?

### Gold answer

> Ulta Beauty did not make any acquisitions in FY2023 and FY2022.

### V1 system answer (for HALLU_GROUNDED labeling)

```
I don't have enough information to answer this question.

The retrieved document chunks contain no evidence about Ulta Beauty's acquisitions in FY2023 or FY2022. To get a definitive answer, I recommend reviewing Ulta Beauty's 10-K filings for those fiscal years — specifically the **Notes to Financial Statements** section covering "Business Combinations" or "Acquisitions."
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```

```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `ulta_beauty`  (display: Ulta Beauty)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=ulta_beauty; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Empty retrieval; refusal is grounded.

---
## Record 3 of 75  —  `diag_003`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_00807`
**company:** 3M
**doc:** 3M_2023Q2_10Q
**question_type:** domain-relevant

### Question

Does 3M have a reasonably healthy liquidity profile based on its quick ratio for Q2 of FY2023? If the quick ratio is not relevant to measure liquidity, please state that and explain why.

### Gold answer

> No. The quick ratio for 3M was 0.96 by Jun'23 close, which needs a bit of an improvement to touch the 1x mark

### V1 system answer (for HALLU_GROUNDED labeling)

```
I don't have enough information to answer this question.

The research synthesis confirms that no balance sheet data was retrieved from the underlying 3M filings for Q2 FY2023 (quarter ending June 30, 2023). Specifically, the following figures needed to compute the quick ratio are absent from the retrieved context:

- **Current assets**
- **Current liabilities**
- **Inventories**
- **Prepaid expenses / other non-quick current assets**

Without these figures from the actual filed documents, I cannot compute 3M's quick ratio or assess its liquidity profile for that period. Fabricating or importing numbers from general knowledge would violate the sourcing requirement of this analysis.

**Relevance note (general, unsourced):** For context, the quick ratio *is* generally a relevant liquidity metric for an industrial/manufacturing company like 3M, since such companies typically carry significant inventory — meaning the current ratio alone could overstate short-term liquidity. However, this observation cannot be confirmed or quantified without the actual Q2 FY2023 balance sheet data.

**Bottom line:** No relevant financial evidence was retrieved from the 3M filings for Q2 FY2023. A defini

[... truncated, total 1277 chars]
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```

```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `3m`  (display: 3M)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=3m; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. 3M Q2 FY2023 quick assets components: cash, receivables, short-term investments, and other quick assets.
2. 3M Q2 FY2023 total current liabilities.
3. Whether quick ratio is a relevant liquidity metric for 3M.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Refusal is grounded in empty retrieval, but the general relevance discussion about 3M is unsupported.

---
## Record 4 of 75  —  `diag_004`  **[FAILING]**  audit=PASS_JUDGE_BUG

**fb_id:** `financebench_id_01079`
**company:** Amcor
**doc:** AMCOR_2023_10K
**question_type:** domain-relevant

### Question

What are major acquisitions that AMCOR has done in FY2023, FY2022 and FY2021?

### Gold answer

> Amcor completed these acquisitions during FY2023:
-100% equity interest of a flexibles manufacturing company in the Czech Republic
- 100% equity interest in a medical device packaging manufacturing site in
Shanghai, China.
-acquisition of a New Zealand-based leading manufacturer of state-of-the-art, automated protein
packaging machines.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## AMCOR Major Acquisitions: FY2023, FY2022, and FY2021

### FY2023 (Year Ended June 30, 2023) — Three Bolt-On Acquisitions Confirmed

| # | Target | Completion Date | Consideration | Segment | Net Assets | Goodwill |
|---|--------|----------------|---------------|---------|------------|---------|
| 1 | Czech Republic flexible packaging manufacturer | Aug 1, 2022 | $59M (incl. $5M deferred) | Flexibles | $36M | $23M |
| 2 | Medical device packaging site, Shanghai, China | Mar 17, 2023 | $60M (incl. $20M contingent over 3 yrs) | Flexibles | $21M | $39M |
| 3 | New Zealand automated protein packaging machine manufacturer | May 31, 2023 | $45M (incl. $13M contingent over 2 yrs) | Not specified | $21M | $39M* |

*Preliminary figures as of June 30, 2023 [Source: AMCOR_2023_10K.pdf, Page 64]

**Notable details:**
- The Shanghai acquisition generates ~$50M in annual sales [Source: AMCOR_2023Q2_10Q.pdf, Page 32]
- All three are characterized as "bolt-on" acquisitions [Source: AMCOR_2023Q4_EARNINGS.pdf, Page 2]
- The New Zealand acquisition's purchase price allocation was still pending completion as of June 30, 2023

---

### FY2022 (Year Ended June 30, 2022) — **Not Available**

The retrie

[... truncated, total 2105 chars]
```

### V1 retrieved chunks (top 5 of 5 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 10K | Page 2] Cash Returns to Shareholders
Amcor generates significant annual cash flow, maintains strong credit metrics, and is committed to an investment
grade credit rating. The Company's strong annual cash flow and balance sheet provide substantial capacity to reinvest
in the business for organic growth, pursue acquisitions, and return cash to shareholders through a compelling and
growing dividend as well as regular share repurchases.
During fiscal 2023, the Company returned approximately $1.2 billion to shareholders through cash dividends and share
repurchases in addition to completing three bolt-on acquisitions.
Dividend
The Amcor Board of Directors today declared a quarterly cash dividend of 12.25 cents per share (compared with 12.0
```

**Chunk 2:**
```
[FY2023 10Q | Page 32] Note 16 - Subsequent Events
On January 16, 2023, the Company announced it had entered into an agreement to acquire a medical device packaging company based in
Shanghai, China, which generates annual sales of approximately $50 million. The acquisition is subject to customary regulatory approvals and is
expected to close by the end of the third quarter of fiscal year 2023.
On February 7, 2023, the Company's Board of Directors declared a quarterly cash dividend of $0.1225 per share to be paid on March 21, 2023
to shareholders of record as of March 1, 2023. Amcor has received a waiver from the Australian Securities Exchange ("ASX") settlement
operating rules, which will allow Amcor to defer processing conversions between ordinary share and CHESS Depositary Instrument ("C...
```

**Chunk 3:**
```
[FY2023 10K | Page 64] red
identifiable net assets of $21 million and goodwill of $39 million. Goodwill is not deductible for tax purposes. The fair values of the contingent consideration, identifiable net assets acquired, and goodwill are based on the Company's best estimate as of June 30, 2023, and are considered
preliminary. The Company aims to complete the purchase price allocation as soon as practicable but no later than one year from the date of the
acquisition.
On May 31, 2023, the Company completed the acquisition of a New Zealand based leading manufacturer of state-of-the-art, automated protein
packaging machines. The purchase consideration of $45 million is subject to customary post-closing adjustments. The consideration includes
contingent consideration of $13 million, to be ear...
```

**Chunk 4:**
```
[FY2023 10K | Page 64] e for tax purposes. The fair values of the identifiable
net assets acquired and goodwill are based on the Company's best estimate as of June 30, 2023. On March 17, 2023, the Company completed the acquisition of 100% equity interest in a medical device packaging manufacturing site in
Shanghai, China. The purchase consideration of $60 million is subject to customary post-closing adjustments. The consideration includes
contingent consideration of $20 million, to be earned and paid in cash over the three years following the acquisition date, subject to meeting
certain performance targets. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired
identifiable net assets of $21 million and goodwill of $39 million. Goo...
```

**Chunk 5:**
```
[FY2023 10K | Page 64] Note 5 - Acquisitions and Divestitures
Year ended June 30, 2023
Acquisitions
On August 1, 2022, the Company completed the acquisition of 100% equity interest in a Czech Republic company that operates a world-class
flexible packaging manufacturing plant. The purchase consideration of $59 million included a deferred portion of $5 million that was paid in the
first quarter of fiscal year 2024. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired
identifiable net assets of $36 million and goodwill of $23 million. Goodwill is not deductible for tax purposes. The fair values of the identifiable
net assets acquired and goodwill are based on the Company's best estimate as of June 30, 2023.
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `amcor`  (display: Amcor)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=amcor; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** FY2023 acquisitions are mostly grounded, but some detailed allocations and FY2022/FY2021 availability statements are not supported by the shown chunks.

---
## Record 5 of 75  —  `diag_005`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_01482`
**company:** PepsiCo
**doc:** PEPSICO_2023_8K_dated-2023-05-05
**question_type:** novel-generated

### Question

At the Pepsico AGM held on May 3, 2023, what was the outcome of the shareholder vote on the shareholder proposal for a congruency report by Pepsico on net-zero emissions policies?

### Gold answer

> The shareholder proposal for a congruency report by Pepsico on net-zero emissions policies was defeated.

### V1 system answer (for HALLU_GROUNDED labeling)

```
I'm sorry, but that question is outside my scope. I can only help with
financial document queries such as company filings, invoices, and expense policies.
Please ask a question related to financial documents.
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```

```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `pepsico`  (display: PepsiCo)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=pepsico; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Empty retrieval; refusal/out-of-scope response contains no document factual claims.

---
## Record 6 of 75  —  `diag_006`  **[PASSING]**

**fb_id:** `financebench_id_04080`
**company:** Nike
**doc:** NIKE_2021_10K
**question_type:** metrics-generated

### Question

When primarily referencing the income statement and the statement of financial position, what is the FY2021 inventory turnover ratio for Nike? Inventory turnover ratio is defined as: (FY2021 COGS) / (average inventory between FY2020 and FY2021). Round your answer to two decimal places.

### Gold answer

> 3.46

### V1 system answer (for HALLU_GROUNDED labeling)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Nike FY2021 Inventory Turnover Ratio

### Key Inputs

| Item | Value | Source |
|------|-------|--------|
| FY2021 COGS | $24,576M | [Source: NIKE_2021_10K.pdf, Income Statement] |
| FY2021 Total Inventories | $6,854M | [Source: NIKE_2021_10K.pdf, Page 92] |
| FY2020 Total Inventories | $7,367M | [Source: NIKE_2021_10K.pdf, Page 92] |

### Calculation

**Average Inventory** = ($6,854M + $7,367M) / 2 = **$7,110.5M**

**Inventory Turnover Ratio** = $24,576M / $7,110.5M = **3.46**

---

**Bottom line**: Nike's FY2021 inventory turnover ratio is **3.46**, computed using FY2021 COGS of $24,576M divided by average inventory of $7,110.5M (derived from FY2021 ending inventory of $6,854M and FY2020 ending inventory of $7,367M per [Source: NIKE_2021_10K.pdf, Page 92]).
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2021 10K | Page 92] Table of Contents AS OF MAY 31, (Dollars in millions)2021 2020 ACCOUNTS RECEIVABLE, NETNorth America$ 1,777 $1,020 Europe, Middle East & Africa1,349 712 Greater China288 321 Asia Pacific & Latin America643 425 Global Brand Divisions128 65 Total NIKE Brand4,185 2,543 Converse225 149 Corporate53 57 TOTAL ACCOUNTS RECEIVABLE, NET$ 4,463 $2,749 INVENTORIESNorth America$ 2,851 $3,077 Europe, Middle East & Africa1,821 2,070 Greater China1,247 882 Asia Pacific & Latin America667 770 Global Brand Divisions153 137 Total NIKE Brand6,739 6,936 Converse290 341 Corporate(175) 90 TOTAL INVENTORIES$ 6,854 $7,367 PROPERTY, PLANT AND EQUIPMENT, NETNorth America$ 617 $645 Europe, Middle East & Africa982 885 Greater China288 214 Asia Pacific & Latin America304 296 Global Brand Division...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `nike`  (display: Nike)
- **Auto target_fiscal_year:** `2021`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=nike; override if wrong)

**TARGET_YEAR:** `OK` (auto=2021; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Nike FY2021 cost of goods sold.
2. Nike FY2021 total inventories.
3. Nike FY2020 total inventories.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Inventory values are grounded; COGS and the final ratio are not supported by the retrieved chunk.

---
## Record 7 of 75  —  `diag_007`  **[PASSING]**

**fb_id:** `financebench_id_01488`
**company:** Johnson & Johnson
**doc:** JOHNSON_JOHNSON_2023_8K_dated-2023-08-30
**question_type:** novel-generated

### Question

Which business segment of JnJ will be treated as a discontinued operation from August 30, 2023 onward?

### Gold answer

> The Consumer Health business segment will be treated as a discontinued operation from August 30, 2023 onward.

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the provided context, **Johnson & Johnson's Consumer Health business** (now operating as **Kenvue Inc.**) will be treated as a discontinued operation from August 30, 2023 onward.

Following the completion of the exchange offer to finalize the Kenvue Separation, Johnson & Johnson announced it would "present its Consumer Health business financial results as discontinued operations, including a gain of approximately $20 billion in the third quarter of 2023." [Source: JOHNSON_JOHNSON_2023_8K_dated-2023-08-30.pdf, Page 4]

**Bottom line:** Johnson & Johnson's Consumer Health business segment, separated and rebranded as Kenvue Inc., is classified as a discontinued operation effective August 30, 2023, following the completion of the exchange offer. [Source: JOHNSON_JOHNSON_2023_8K_dated-2023-08-30.pdf, Pages 2 & 4]
```

### V1 retrieved chunks (top 4 of 4 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 8K | Page 4] c., formerly Johnson &
Johnson’s Consumer Health business. As a result of the completion of the exchange offer, Johnson & Johnson will now present its Consumer Health business financial results as discontinued operations, including a gain of approximately $20 billion in the third quarter of
2023.
```

**Chunk 2:**
```
[FY2023 8K | Page 2] Item 2.02     Results of Operations and Financial Condition
Johnson & Johnson completed an exchange offer to finalize the separation of Kenvue Inc. (the "Kenvue Separation"). On August 30, 2023, Johnson &Johnson issued the attached press release (Exhibit 99.1) providing updated financials and 2023 guidance following completion of the Kenvue Separation.
 
Item 9.01    Financial Statements and Exhibits
(d)     Exhibits. 
 
Exhibit No.   Description of Exhibit  
99.1 Press Release dated August 30, 2023
99.2 Updated Financial Data
104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
```

**Chunk 3:**
```
[FY2023 10K | Page 6] ion can also be found
in the Investors section of the company's website at quarterly results.
NOTE TO INVESTORS CONCERNING FORWARD-LOOKING STATEMENTS: This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act
of 1995 regarding, among other things: future operating and financial performance, product development, market
position and business strategy, and the anticipated separation of the Company’s Consumer Health business.  The
reader is cautioned not to rely on these forward -looking statements.  These statements are based on current
expectations of future events.  If underlying assumptions prove inaccurate or known or unknown risks or
uncertainties materialize, actual results could vary materially from the exp...
```

**Chunk 4:**
```
[FY2023 8K | Page 4] and 2023 guidance
found in this release, which may be accessed by visiting the Investors section of the Company's website at webcasts & presentations. “The completion of this transaction uniquely positions Johnson & Johnson as a Pharmaceutical and MedTech company focused on delivering
transformative healthcare solutions to patients,” said Joaquin Duato, Chairman of the Board and Chief Executive Officer. “We are incredibly
proud of the focus and dedication of our employees worldwide to achieve this milestone, which we are confident will unlock near- and long-
term value for all of our stakeholders.”
As previously announced, the Company recently completed an exchange offer to finalize the separation of Kenvue Inc., formerly Johnson &
Johnson’s Consumer Health business. A...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `johnson_johnson`  (display: Johnson & Johnson)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=johnson_johnson; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 8 of 75  —  `diag_008`  **[FAILING]**  audit=PARTIAL_ANSWER

**fb_id:** `financebench_id_00394`
**company:** JPMorgan
**doc:** JPMORGAN_2022Q2_10Q
**question_type:** novel-generated

### Question

In 2022 Q2, which of JPM's business segments had the highest net income?

### Gold answer

> Corporate & Investment Bank. Its net income was $3725 million.

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the provided context, I can see total net revenue figures for Q2 2022 (three months ended June 30), but **net income figures are not explicitly provided** in the chunks — only revenue, provision for credit losses, noninterest expense, and income before tax are shown (and those are for the **six-month** period in Source 2, not the standalone Q2 quarter).

From the **six months ended June 30, 2022** data [Source 2: JPMORGAN_2022Q2_10Q.pdf, Page 178], the **Income before income tax** figures are:

| Segment | Income Before Tax (6M 2022) |
|---|---|
| Consumer & Community Banking (CCB) | $7,961M |
| Corporate & Investment Bank (CIB) | $10,929M |
| Commercial Banking (CB) | $2,430M |
| Asset & Wealth Management (AWM) | $2,644M |

The **Corporate & Investment Bank (CIB)** had the highest pre-tax income for the six-month period.

---

**Bottom line (partial evidence):** Net income by segment for standalone Q2 2022 is not available in the provided context; however, based on the closest available metric (six-month 2022 pre-tax income), **Corporate & Investment Bank** led all segments at **$10,929M** [Source 2: JPMORGAN_2022Q2_10Q.pdf, Page 178]. The standalone Q2 net income breakdo

[... truncated, total 1250 chars]
```

### V1 retrieved chunks (top 2 of 2 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10Q | Page 177]  managed basis.
Capital allocation
The amount of capital assigned to each business segment is
referred to as equity. Periodically, the assumptions and methodologies used to allocate capital are reassessed and
as a result, the capital allocated to the LOBs may change.
Refer to Line of business equity on page 93 of JPMorgan
Chase’s 2021 Form 10-K for additional information on
capital allocation.
Segment results and reconciliation(a)
As of or for the three months
ended June  30,
(in millions, except ratios)
Consumer &
Community Banking
Corporate &
Investment Bank Commercial Banking
Asset & Wealth
Management
2022 2021 2022 2021 2022 2021 2022 2021
Noninterest revenue $ 3,906 $ 4,726 $ 8,749 $ 9,912 $ 904 $ 950 $ 3,084 $ 3,165
Net interest income  8,708  8,034  3,198  3,...
```

**Chunk 2:**
```
[FY2022 10Q | Page 178] Segment results and reconciliation(a)
As of or for the six months
ended June  30,
(in millions, except ratios)
Consumer &
Community Banking
Corporate &
Investment Bank Commercial Banking
Asset & Wealth
Management
2022 2021 2022 2021 2022 2021 2022 2021
Noninterest revenue $ 7,808 $ 9,314 $ 18,706 $ 21,000 $ 1,771 $ 1,867 $ 6,323 $ 6,311
Net interest income  17,035  15,963  6,770  6,819  3,310  3,009  2,298  1,873
Total net revenue  24,843  25,277  25,476  27,819  5,081  4,876  8,621  8,184
Provision for credit losses  1,439  (5,470)  504  (410)  366  (495)  198  (131)
Noninterest expense  15,443  14,264  14,043  13,627  2,285  1,950  5,779  5,160
Income/(loss) before
income tax expense/
(benefit)  7,961  16,483  10,929  14,602  2,430  3,421  2,644  3,155
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `jpmorgan`  (display: JPMorgan)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=jpmorgan; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. JPMorgan Q2 2022 net income figures by business segment for the three months ended June 30, 2022.
2. JPMorgan Q2 2022 segment results table definitions and reporting period.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** System accurately reflects the retrieved six-month pre-tax evidence and missing standalone Q2 net income in the shown chunks.

---
## Record 9 of 75  —  `diag_009`  **[PASSING]**

**fb_id:** `financebench_id_01346`
**company:** Corning
**doc:** CORNING_2022_10K
**question_type:** domain-relevant

### Question

How much has the effective tax rate of Corning changed between FY2021 and FY2022?

### Gold answer

> The effective tax rate of Corning has changed from 20% in FY2021 to 23% in FY 2022.

### V1 system answer (for HALLU_GROUNDED labeling)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Corning's Effective Tax Rate Change: FY2021 → FY2022

**The effective tax rate increased by +2.7 percentage points**, from **20.2% in FY2021** to **22.9% in FY2022**.

| Year | Effective Tax Rate | Source |
|------|--------------------|--------|
| FY2021 | 20.2% | [Source 10: CORNING_2022_10K.pdf, Page 77] |
| FY2022 | 22.9% | [Source 10: CORNING_2022_10K.pdf, Page 77] |
| **Change** | **+2.7 pp** | |

> **Note on FY2021 figure**: The FY2021 10K reports the rate as **20.5%** [Source 1: CORNING_2021_10K.pdf, Page 29], which would imply a smaller increase of +2.4 pp. The 20.2% figure from the FY2022 10K's comparative reconciliation table is the most internally consistent basis for year-over-year comparison.

### Key Drivers of the Increase [Source 10: CORNING_2022_10K.pdf, Page 77]

| Driver | FY2022 | FY2021 | Change |
|--------|--------|--------|--------|
| Audit settlements & tax reserves | +3.7% | +1.6% | +2.1 pp (unfavorable) |
| Valuation allowance | +2.1% | −0.5% | +2.6 pp (unfavorable) |
| Foreign derived intangible income | −2.7% | −1.3% | −1.4 pp (fav

[... truncated, total 1646 chars]
```

### V1 retrieved chunks (top 5 of 10 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2021 10K | Page 29] ollows (in millions): Year ended December 31, 2021  2020  2019 Provision for income taxes $(491) $(111 ) $(256 )Effective tax rate 20.5%  17.8 %  21.1 ollows (in millions): Year ended December 31, 2021  2020  2019 Provision for income taxes $(491) $(111 ) $(256 )Effective tax rate 20.5%  17.8 %  21.1 % For the year ended December 31, 2021, the effective income tax rate differed from the U.S. statutory rate of 21% primarily due to the following: •A net provision of $52 million due to differences arising from foreign earnings, including the impact of intercompany asset sales;•A net benefit of $37 million related to share-based compensation payments; and•A net benefit of $62 million due to tax credits. For the year ended December 31, 2020, the effective income tax rate ...
```

**Chunk 2:**
```
[FY2022 10K | Page 24] Year ended December 31,   % change
2022   2021   22 vs. 21 Net sales $ 14,189 $ 14,082 1% Gross margin $ 4,506 $ 5,063 (11%)(gross margin %) 32% 36% Selling, general and administrative expenses $ 1,898 $ 1,827 4%(as a % of net sales) 13% 13% Research, development and engineering expenses $ 1,047 $ 995 5%(as a % of net sales) 7% 7% Translated earnings contract gain, net $ 351 $ 354 (1%)(as a % of net sales) 2% 3% Income before income taxes $ 1,797 $ 2,426 (26%)(as a % of net sales) 13% 17% Provision for income taxes $ (411) $ (491) 16%Effective tax rate 23% 20% Net income attributable to Corning Incorporated $ 1,316 $ 1,906 (31%)(as a % of net sales) 9% 14% Comprehensive income attributable to Corning Incorporated $ 661 $ 1,471 (55%)
```

**Chunk 3:**
```
[FY2021 10K | Page 29] Table of Contents Income Before Income Taxes The translation impact of fluctuations in foreign currency exchange rates, including the impact of hedges realized in the current year, positively impacted Corning’s incomebefore income taxes by $134 million in the year ended December 31, 2021, when compared to the same period in 2020. Provision for Income Taxes Our provision for income taxes and the related effective income tax rates were as follows (in millions): Year ended December 31, 2021  2020  2019 Provision for income taxes $(491) $(111 ) $(256 )Effective tax rate 20.5%  17.8 %  21.1
```

**Chunk 4:**
```
[FY2021 10K | Page 86]  )  (1.7 )  (0.6 )Legal entity rationalization (2.2 ) Intercompany loan adjustment 6.2 (0.5 )Non-deductible expenses 1.4 7.0 2.1 Other items, net (0.8  )  (1.7 )  (0.6 )Legal entity rationalization (2.2 ) Intercompany loan adjustment 6.2 (0.5 )Non-deductible expenses 1.4 7.0 2.1 Other items, net (0.8  )  (1.7 )  (0.6 )Legal entity rationalization (2.2 ) Intercompany loan adjustment 6.2 (0.5 )Non-deductible expenses 1.4 7.0 2.1 Other items, net (0.8 )  (0.1 )  (1.0 )Effective income tax rate 20.5 %  17.8 %  21.1 % (1)Includes impact of intercompany asset sales. On September 9, 2020, Corning obtained a 100% controll ing interest in HS LLC and an 80.5% controlling interest in HSO LLC. As a result, the deferred tax liability on theoutside basis difference between book an...
```

**Chunk 5:**
```
[FY2022 10K | Page 32] ment (8) 11 10 0.01 Gain on investments (9) (8) (8) (0.01)Gain on sale of business (10) (53) (41) (0.05)Contingent consideration (11) (32) (25) (0.03) Core performance measures  $ 14,805  $ 2,310  $ 1,794   19.3% $ 2.09
(a) Based upon statutory tax rates in the specific jurisdiction for each event.(b) The calculation of the effective tax rate excludes net income attributable to non-controlling interest of $70 million.
Year ended December 31, 2021
Net income                Income   attributable   Effective        Net    before    to Corning   tax    Per     sales    income taxes   Incorporated   rate (a)(b)   share
As reported - GAAP  $ 14,082  $ 2,426  $ 1,906   20.2% $ 1.28 Preferred stock redemption (c)                   0.90
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `corning`  (display: Corning)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=corning; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Corning FY2022 effective tax rate.
2. Corning FY2021 effective tax rate.
3. Drivers of Corning's FY2022 versus FY2021 effective tax rate change.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Core tax-rate comparison is supported; detailed driver table is not shown in the retrieved chunks.

---
## Record 10 of 75  —  `diag_010`  **[FAILING]**  audit=WRONG_NUMBER

**fb_id:** `financebench_id_00216`
**company:** Verizon
**doc:** VERIZON_2022_10K
**question_type:** domain-relevant

### Question

Does Verizon have a reasonably healthy liquidity profile based on its quick ratio for FY 2022? If the quick ratio is not relevant to measure liquidity, please state that and explain why.

### Gold answer

> No. The quick ratio was approximately 0.54 for Verizon. It indicated that Verizon does not have a healthy liquidity profile.

### V1 system answer (for HALLU_GROUNDED labeling)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Verizon FY 2022 Quick Ratio Analysis

### Confirmed Numerator Components

From the consolidated balance sheet [Source 1: VERIZON_2022_10K.pdf, Page 56]:

| Component | FY 2022 ($ millions) |
|---|---|
| Cash & cash equivalents | $2,605 |
| Accounts receivable, net | $24,506 |
| **Quick Assets Total** | **$27,111** |

*Excluded per quick ratio methodology: Inventories ($2,388M) and Prepaid expenses & other ($8,358M)*

### Denominator: Current Liabilities — Partial Evidence

The consolidated balance sheet page showing **total current liabilities was not retrieved** from the 10-K. Page 81 [Source 2: VERIZON_2022_10K.pdf, Page 81] shows only a **subsidiary/VIE-level** liability schedule (not consolidated), which is not usable as the denominator.

> ⚠️ **Assumption flagged**: Using publicly known Verizon FY 2022 total current liabilities of ~$37,466M (not confirmed from retrieved chunks), the implied quick ratio would be approximately:
> **$27,111M ÷ $37,466M ≈ 0.72x**

---

### Is the Quick Ratio the Right Lens Here?

**The quick ratio is of limited analytical re

[... truncated, total 2842 chars]
```

### V1 retrieved chunks (top 3 of 3 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 56] Consolidated Balance Sheets
Verizon Communications Inc. and Subsidiaries
(dollars in millions, except per share amounts)
At December 31, 2022 2021
Assets
Current assets
Cash and cash equivalents $ 2,605 $ 2,921
Accounts receivable  25,332  24,742
Less Allowance for credit losses  826  896
Accounts receivable, net  24,506  23,846
Inventories  2,388  3,055
Prepaid expenses and other  8,358  6,906
Total current assets  37,857  36,728
Property, plant and equipment  307,689  289,897
Less Accumulated depreciation  200,255  190,201
Property, plant and equipment, net  107,434  99,696
Investments in unconsolidated businesses  1,071  1,061
Wireless licenses  149,796  147,619
Goodwill  28,671  28,603
Other intangible assets, net  11,461  11,677
Operating lease right-of-use asse...
```

**Chunk 2:**
```
[FY2022 10K | Page 81] es and other 1,409 1,094
Other assets 9,894 5,455
Liabilities
Accounts payable and accrued liabilities 22 10
Debt maturing within one year 6,809 5,024 Long-term debt 13,199 9,178
See Note 8 for additional information on certain receivables used to secure asset-backed debt.
81              Verizon 2022 Annual Report on Form 10-K
```

**Chunk 3:**
```
[FY2022 10K | Page 62] ies, primarily consisting of
restricted stock units, included in the computation of diluted earnings per common share for the years ended December 31, 2022, 2021, and 2020, respectively.
Cash, Cash Equivalents and Restricted Cash
We consider all highly liquid investments with an original maturity of 90 days or less when purchased to be cash equivalents.
Cash equivalents are stated at cost, which approximates quoted market value and includes amounts held in money market
funds.
Cash collections on the receivables collateralizing our asset-backed debt securities are required at certain specified times to be
placed into segregated accounts. Deposits to the segregated accounts are considered restricted cash and are included in
Prepaid expenses and other and Other assets i...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `verizon`  (display: Verizon)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=verizon; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Verizon FY2022 quick assets components, including cash and accounts receivable.
2. Verizon FY2022 total current liabilities.
3. Whether quick ratio is a relevant liquidity metric for Verizon.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Numerator components are grounded; denominator estimate and liquidity relevance discussion rely on unsupported information.

---
## Record 11 of 75  —  `diag_011`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_10130`
**company:** Corning
**doc:** CORNING_2020_10K
**question_type:** metrics-generated

### Question

Based on the information provided primarily in the balance sheet and the statement of income, what is FY2020 days payable outstanding (DPO) for Corning? DPO is defined as: 365 * (average accounts payable between FY2019 and FY2020) / (FY2020 COGS + change in inventory between FY2019 and FY2020). Round your answer to two decimal places.

### Gold answer

> 63.86

### V1 system answer (for HALLU_GROUNDED labeling)

```
I don't have enough information to answer this question.

The retrieved chunks contain no source documents with Corning's balance sheet or income statement data for FY2019 or FY2020. Without verified figures for accounts payable, COGS, and inventory from the actual source documents, I cannot produce a reliable DPO calculation.

**Note:** The research agent flagged some commonly cited reference figures (AP FY2020 ≈ $681M, COGS ≈ $6,808M, etc.) that would yield a DPO of approximately 33.59 days, but these **cannot be verified against any retrieved source document** and therefore cannot be presented as a confirmed answer.
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```

```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `corning`  (display: Corning)
- **Auto target_fiscal_year:** `2020`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=corning; override if wrong)

**TARGET_YEAR:** `OK` (auto=2020; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Corning FY2020 accounts payable and FY2019 accounts payable.
2. Corning FY2020 cost of goods sold.
3. Corning FY2020 and FY2019 inventory balances.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Main refusal is grounded in empty retrieval, but the unverified reference figures are not supported by chunks.

---
## Record 12 of 75  —  `diag_012`  **[FAILING]**  audit=PASS_OTHER

**fb_id:** `financebench_id_01484`
**company:** Johnson & Johnson
**doc:** JOHNSON_JOHNSON_2022Q4_EARNINGS
**question_type:** novel-generated

### Question

How did JnJ's US sales growth compare to international sales growth in FY2022?

### Gold answer

> US sales increased 3.0% vs international sales decline of 0.6%.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## J&J FY2022: US vs. International Sales Growth

### As-Reported (Total) Growth

| Geography | As-Reported Growth | Operational Growth | Currency Impact |
|---|---|---|---|
| **US** | **+3.3%** | +3.3% | — |
| **International** | **−0.2%** | +10.0% | −10.2% |
| **Worldwide** | +1.6% | +6.5% | −4.9% |

[Source 4: JOHNSON_JOHNSON_2023_8K_dated-2023-08-30.pdf, Page 18; Source 6: JOHNSON_JOHNSON_2023_8K_dated-2023-08-30.pdf, Page 11]

In absolute terms, US sales were **$41,981M in FY2022 vs. $40,640M in FY2021** (+$1,341M). [Source 6, Page 11]

---

### Segment-Level Breakdown (As-Reported, FY2022)

| Segment | US Growth | International Growth |
|---|---|---|
| Consumer Health | +1.3% | −1.9% |
| Pharmaceutical | +2.3% | +1.0% |
| MedTech | +5.4% | −2.3% |
| **Total Company** | **+3.0%** | **−0.6%** |

[Source 8: JOHNSON_JOHNSON_2022Q4_EARNINGS.pdf, Page 14]

> *Note: A minor discrepancy exists between the geographic-area basis (+3.3% US, Source 6) and the segment-reconciliation basis (+3.0% US, Source 8); both are valid representations of FY2022.*

---

### Key Insight: Currency Distorts the Picture

- **On an as-reported basis**, US outperformed International by ~**3.5 percentage po

[... truncated, total 1916 chars]
```

### V1 retrieved chunks (top 5 of 9 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 9] Johnson & Johnson and Subsidiaries
Supplementary Sales Data
(Unaudited; Dollars in Millions)
Percent Change
2022 2021 Total Operations Currency 2022 2021 Total Operations Currency
Sales to customers by
geographic area
U.S. 12,516$      12,163        2.9             % 2.9             -                 48,580$      47,156        3.0             % 3.0             -
Europe 5,816          6,925          (16.0) (6.3)            (9.7)            23,449        23,594        (0.6)            11.0           (11.6)
Western Hemisphere excluding U.S. 1,545          1,459          5.9             11.8           (5.9)            6,125          5,750          6.5             10.2           (3.7)
```

**Chunk 2:**
```
[FY2022 10K | Page 8] Johnson & Johnson and Subsidiaries
Supplementary Sales Data
(Unaudited; Dollars in Millions)
Percent Change
2022 2021 Total Operations Currency 2022 2021 Total Operations Currency
Sales to customers by
segment of business
Consumer Health (1)
U.S. 1,696$        1,529          10.9           % 10.9           -                 6,599$        6,516          1.3             % 1.3             -
International 2,071          2,199          (5.8)            3.2             (9.0)            8,354          8,519          (1.9)            5.3             (7.2)
3,767           3,728          1.0             6.4             (5.4)            14,953         15,035        (0.5)            3.6             (4.1)
Pharmaceutical (1)
```

**Chunk 3:**
```
[FY2023 10K | Page 8] Johnson & Johnson and Subsidiaries
Supplementary Sales Data
(Unaudited; Dollars in Millions)
Percent Change
2023 2022 Total Operations Currency 2023 2022 Total Operations Currency
Sales to customers by
segment of business
Consumer Health
U.S. 1,787$        1,687      6.0      % 6.0              -               3,522$     3,244      8.6      % 8.6              -
International 2,224          2,118      5.0      9.0              (4.0)          4,341       4,147      4.7      10.1            (5.4)
4,011           3,805     5.4      7.7              (2.3)          7,863        7,391     6.4      9.5              (3.1)
Pharmaceutical (1)
U.S. 7,818          7,159      9.2      9.2              -               14,841     13,791    7.6      7.6              -
```

**Chunk 4:**
```
[FY2023 8K | Page 18] Johnson & Johnson andSubsidiaries
Reconciliation of Non-GAAP FinancialMeasure
Adjusted Operational Sales Growth
2022 ACTUAL vs. 2021 ACTUAL
Q1 Q2 SIXMONTHS Q3 NINEMONTHS Q4 TWELVEMONTHS
WW As Reported 6.2 % 3.9 % 5.0 % 2.4 % 4.1 % (5.4)% 1.6 %
U.S. 3.8 % 3.4 % 3.6 % 4.4 % 3.8 % 1.7 % 3.3 %
International 8.7 % 4.5 % 6.6 % 0.1 % 4.5 % (12.7)% (0.2)%
WW Currency (2.9) (5.2) (4.1) (6.3) (4.8) (5.3) (4.9)
U.S. — — — — — — —
International (5.8) (10.9) (8.4) (13.5) (10.0) (10.8) (10.2)
WW Operational 9.1 % 9.1 % 9.1 % 8.7 % 8.9 % (0.1)% 6.5 %
U.S. 3.8 % 3.4 % 3.6 % 4.4 % 3.8 % 1.7 % 3.3 %
International 14.5 % 15.4 % 15.0 % 13.6 % 14.5 % (1.9)% 10.0 %
Abiomed (0.1)
U.S. (0.3)
International 0.0
All Other Acquisitions andDivestitures 0.0 0.1 0.1 0.1 0.1 0.1 0.0
U.S. 0.0 0.1 0.0...
```

**Chunk 5:**
```
[FY2022 10K | Page 30] Pharmaceutical Segment
Pharmaceutical segment sales in 2022 were $52.6 billion, an increase of 1.7% from 2021, which included operational growth of 6.7% and a negative
currency impact of 5.0%. U.S. sales were $28.6 billion, an increase of 2.3%. International sales were $24.0 billion, an increase of 1.0%, which included
11.9% operational growth and a negative currency impact of 10.9%. In 2022, acquisitions and divestitures had a net negative impact of 0.1% on the
operational sales growth of the worldwide Pharmaceutical segment. Adjustments to previous sales reserve estimates were approximately $0.1 billion and
$0.7 billion in fiscal years 2022 and 2021, respectively.
Major Pharmaceutical Therapeutic Area Sales*:
Total Operations Currency
(Dollars in Millions) 2022 202...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `johnson_johnson`  (display: Johnson & Johnson)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=johnson_johnson; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Johnson & Johnson FY2022 U.S. sales growth.
2. Johnson & Johnson FY2022 international sales growth.
3. Johnson & Johnson FY2022 segment-level U.S. and international sales growth, if needed to reconcile bases.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Some geography and segment claims are supported, but several cited figures/sources are not in the shown chunks.

---
## Record 13 of 75  —  `diag_013`  **[FAILING]**  audit=PARTIAL_ANSWER

**fb_id:** `financebench_id_00222`
**company:** AMD
**doc:** AMD_2022_10K
**question_type:** domain-relevant

### Question

Does AMD have a reasonably healthy liquidity profile based on its quick ratio for FY22? If the quick ratio is not relevant to measure liquidity, please state that and explain why.

### Gold answer

> Yes. The quick ratio is 1.57, calculated as (cash and cash equivalents+Short term investments+Accounts receivable, net+receivables from related parties)/ (current liabilities).

### V1 system answer (for HALLU_GROUNDED labeling)

```
## AMD FY22 Quick Ratio & Liquidity Assessment

### What We Know from the Balance Sheet

[Source: AMD_2022_10K.pdf, Page 56]

| Component | FY2022 ($M) |
|---|---|
| Cash & cash equivalents | $4,835 |
| Short-term investments | $1,020 |
| Accounts receivable, net | $4,126 |
| Receivables from related parties | $2 |
| **Quick Assets Total** | **$9,983** |
| Inventories (excluded) | $3,771 |
| Prepaid expenses (excluded) | $1,265 |
| Total current assets | $15,019 |
| **Current liabilities** | **NOT FOUND** |

---

### Is the Quick Ratio Relevant for AMD?

**Yes — the quick ratio is a meaningful metric for AMD.** Here's why:

- AMD is a **fabless semiconductor company**, meaning it outsources manufacturing. Its inventories ($3,771M) represent ~**25% of total current assets** — a non-trivial portion that may not be immediately convertible to cash (semiconductor inventory can become obsolete or require time to liquidate).
- Excluding inventories and prepaid expenses ($1,265M) from the liquidity assessment gives a more conservative and arguably more accurate picture of AMD's ability to meet near-term obligations.

---

### Can the Quick Ratio Be Computed?

**Partially.** The quick asset

[... truncated, total 2756 chars]
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 56] Table of Contents
Advanced Micro Devices, Inc.
Consolidated Balance Sheets
December 31,2022 December 25,2021
(In millions, except par value amounts)
ASSETSCurrent assets:
Cash and cash equivalents $ 4,835 $ 2,535 Short-term investments 1,020 1,073 Accounts receivable, net 4,126 2,706
Inventories 3,771 1,955 Receivables from related parties 2 2 Prepaid expenses and other current assets 1,265 312
Total current assets 15,019 8,583
Property and equipment, net 1,513 702 Operating lease right-of-use assets 460 367 Goodwill 24,177 289
Acquisition-related intangibles 24,118 — Investment: equity method 83 69 Deferred tax assets 58 931
Other non-current assets 2,152 1,478
Total assets $ 67,580 $ 12,419
LIABILITIES AND STOCKHOLDERS’ EQUITY
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `amd`  (display: AMD)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=amd; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. AMD FY2022 quick assets components: cash, short-term investments, accounts receivable, and related-party receivables.
2. AMD FY2022 total current liabilities.
3. Whether quick ratio is a relevant liquidity metric for AMD.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Quick-asset components are grounded; current liabilities are missing and the relevance discussion is not fully supported by retrieved chunks.

---
## Record 14 of 75  —  `diag_014`  **[FAILING]**  audit=DATASET_SUSPECT

**fb_id:** `financebench_id_01902`
**company:** Best Buy
**doc:** BESTBUY_2024Q2_10Q
**question_type:** novel-generated

### Question

Which Best Buy product category performed the best (by top line) in the domestic (USA) Market during Q2 of FY2024?

### Gold answer

> The entertainment segment experienced the highest growth of 9% during Q2 FY2024, primarily from gaming division.

### V1 system answer (for HALLU_GROUNDED labeling)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Best Buy Domestic Segment — Q2 FY2024 Revenue by Product Category

| Rank | Product Category | Revenue (Q2 FY2024) | Revenue Mix |
|------|-----------------|-------------------|-------------|
| 1 | **Computing and Mobile Phones** | **$3,674M** | **41%** |
| 2 | Consumer Electronics | $2,658M | 30% |
| 3 | Appliances | $1,384M | 16% |
| 4 | Services | $550M | 6% |
| 5 | Entertainment | $544M | 6% |
| 6 | Other | $80M | 1% |
| — | **Total Domestic** | **$8,890M** | **100%** |

[Source: BESTBUY_2024Q2_10Q.pdf, Page 13; revenue mix percentages confirmed at Page 17]

---

**Bottom line:** **Computing and Mobile Phones** was the top-performing domestic product category in Q2 FY2024 (three months ended July 29, 2023), generating **$3,674 million** in revenue — representing 41% of total Domestic revenue of $8,890 million, and outpacing the next largest category (Consumer Electronics at $2,658M) by over $1 billion.
```

### V1 retrieved chunks (top 4 of 4 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2024 10Q | Page 13]  Condensed Consolidated Financial Statements. 11. Segments Reportable segment and product category revenue information was as follows ($ in millions): Three Months Ended  Six Months Ended
July 29, 2023  July 30, 2022  July 29, 2023  July 30, 2022
Revenue by reportable segment
Domestic     $  8,890   $  9,569   $  17,691   $  19,463
International       693     760     1,359     1,513
Total revenue     $  9,583   $  10,329   $  19,050   $  20,976
Revenue by product category
Domestic:
Computing and Mobile Phones     $  3,674   $  3,964   $  7,362   $  8,249
Consumer Electronics       2,658     2,845     5,250     5,741
Appliances       1,384     1,657     2,723     3,247
Entertainment       544     508     1,135     1,081
Services       550     516     1,087     1,005
O...
```

**Chunk 2:**
```
[FY2023 10K | Page 63] 2023  2022  2021
Revenue by product category
Domestic:
Computing and Mobile Phones $  18,191   $  20,693   $  19,799
Consumer Electronics   13,040     15,009     13,022
Appliances   6,381     6,784     5,489
Entertainment   2,786     2,963     2,769
Services   2,149     2,190     2,082
Other   247     191     132
Total Domestic revenue $  42,794   $  47,830   $  43,293
International:
Computing and Mobile Phones $  1,575   $  1,785   $  1,854
Consumer Electronics   1,054     1,194     1,189
Appliances   355     383     384
Entertainment   267     312     310
Services   183     190     170
Other   70     67     62
Total International revenue $  3,504   $  3,931   $  3,969
```

**Chunk 3:**
```
[FY2024 10Q | Page 17]  -    20     21     -    -    21
Yardbird   18     4     -    22     9     4     -    13
Total   966     5     (2)    969     977     7     (2)    982 We continuously monitor store performance as part of a market-driven, omnichannel strategy. As we approach the expiration of leases, we evaluate various options for each location, including whether a store should remain open. We currently expect to close a total of 20 to 30 Best Buy stores and open approximately 5 Outlet Centers in fiscal 2024. Domestic segment revenue mix percentages and comparable sales percentage changes by revenue category were as follows:
Revenue Mix    Comparable Sales
Three Months Ended    Three Months Ended
July 29, 2023  July 30, 2022  July 29, 2023  July 30, 2022
Computing and Mobile Phones  ...
```

**Chunk 4:**
```
[FY2024 10Q | Page 19] ages and comparable sales percentage changes by revenue category were as follows:
Revenue Mix  Comparable Sales
Three Months Ended  Three Months Ended July 29, 2023  July 30, 2022  July 29, 2023  July 30, 2022
Computing and Mobile Phones   45 %   43 %   (2.4)%   (7.6)%
Consumer Electronics   28 %   29 %   (10.4)%   (4.8)%
Appliances   13 %   14 %   (6.1)%   6.8 %
Entertainment   7 %   7 %   2.5 %   (5.8)%
Services   5 %   5 %   4.6 %   (0.4)%
Other   2 %   2 %   (38.1)%   12.6 %
Total   100 %   100 %   (5.4)%   (4.2)%
Notable comparable sales changes by revenue category were as follows:
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `best_buy`  (display: Best Buy)
- **Auto target_fiscal_year:** `2024`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=best_buy; override if wrong)

**TARGET_YEAR:** `OK` (auto=2024; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Best Buy Domestic Q2 FY2024 revenue by product category.
2. Best Buy Domestic Q2 FY2024 comparable sales or growth by product category.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Answer is grounded in the retrieved product-category table, even though the gold appears to use growth rather than absolute top-line.

---
## Record 15 of 75  —  `diag_015`  **[FAILING]**  audit=WRONG_NUMBER

**fb_id:** `financebench_id_02987`
**company:** Activision Blizzard
**doc:** ACTIVISIONBLIZZARD_2019_10K
**question_type:** metrics-generated

### Question

What is the FY2019 fixed asset turnover ratio for Activision Blizzard? Fixed asset turnover ratio is defined as: FY2019 revenue / (average PP&E between FY2018 and FY2019). Round your answer to two decimal places. Base your judgments on the information provided primarily in the statement of income and the statement of financial position.

### Gold answer

> 24.26

### V1 system answer (for HALLU_GROUNDED labeling)

```
## FY2019 Fixed Asset Turnover Ratio — Activision Blizzard

### Confirmed Data

| Item | Value | Source |
|------|-------|--------|
| FY2019 Total Net Revenues | $6,489M | [Source 1: ACTIVISIONBLIZZARD_2019_10K.pdf, Page 70] |
| FY2019 Net PP&E | **Not confirmed in retrieved chunks** | Balance sheet not retrieved |
| FY2018 Net PP&E | **Not confirmed in retrieved chunks** | Balance sheet not retrieved |

### Assessment

The **revenue figure is confirmed**: FY2019 Total Net Revenues = **$6,489 million** [Source 1: ACTIVISIONBLIZZARD_2019_10K.pdf, Page 70].

However, the **PP&E figures from the balance sheet (statement of financial position) were not present in any of the retrieved chunks**. The research agent notes commonly reported figures of ~$253M (FY2019) and ~$267M (FY2018), but these are **unverified against the actual document** and cannot be cited with a source.

### Partial Computation (flagged as unverified)

If the PP&E figures noted by the research agent are accurate:
- Average PP&E = ($267M + $253M) / 2 = **$260M**
- Fixed Asset Turnover = $6,489M / $260M ≈ **24.96**

⚠️ **This result carries significant uncertainty** because the PP&E values have not been verified from 

[... truncated, total 1694 chars]
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 70] Table of Contents
ACTIVISION BLIZZARD, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF OPERATIONS(Amounts in millions, except per share data)
For the Years Ended December 31,
2019  2018  2017
Net revenues
Product sales $ 1,975  $ 2,255  $ 2,110
Subscription, licensing, and other revenues 4,514  5,245  4,907
Total net revenues 6,489  7,500  7,017
Costs and expenses
Cost of revenues—product sales:
Product costs 656  719  733
Software royalties, amortization, and intellectual property licenses 240  371  300
Cost of revenues—subscription, licensing, and other revenues:
Game operations and distribution costs 965  1,028  984
Software royalties, amortization, and intellectual property licenses 233  399  484
Product development 998  1,101  1,069
Sales and marketing 926  1,062  1,37...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `activision_blizzard`  (display: Activision Blizzard)
- **Auto target_fiscal_year:** `2019`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=activision_blizzard; override if wrong)

**TARGET_YEAR:** `OK` (auto=2019; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Activision Blizzard FY2019 total net revenues.
2. Activision Blizzard FY2019 net PP&E.
3. Activision Blizzard FY2018 net PP&E.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Revenue is grounded; PP&E inputs and the final ratio rely on unverified figures outside the retrieved chunk.

---
## Record 16 of 75  —  `diag_016`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_01319`
**company:** AES Corporation
**doc:** AES_2022_10K
**question_type:** domain-relevant

### Question

What is the quantity of restructuring costs directly outlined in AES Corporation's income statements for FY2022? If restructuring costs are not explicitly outlined then state 0.

### Gold answer

> 0

### V1 system answer (for HALLU_GROUNDED labeling)

```
I couldn't find relevant information in the available documents to answer your question.
This could mean the information isn't in the documents I have access to, or the question
may need to be rephrased. Could you try asking in a different way?
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```

```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `aes_corporation`  (display: AES Corporation)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=aes_corporation; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Empty retrieval; refusal is grounded.

---
## Record 17 of 75  —  `diag_017`  **[FAILING]**  audit=DATASET_SUSPECT

**fb_id:** `financebench_id_00460`
**company:** Best Buy
**doc:** BESTBUY_2024Q2_10Q
**question_type:** novel-generated

### Question

Was there any change in the number of Best Buy stores between Q2 of FY2024 and FY2023?

### Gold answer

> Yes, there is decline in number stores by 1.32% from 982 stores in Q2 FY 2023 to 969 by the end of Q2 FY2024.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Change in Best Buy Store Count: Q2 FY2024 vs. Q2 FY2023

### Domestic Segment (Best Buy Banner)

| Metric | Q2 FY2024 (ended Jul 29, 2023) | Q2 FY2023 (ended Jul 30, 2022) | Change |
|---|---|---|---|
| Best Buy stores (end of quarter) | 907 | 930 | **−23 stores** |

[Source: BESTBUY_2024Q2_10Q.pdf, Page 17]

During Q2 FY2024, Best Buy opened **0** stores and closed **1**, ending at 907. In Q2 FY2023, it opened **1** and closed **2**, ending at 930. The net year-over-year decline of 23 stores is consistent with management's stated plan to close **20–30 large-format Best Buy stores** in fiscal 2024. [Source: BESTBUY_2024Q2_10Q.pdf, Pages 15 & 17]

---

### International Segment (Canada — Best Buy Banner)

| Metric | Q2 FY2024 | Q2 FY2023 | Change |
|---|---|---|---|
| Best Buy Canada stores (end of quarter) | 128 | 127 | **+1 store** |

[Source: BESTBUY_2024Q2_10Q.pdf, Page 19]

---

**Bottom line:** Yes — domestically, the Best Buy banner shrank by **23 stores** year-over-year (930 → 907), while in Canada it grew by **1 store** (127 → 128), for a combined net change of **−22 stores** globally between Q2 FY2023 and Q2 FY2024.
```

### V1 retrieved chunks (top 5 of 8 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2024 10Q | Page 17] ere as follows:
Fiscal 2024  Fiscal 2023
Total Stores at Beginning of Second Quarter
Stores Opened
Stores Closed
Total Stores at End of Second Quarter Total Stores at Beginning of Second Quarter
Stores Opened
Stores Closed
Total Stores at End of Second Quarter
Best Buy   908     -    (1)    907     931     1     (2)    930
Outlet Centers   20     1     (1)    20     16     2     -    18
Pacific Sales   20     -    -    20     21     -    -    21
Yardbird   18     4     -    22     9     4     -    13
Total   966     5     (2)    969     977     7     (2)    982
```

**Chunk 2:**
```
[10K | Page 26] stores Domestic 1,363 1,415 1,448 1,495 1,503International 212 216 283 284 276Total 1,575 1,631 1,731 1,779 1,779Retail square footage (000s) Domestic stores Domestic 1,363 1,415 1,448 1,495 1,503International 212 216 283 284 276Total 1,575 1,631 1,731 1,779 1,779Retail square footage (000s) Domestic stores Domestic 1,363 1,415 1,448 1,495 1,503International 212 216 283 284 276Total 1,575 1,631 1,731 1,779 1,779Retail square footage (000s) Domestic 40,828 41,216 41,716 42,051 42,232International 4,511 4,543 6,470 6,636 6,613Total 45,339 45,759 48,186 48,687 48,845(1)Included within net earnings (loss) from continuing operations and net earnings (loss) attributable to Best Buy Co., Inc. shareholders for fiscal 2017 includes $161 million ($100 million netof taxes) due to cath...
```

**Chunk 3:**
```
[FY2024 10Q | Page 17]  -    20     21     -    -    21
Yardbird   18     4     -    22     9     4     -    13
Total   966     5     (2)    969     977     7     (2)    982 We continuously monitor store performance as part of a market-driven, omnichannel strategy. As we approach the expiration of leases, we evaluate various options for each location, including whether a store should remain open. We currently expect to close a total of 20 to 30 Best Buy stores and open approximately 5 Outlet Centers in fiscal 2024. Domestic segment revenue mix percentages and comparable sales percentage changes by revenue category were as follows:
Revenue Mix    Comparable Sales
Three Months Ended    Three Months Ended
July 29, 2023  July 30, 2022  July 29, 2023  July 30, 2022
Computing and Mobile Phones  ...
```

**Chunk 4:**
```
[FY2024 10Q | Page 19] Table of Contents International segment stores open at the beginning and end of the second quarters of fiscal 2024 and fiscal 2023 were as follows:
Fiscal 2024  Fiscal 2023
Total Stores at Beginning of Second Quarter  Stores Opened  Stores Closed
Total Stores at End of Second Quarter
Total Stores at Beginning of Second Quarter  Stores Opened  Stores Closed
Total Stores at End of Second Quarter
Canada
Best Buy   127     1     -    128     127     -    -    127
Best Buy Mobile   32     -    -    32     33     -    -    33
Total   159     1     -    160     160     -    -    160
International segment revenue mix percentages and comparable sales percentage changes by revenue category were as follows:
Revenue Mix  Comparable Sales
Three Months Ended  Three Months Ended
```

**Chunk 5:**
```
[FY2023 10K | Page 26] tic segment stores   991    13    (20)   984    9    (15)   978
(1) Excludes stores that were temporarily closed as a result of the COVID-19 pandemic. We continuously monitor store performance as part of a market-driven, omnichannel strategy. As we approach the expiration of leases, we evaluate various options for each location, including whether a store should remain open. In fiscal 2024, we currently expect to close approximately 20 to 30 Best Buy stores and to increase the number of Outlet Centers to approximately 30. Domestic segment revenue mix percentages and comparable sales percentage changes by revenue category were as follows:
Revenue Mix Summary  Comparable Sales Summary
2023  2022  2023  2022
Computing and Mobile Phones  43 %   44 %   (12.0)%   5.1 %
Cons...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `best_buy`  (display: Best Buy)
- **Auto target_fiscal_year:** `2024`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=best_buy; override if wrong)

**TARGET_YEAR:** `OK` (auto=2024; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Best Buy Q2 FY2024 ending store count.
2. Best Buy Q2 FY2023 ending store count.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Claims are supported by the retrieved domestic and international store-count tables.

---
## Record 18 of 75  —  `diag_018`  **[PASSING]**

**fb_id:** `financebench_id_00822`
**company:** Foot Locker
**doc:** FOOTLOCKER_2022_8K_dated-2022-05-20
**question_type:** novel-generated

### Question

Were there any board member nominees who had substantially more votes against joining than the other nominees?

### Gold answer

> Yes, his name is Richard A. Johnson

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Board Nominee Vote Analysis

### Foot Locker — 2022 Annual Meeting

[Source: FOOTLOCKER_2022_8K_dated-2022-05-20.pdf, Page 2]

| Nominee | Votes Against |
|---|---|
| Virginia C. Drosos | 294,935 |
| Tristan Walker | 4,419,340 |
| Steven Oakland | 4,524,393 |
| Darlene Nicosia | 4,827,808 |
| Kimberly Underhill | 4,906,500 |
| Ulice Payne, Jr. | 4,950,917 |
| Alan D. Feldman | 5,184,437 |
| Guillermo G. Marmol | 5,753,395 |
| Dona D. Young | 6,074,467 |
| **Richard A. Johnson** | **16,105,005** |

**Richard A. Johnson** stands out dramatically — his 16.1M votes against is roughly **2.6× the next highest** (Young at 6.1M) and over **54× the lowest** (Drosos at ~295K). All other nominees clustered between ~295K and ~6.1M.

---

### PepsiCo — 2023 Annual Meeting

[Source: PEPSICO_2023_8K_dated-2023-05-05.pdf, Page 3]

| Nominee | Votes Against |
|---|---|
| Jennifer Bailey | 4,200,722 |
| Susan M. Diamond | 4,427,794 |
| Edith W. Cooper | 7,917,877 |
| Dave J. Lewis | 11,070,996 |
| Segun Agbaje | 12,334,137 |
| David C. Page, MD | 14,249,896 |
| Darren Walker | 16,593,233 |
| Michelle Gass | 17,641,092 |
| Cesar Conde | 21,945,852 |
| Dina Dublon | 32,153,405 |
| Alberto Weisser |

[... truncated, total 2085 chars]
```

### V1 retrieved chunks (top 4 of 4 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 8K | Page 2]  Annual Meeting. At the Annual Meeting, 77,551,206 shares of Common Stock
were represented in person or by proxy and, therefore, a quorum was present. Proposal 1. With respect to the proposal to elect ten nominees to the Board of Directors (the “Board”), each for a one-year term expiring at the
annual meeting of shareholders to be held in 2023, the votes were cast for the proposal as set forth below:
Name  Votes For Votes Against Abstentions Broker Non-Votes
Virginia C. Drosos  59,657,810 294,935  10,714,238  6,884,223
Alan D. Feldman  54,760,830 5,184,437  10,721,716  6,884,223
Richard A. Johnson  54,484,293 16,105,005  77,685  6,884,223
Guillermo G. Marmol  54,193,921 5,753,395  10,719,667  6,884,223
Darlene Nicosia  55,123,930 4,827,808  10,715,245  6,884,223
Steven...
```

**Chunk 2:**
```
[FY2023 8K | Page 3] Item 5.07. Submission of Matters to a Vote of Security Holders.
PepsiCo, Inc. (“PepsiCo”) held its 2023 Annual Meeting of Shareholders on May 3, 2023. For more information on the following proposals, see PepsiCo’s
proxy statement for the 2023 Annual Meeting of Shareholders, filed with the Securities and Exchange Commission on March 21, 2023. Below are the final
voting results.
(1) The following 15 persons were elected to serve as directors of PepsiCo:
Nominee For Against Abstain Broker Non-Votes
Segun Agbaje 1,005,178,935 12,334,137 2,634,817 172,969,325
Jennifer Bailey 1,013,605,781 4,200,722 2,341,386 172,969,325
Cesar Conde 995,535,275 21,945,852 2,666,762 172,969,325
Ian Cook 970,556,463 46,852,800 2,738,626 172,969,325
Edith W. Cooper 1,009,691,687 7,917,877 2,538...
```

**Chunk 3:**
```
[FY2022 8K | Page 2] 7,808  10,715,245  6,884,223
Steven Oakland  55,421,657 4,524,393  10,720,933  6,884,223
Ulice Payne, Jr.  54,993,396 4,950,917  10,722,670  6,884,223 Kimberly Underhill  55,046,260 4,906,500  10,714,223  6,884,223
Tristan Walker  55,528,794 4,419,340  10,718,849  6,884,223
Dona D. Young  53,876,257 6,074,467  10,716,259  6,884,223
Based on the votes set forth above, each of the ten nominees to the Board was duly elected.
Proposal 2. With respect to the proposal to approve, on an advisory basis, the Company’s named executive officers’ (“NEOs”) compensation, the
votes were cast for the proposal as set forth below:
Votes For  Votes Against  Abstentions  Broker Non-Votes
57,172,731  13,324,080  170,172  6,884,223
Based on the votes set forth above, the NEOs’ compensation ...
```

**Chunk 4:**
```
[FY2023 8K | Page 3] 5 21,945,852 2,666,762 172,969,325
Ian Cook 970,556,463 46,852,800 2,738,626 172,969,325
Edith W. Cooper 1,009,691,687 7,917,877 2,538,325 172,969,325 Susan M. Diamond 1,013,305,062 4,427,794 2,415,033 172,969,325
Dina Dublon 985,425,035 32,153,405 2,569,449 172,969,325
Michelle Gass 1,000,092,389 17,641,092 2,414,408 172,969,325
Ramon L. Laguarta 943,626,804 69,085,058 7,436,027 172,969,325
Dave J. Lewis 1,006,427,071 11,070,996 2,649,822 172,969,325
David C. Page, MD 1,003,283,751 14,249,896 2,614,242 172,969,325
Robert C. Pohlad 979,380,661 38,117,910 2,649,318 172,969,325
Daniel Vasella, MD 955,503,117 61,979,746 2,665,026 172,969,325
Darren Walker 1,000,905,148 16,593,233 2,649,508 172,969,325
Alberto Weisser 981,592,374 35,889,239 2,666,276 172,969,325
(2) The sh...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `foot_locker`  (display: Foot Locker)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=foot_locker; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Foot Locker 2022 annual meeting votes against for each board nominee.
2. Identify which nominee had substantially more votes against than the other nominees.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 19 of 75  —  `diag_019`  **[FAILING]**  audit=WRONG_NUMBER

**fb_id:** `financebench_id_03849`
**company:** MGM Resorts
**doc:** MGMRESORTS_2020_10K
**question_type:** metrics-generated

### Question

What is the FY2018 - FY2020 3 year average of capex as a % of revenue for MGM Resorts? Answer in units of percents and round to one decimal place. Please utilize information provided primarily within the statement of cash flows and the statement of income.

### Gold answer

> 7.9%

### V1 system answer (for HALLU_GROUNDED labeling)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## MGM Resorts: FY2018–FY2020 Average Capex as % of Revenue

### Capex Figures (from segment capex tables / cash flow disclosures)

| Year | Capex ($ thousands) | Source |
|------|-------------------|--------|
| FY2018 | $1,486,843 | [Source: MGMRESORTS_2018_10K.pdf, Page 92] & [Source: MGMRESORTS_2020_10K.pdf, Page 102] |
| FY2019 | $739,006 | [Source: MGMRESORTS_2020_10K.pdf, Page 102] |
| FY2020 | $270,579 | [Source: MGMRESORTS_2020_10K.pdf, Page 102] |

### Revenue Figures (from statement of income)

The retrieved chunks do not directly quote the income statement revenue lines. The research synthesis provides the following widely reported net revenue figures:

| Year | Net Revenue ($ thousands) |
|------|--------------------------|
| FY2018 | $12,899,672 |
| FY2019 | $12,902,958 |
| FY2020 | $5,162,085 |

> ⚠️ **Note**: Revenue figures were not directly quoted in the retrieved source chunks. These are based on MGM Resorts' publicly reported financials referenced in the research synthesis. The capex figures are fully confirmed by source documents.

### Calcul

[... truncated, total 1918 chars]
```

### V1 retrieved chunks (top 4 of 4 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 102] Year Ended December 31, 2020 2019 2018 Capital expenditures: (In thousands) Las Vegas Strip Resorts $87,511  $285,863  $501,044 Regional Operations 41,456   187,489   72,865 MGM China 108,352   145,634   390,212 Reportable segment capital expenditures 237,319   618,986   964,121 Corporate and other 33,260   120,020   537,347 Eliminated in consolidation — — (14,625) $270,579  $739,006  $1,486,843 Total assets are not allocated to segments for internal reporting presentations or when determining the allocation of resources and, accordingly, are
```

**Chunk 2:**
```
[10K | Page 92] ber
31,
2018
2017
2016
Property
and
equipment,
net:
(In thousands)   Las Vegas Strip Resorts
$10,605,454  $10,568,296  $10,568,317 Regional Operations 4,503,104   3,752,528   3,785,654 MGM China  3,818,460   3,827,391   2,857,626 Reportable segment property and equipment, net  18,927,018   18,148,215   17,211,597 Corporate and other  1,887,619   1,557,368   1,268,622 Eliminated in consolidation  (84,749)  (70,124)  (55,196)  $20,729,888  $19,635,459  $18,425,023
Year
Ended
December
31,
2018
2017
2016
Capital
expenditures: (In thousands)   Las Vegas Strip Resorts $501,044  $419,983  $288,526 Regional Operations  72,865   66,628   29,425 MGM China  390,212   923,346   984,355 Reportable segment capital expenditures  964,121   1,409,957   1,302,306 Corporate and other  537,347...
```

**Chunk 3:**
```
[10K | Page 46] l  Harbor,partially offset by increased expenditures for MGM Springfield and the rebranding of Park MGM, as discussed in further detail below. Capital Expenditures In 2018, we had capital expenditures of $1.5 billion, of which $376 million related to MGM China, excluding development fees and capitalized interest ondevelopment fees eliminated in consolidation. Capital expenditures at MGM China included $340 million related to the construction of MGM Cotai and $36 millionrelated to projects at MGM Macau. Capital expenditures at our Las Vegas Strip Resorts, Regional Operations and corporate entities of $1.1 billion included $368million related to the construction of MGM Springfield, $228 million related to the Park MGM rebranding project, as well as expenditures relating to th...
```

**Chunk 4:**
```
[10K | Page 52] anding at Park MGM, and the expansion of the convention center at MGM Grand Las Vegas in the prior year, as discussed in further detail below. Capital anding at Park MGM, and the expansion of the convention center at MGM Grand Las Vegas in the prior year, as discussed in further detail below. Capital Expenditures In 2020, we made capital expenditures of $271 million, of which $108 million related to MGM China. Capital expenditures at MGM China included $95million primarily related to construction close-out and projects at MGM Cotai and $13 million related to projects at MGM Macau. Capital expenditures at our LasVegas Strip Resorts, Regional Operations and corporate entities of $162 million included expenditures relating to information technology, health and safetyinitiative...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `mgm_resorts`  (display: MGM Resorts)
- **Auto target_fiscal_year:** `2020`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=mgm_resorts; override if wrong)

**TARGET_YEAR:** `OK` (auto=2020; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. MGM Resorts FY2018, FY2019, and FY2020 capital expenditures.
2. MGM Resorts FY2018, FY2019, and FY2020 revenue.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Capex figures are grounded; revenue inputs and final average are not directly supported by retrieved chunks.

---
## Record 20 of 75  —  `diag_020`  **[PASSING]**

**fb_id:** `financebench_id_04254`
**company:** American Water Works
**doc:** AMERICANWATERWORKS_2021_10K
**question_type:** metrics-generated

### Question

Basing your judgments off of the cash flow statement and the income statement, what is American Water Works's FY2021 unadjusted operating income + depreciation and amortization from the cash flow statement (unadjusted EBITDA) in USD millions?

### Gold answer

> $1832.00

### V1 system answer (for HALLU_GROUNDED labeling)

```
## American Water Works FY2021 Unadjusted EBITDA

### Key Components

| Item | FY2021 Value | Source |
|------|-------------|--------|
| Operating Income | $1,196M | [Source 2: AMERICANWATERWORKS_2021_10K.pdf, Page 86]; confirmed [Source 1: AMERICANWATERWORKS_2022_10K.pdf, Page 83] |
| Depreciation & Amortization (Cash Flow Statement) | $636M | [Source 3: AMERICANWATERWORKS_2021_10K.pdf, Page 88]; confirmed [Source 5: AMERICANWATERWORKS_2022_10K.pdf, Page 85] |

### Calculation

$$\text{Unadjusted EBITDA} = \$1{,}196M + \$636M = \textbf{\$1,832 million}$$

> **Note:** The D&A figure used ($636M) is drawn directly from the Cash Flow Statement's operating activities reconciliation, consistent with the question's specification. This figure also matches the D&A line on the Income Statement, confirming internal consistency across both statements.

---

**Bottom line:** American Water Works's FY2021 unadjusted EBITDA (Operating Income + D&A from the cash flow statement) was **$1,832 million USD**.
```

### V1 retrieved chunks (top 5 of 6 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 83] Table of Contents
American Water Works Company, Inc. and Subsidiary Companies
Consolidated Statements of Operations
(In millions, except per share data)
For the Years Ended December 31,
2022 2021 2020
Operating revenues $ 3,792 $ 3,930 $ 3,777
Operating expenses:
Operation and maintenance 1,589 1,777 1,622
Depreciation and amortization 649 636 604
General taxes 281 321 303
Total operating expenses, net 2,519 2,734 2,529
Operating income 1,273 1,196 1,248
Other income (expense):
Interest expense (433) (403) (397)
Interest income 52 4 2
Non-operating benefit costs, net 77 78 49
Gain on sale of businesses 19 747 —
Other, net 20 18 22
Total other income (expense) (265) 444 (324)
Income before income taxes 1,008 1,640 924
Provision for income taxes 188 377 215
```

**Chunk 2:**
```
[FY2021 10K | Page 86] American Water Works Company, Inc American Water Works Company, Inc and Subsidiary CompaniesConsolidated Statements of Operations(In millions, except per share data) For the Years Ended December 31, 2021 2020 2019 Operating revenues$ 3,930 $3,777 $3,610 Operating expenses: Operation and maintenance1,777 1,622 1,544 Depreciation and amortization636 604 582 General taxes321 303 280 Other— — (10) Total operating expenses, net2,734 2,529 2,396 Operating income1,196 1,248 1,214 Other income (expense): Interest expense(403) (397) (386) Interest income4 2 4 Non-operating benefit costs, net78 49 16 Gain or (loss) on sale of businesses747 — (44) Other, net18 22 29 Total other income (expense)444 (324) (381) Income before income taxes1,640 924 833 Provision for income taxes377...
```

**Chunk 3:**
```
[FY2021 10K | Page 88] American Water Works Company, Inc American Water Works Company, Inc and Subsidiary CompaniesConsolidated Statements of Cash Flows(In millions) For the Years Ended December 31, 2021 2020 2019 CASH FLOWS FROM OPERATING ACTIVITIES Net income$ 1,263 $709 $621 Adjustments to reconcile to net cash flows provided by operating activities: Depreciation and amortization636 604 582 Deferred income taxes and amortization of investment tax credits230 207 208 Provision for losses on accounts receivable37 34 28 (Gain) or loss on sale of businesses(747) — 34 Pension and non-pension postretirement benefits(41) (14) 17 Other non-cash, net(23) (20) (41) Changes in assets and liabilities: Receivables and unbilled revenues(74) (97) (25) Pension and non-pension postretirement benefit cont...
```

**Chunk 4:**
```
[FY2021 10K | Page 64] Table of Contents Regulated Businesses SegmentPresented in the table below is financial information for the Regulated Businesses: For the Years Ended December 31, 20212020 2019 (In millions) Operating revenues$ 3,384 $3,255 $3,094 Operation and maintenance1,325 1,258 1,182 Depreciation and amortization601 562 529 General taxes301 285 262 Other operating expenses1 (3) (10) Other income (expenses)(195) (221) (262) Income before income taxes962 932 869 Provision for income taxes172 217 215 Net income attributable to common shareholders789 715 654 Operating RevenuesPresented in the tables below is information regarding the main components of the Regulated Businesses’ operating revenues:For the Years Ended December 31, 2021 2020 2019 (In millions)Water services: Residenti...
```

**Chunk 5:**
```
[FY2022 10K | Page 85] Table of Contents
American Water Works Company, Inc. and Subsidiary Companies
Consolidated Statements of Cash Flows
(In millions)
For the Years Ended December 31,
2022 2021 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net income $ 820 $ 1,263 $ 709
Adjustments to reconcile to net cash flows provided by operating activities:
Depreciation and amortization 649 636 604
Deferred income taxes and amortization of investment tax credits 80 230 207
Provision for losses on accounts receivable 24 37 34
(Gain) or loss on sale of businesses (19) (747) —
Pension and non-pension postretirement benefits (47) (41) (14)
Other non-cash, net 7 (23) (20)
Changes in assets and liabilities:
Receivables and unbilled revenues (114) (74) (97)
Income tax receivable (110) 21 (3)
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `american_water_works`  (display: American Water Works)
- **Auto target_fiscal_year:** `2021`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=american_water_works; override if wrong)

**TARGET_YEAR:** `OK` (auto=2021; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. American Water Works FY2021 operating income.
2. American Water Works FY2021 depreciation and amortization from the cash flow statement.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 21 of 75  —  `diag_021`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_00606`
**company:** Ulta Beauty
**doc:** ULTABEAUTY_2023Q4_EARNINGS
**question_type:** novel-generated

### Question

Did Ulta Beauty's wages expense as a percent of net sales increase or decrease in FY2023?

### Gold answer

> Wages expense as a percent of net sales increased in FY2023. The answer here assumes FY2023 refers to the 12 months ended on January 28, 2023 (although the company refers to this period as its fiscal 2022.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Ulta Beauty: Wages Expense as % of Net Sales in FY2023

**Direct answer: Wages expense is not separately disclosed.** Ulta Beauty does not break out wages/labor costs as a standalone line item in its Consolidated Statements of Income. The closest available proxy is **Selling, General & Administrative (SG&A) expenses**, which embeds labor/wages costs.

### Available Data (Q4 FY2023 Proxy — 13-Week Periods)

| Metric | Q4 FY2023 (Jan 28, 2023) | Q4 FY2022 (Jan 29, 2022) | Change |
|---|---|---|---|
| Net Sales | $3,226,773K | $2,729,388K | +18.2% |
| SG&A Expenses | $762,706K | $649,968K | +17.3% |
| **SG&A as % of Net Sales** | **23.6%** | **23.8%** | **−0.2 pp** |

[Source: ULTABEAUTY_2023Q4_EARNINGS.pdf, Page 6]

### Key Caveats
1. **Wages are not separately disclosed** — they are embedded within SG&A alongside other overhead costs.
2. **This data covers only Q4 (13-week periods)**, not the full fiscal year. Full-year FY2023 annual figures were not available in the retrieved evidence.
3. A wages-specific breakout for any period was **not found** in the available context.

---

**Bottom line (partial evidence):** Using SG&A as the closest proxy, Ulta Beauty's overhead cost ratio

[... truncated, total 1499 chars]
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 10K | Page 6] Exhibit 1
Ulta Beauty, Inc.
Consolidated Statements of Income
(In thousands, except per share data)
13 Weeks Ended
January 28,
January 29,
2023
2022
(Unaudited)
(Unaudited)
Net sales
$
3,226,773
100.0
%
$
2,729,388
100.0
%
Cost of sales
2,014,270
62.4
%
1,702,059
62.4
%
Gross profit
1,212,503
37.6
%
1,027,329
37.6
%
Selling, general and administrative expenses
762,706
23.6
%
649,968
23.8
%
Pre-opening expenses
2,179
0.1
%
1,739
0.1
%
Operating income
447,618
13.9
%
375,622
13.8
%
Interest (income) expense, net
(4,378
)
(0.1
%)
467
0.1
%
Income before income taxes
451,996
14.0
%
375,155
13.7
%
Income tax expense
111,245
3.4
%
85,789
3.1
%
Net income
$
340,751
10.6
%
$
289,366
10.6
%
Net income per common share:
Basic
$
6.73
$
5.44
Diluted
$
6.68
$
5.41
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `ulta_beauty`  (display: Ulta Beauty)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=ulta_beauty; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Ulta Beauty FY2023 wages expense or labor-cost disclosure.
2. Ulta Beauty FY2023 net sales.
3. Ulta Beauty prior-year wages expense as a percent of net sales for comparison.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** System's partial answer is grounded in the retrieved Q4 SG&A/net-sales table and the absence of separate wages disclosure.

---
## Record 22 of 75  —  `diag_022`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_03620`
**company:** PepsiCo
**doc:** PEPSICO_2022_10K
**question_type:** metrics-generated

### Question

What is the FY2022 unadjusted EBITDA less capex for PepsiCo? Define unadjusted EBITDA as unadjusted operating income + depreciation and amortization [from cash flow statement]. Answer in USD millions. Respond to the question by assuming the perspective of an investment analyst who can only use the details shown within the statement of cash flows and the income statement.

### Gold answer

> $9068.00

### V1 system answer (for HALLU_GROUNDED labeling)

```
## FY2022 Unadjusted EBITDA Less Capex — PepsiCo

### Step 1: Build Unadjusted EBITDA

| Component | Amount (USD millions) | Source |
|---|---|---|
| Unadjusted Operating Income | $11,512 | [Source 1: PEPSICO_2022_10K.pdf, Page 62] |
| + Depreciation & Amortization | $2,763 | [Source 2: PEPSICO_2022_10K.pdf, Page 64] |
| **= Unadjusted EBITDA** | **$14,275** | |

### Step 2: Subtract Capital Expenditures

Capital expenditures appear in the **investing activities** section of the cash flow statement. The retrieved chunks only include the **operating activities** section [Source 2: PEPSICO_2022_10K.pdf, Page 64] — the investing activities section was **not provided**. Therefore, capex **cannot be confirmed** from the available evidence.

### Step 3: Result

| Metric | Amount (USD millions) |
|---|---|
| Unadjusted EBITDA | $14,275 |
| Less: Capex | **Not available in provided sources** |
| **EBITDA less Capex** | **Cannot be fully computed** |

---

**Bottom line (partial evidence):** Unadjusted EBITDA is confirmed at **$14,275 million** for FY2022 [Sources: PEPSICO_2022_10K.pdf, Pages 62 & 64]. The final EBITDA-less-capex figure cannot be determined because the investing activities 

[... truncated, total 1514 chars]
```

### V1 retrieved chunks (top 2 of 2 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 62] Table of Contents
Consolidated Statement of Income
PepsiCo, Inc. and Subsidiaries
Fiscal years ended December 31, 2022, December 25, 2021 and December 26, 2020
(in millions except per share amounts)
2022 2021 2020
Net Revenue $ 86,392 $ 79,474 $ 70,372
Cost of sales 40,576 37,075 31,797
Gross profit 45,816 42,399 38,575
Selling, general and administrative expenses 34,459 31,237 28,453
Gain associated with the Juice Transaction (see Note 13) (3,321) — —
Impairment of intangible assets (see Notes 1 and 4) 3,166 — 42
Operating Profit 11,512 11,162 10,080
Other pension and retiree medical benefits income 132 522 117
Net interest expense and other (939) (1,863) (1,128)
Income before income taxes 10,705 9,821 9,069
Provision for income taxes 1,727 2,142 1,894
Net income 8,...
```

**Chunk 2:**
```
[FY2022 10K | Page 64] Table of Contents
Consolidated Statement of Cash Flows
PepsiCo, Inc. and Subsidiaries
Fiscal years ended December 31, 2022, December 25, 2021 and December 26, 2020
(in millions)
2022 2021 2020
Operating Activities
Net income $ 8,978 $ 7,679 $ 7,175
Depreciation and amortization 2,763 2,710 2,548
Gain associated with the Juice Transaction (3,321) — —
Impairment and other charges 3,618 — —
Operating lease right-of-use asset amortization 517 505 478
Share-based compensation expense 343 301 264
Restructuring and impairment charges 411 247 289
Cash payments for restructuring charges (224) (256) (255)
Acquisition and divestiture-related charges 80 (4) 255
Cash payments for acquisition and divestiture-related charges (46) (176) (131)
Pension and retiree medical plan expense...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `pepsico`  (display: PepsiCo)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=pepsico; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. PepsiCo FY2022 operating income.
2. PepsiCo FY2022 depreciation and amortization from the cash flow statement.
3. PepsiCo FY2022 capital expenditures.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Partial refusal is grounded because capex/investing activity was not retrieved.

---
## Record 23 of 75  —  `diag_023`  **[PASSING]**

**fb_id:** `financebench_id_03031`
**company:** Lockheed Martin
**doc:** LOCKHEEDMARTIN_2021_10K
**question_type:** metrics-generated

### Question

What is Lockheed Martin's FY2021 net working capital? Define net working capital as total current assets less total current liabilities. Answer in USD millions. Respond to the question by assuming the perspective of an investment analyst who can only use the details shown within the balance sheet.

### Gold answer

> $5818.00

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Lockheed Martin FY2021 Net Working Capital

### Balance Sheet Components (as of December 31, 2021)

| Line Item | Amount (USD millions) |
|---|---|
| Cash and cash equivalents | $3,604 |
| Receivables, net | $1,963 |
| Contract assets | $10,579 |
| Inventories | $2,981 |
| Other current assets | $688 |
| **Total Current Assets** | **$19,815** |
| | |
| Accounts payable | $780 |
| Salaries, benefits and payroll taxes | $3,108 |
| Contract liabilities | $8,107 |
| Current maturities of long-term debt | $6 |
| Other current liabilities | $1,996 |
| **Total Current Liabilities** | **$13,997** |

[Source: LOCKHEEDMARTIN_2021_10K.pdf, Page 68]

### Calculation

$$\text{Net Working Capital} = \$19,815M - \$13,997M = \textbf{\$5,818 million}$$

This figure is corroborated by the comparative balance sheet in the FY2022 10K, which independently reports the same FY2021 figures of $19,815M in current assets and $13,997M in total current liabilities. [Source: LOCKHEEDMARTIN_2022_10K.pdf, Page 65]

---

**Bottom line:** Lockheed Martin's FY2021 net working capital was **$5,818 million**, reflecting total current assets of $19,815M less total current liabilities of $13,997M, as reported on the

[... truncated, total 1228 chars]
```

### V1 retrieved chunks (top 5 of 5 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2021 10K | Page 68] Table of Contents
Lockheed Martin CorporationConsolidated Balance Sheets(in millions, except par value)
December 31,
2021 2020
AssetsCurrent assetsCash and cash equivalents $ 3,604 $ 3,160 Receivables, net 1,963 1,978 Contract assets 10,579 9,545 Inventories 2,981 3,545 Other current assets 688 1,150
Total current assets 19,815 19,378 Property, plant and equipment, net 7,597 7,213 Goodwill 10,813 10,806 Intangible assets, net 2,706 3,012 Deferred income taxes 2,290 3,475 Other noncurrent assets 7,652 6,826
Total assets $ 50,873 $ 50,710
Liabilities and equityCurrent liabilitiesAccounts payable $ 780 $ 880 Salaries, benefits and payroll taxes 3,108 3,163 Contract liabilities 8,107 7,545 Current maturities of long-term debt 6 500 Other current liabilities 1,996 1,845
```

**Chunk 2:**
```
[FY2022 10K | Page 65] Lockheed Martin Corporation
Consolidated Balance Sheets
(in millions, except par value)
December 31,
2022 2021
Assets
Current assets
Cash and cash equivalents $ 2,547 $ 3,604
Receivables, net  2,505  1,963
Contract assets  12,318  10,579
Inventories  3,088  2,981
Other current assets  533  688
Total current assets  20,991  19,815
Property, plant and equipment, net  7,975  7,597
Goodwill  10,780  10,813
Intangible assets, net  2,459  2,706
Deferred income taxes  3,744  2,290
Other noncurrent assets  6,931  7,652
Total assets $ 52,880 $ 50,873
Liabilities and equity
Current liabilities
Accounts payable $ 2,117 $ 780
Salaries, benefits and payroll taxes  3,075  3,108
Contract liabilities  8,488  8,107
Other current liabilities  2,207  2,002
Total current liabilities  15...
```

**Chunk 3:**
```
[10K | Page 69] Table of Contents
Lockheed Martin Corporation
Consolidated Balance Sheets
(in millions, except par value)
December 31,
2020 2019
Assets
Current assets
Cash and cash equivalents $ 3,160 $ 1,514
Receivables, net 1,978 2,337
Contract assets 9,545 9,094
Inventories 3,545 3,619
Other current assets 1,150 531
Total current assets 19,378 17,095
Property, plant and equipment, net 7,213 6,591
Goodwill 10,806 10,604
Intangible assets, net 3,012 3,213
Deferred income taxes 3,475 3,319
Other noncurrent assets 6,826 6,706
Total assets $ 50,710 $ 47,528
Liabilities and equity
Current liabilities
Accounts payable $ 880 $ 1,281
Contract liabilities 7,545 7,054
Salaries, benefits and payroll taxes 3,163 2,466
Current maturities of long-term debt 500 1,250
Other current liabilities 1,845 1,9...
```

**Chunk 4:**
```
[FY2021 10K | Page 68] nefits and payroll taxes 3,108 3,163 Contract liabilities 8,107 7,545 Current maturities of long-term debt 6 500 Other current liabilities 1,996 1,845 Total current liabilities 13,997 13,933 Long-term debt, net 11,670 11,669 Accrued pension liabilities 8,319 12,874 Other noncurrent liabilities 5,928 6,196
Total liabilities 39,914 44,672 Stockholders’ equityCommon stock, $1 par value per share 271 279 Additional paid-in capital 94 221 Retained earnings 21,600 21,636 Accumulated other comprehensive loss (11,006) (16,121)
Total stockholders’ equity 10,959 6,015 Noncontrolling interests in subsidiary — 23
Total equity 10,959 6,038
Total liabilities and equity $ 50,873 $ 50,710
The accompanying notes are an integral part of these consolidated financial statements.
68
```

**Chunk 5:**
```
[10K | Page 69] ties 7,545 7,054
Salaries, benefits and payroll taxes 3,163 2,466
Current maturities of long-term debt 500 1,250
Other current liabilities 1,845 1,921 Total current liabilities 13,933 13,972
Long-term debt, net 11,669 11,404
Accrued pension liabilities 12,874 13,234
Other noncurrent liabilities 6,196 5,747
Total liabilities 44,672 44,357
Stockholders’ equity
Common stock, $1 par value per share 279 280
Additional paid-in capital 221 —
Retained earnings 21,636 18,401
Accumulated other comprehensive loss (16,121) (15,554)
Total stockholders’ equity 6,015 3,127
Noncontrolling interests in subsidiary 23 44
Total equity 6,038 3,171
Total liabilities and equity $ 50,710 $ 47,528
The accompanying notes are an integral part of these consolidated financial statements.
69
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `lockheed_martin`  (display: Lockheed Martin)
- **Auto target_fiscal_year:** `2021`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=lockheed_martin; override if wrong)

**TARGET_YEAR:** `OK` (auto=2021; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Lockheed Martin FY2021 total current assets.
2. Lockheed Martin FY2021 total current liabilities.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 24 of 75  —  `diag_024`  **[FAILING]**  audit=DATASET_SUSPECT

**fb_id:** `financebench_id_02419`
**company:** Pfizer
**doc:** Pfizer_2023Q2_10Q
**question_type:** novel-generated

### Question

As of Q2'2023, is Pfizer spinning off any large business segments?

### Gold answer

> Yes, it's spinning off Upjohn.

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the provided context, Pfizer is not currently spinning off a large business segment as of Q2 2023. However, the context references a **past separation of Upjohn**, which was a previously completed spinoff.

Key details from the filing:

- Pfizer expects to incur total costs of approximately **$700 million** in connection with separating Upjohn, of which **approximately 90% has been incurred** since inception through Q2 2023. [Source: Pfizer_2023Q2_10Q.pdf, Page 41]
- As of Q2 2023, Pfizer manages its commercial operations through **two operating segments: Biopharma and Business Innovation**, with **Biopharma as the only reportable segment**. [Source: Pfizer_2023Q2_10Q.pdf, Page 41]

---

**Bottom line (Partial evidence):** The Upjohn separation is a largely completed historical transaction (~90% of costs already incurred), and there is no mention in the provided context of any new or ongoing large business segment spinoff as of Q2 2023. The current structure consists of Biopharma and Business Innovation segments, with no active divestiture disclosed in this excerpt.
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 10Q | Page 41] le that extend and significantly improve their lives. In 2023, we are making additional investments in both R&D and SI&A to support Pfizer’s near- and longer-term growth plans, including to support anticipated new launches, commercial launch of COVID-19 products, potential pipeline programs and recently
acquired assets. We manage our commercial operations through a global structure consisting of two operating segments: Biopharma and Business Innovation.
Biopharma is the only reportable segment. See Note 13A.
We expect to incur costs of approximately $700 million in connection with separating Upjohn, of which approximately 90% has been incurred since inception
and through the second quarter of 2023. These charges include costs and expenses related to separation of leg...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `pfizer`  (display: Pfizer)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=pfizer; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Cost and segment-structure facts are grounded, but the conclusion that Upjohn is only a completed historical spinoff is not fully supported by the shown chunk.

---
## Record 25 of 75  —  `diag_025`  **[PASSING]**

**fb_id:** `financebench_id_04458`
**company:** Netflix
**doc:** NETFLIX_2015_10K
**question_type:** metrics-generated

### Question

We want to calculate a financial metric. Please help us compute it by basing your answers off of the statement of income and the statement of cash flows. Here's the question: what is the FY2015 unadjusted EBITDA % margin for Netflix? Calculate unadjusted EBITDA using unadjusted operating income and D&A (from cash flow statement).

### Gold answer

> 5.4%

### V1 system answer (for HALLU_GROUNDED labeling)

```
## FY2015 Unadjusted EBITDA % Margin — Netflix

### Key Inputs

| Item | Value | Source |
|---|---|---|
| Total Revenues | $6,779,511K | [Source 1: NETFLIX_2015_10K.pdf, Page 40] |
| Operating Income | $305,826K | [Source 1: NETFLIX_2015_10K.pdf, Page 40] |
| D&A (property, equipment & intangibles) | $62,283K | [Source 4: NETFLIX_2015_10K.pdf, Page 42] |

### Calculation

$$\text{Unadjusted EBITDA} = \text{Operating Income} + \text{D\&A}$$
$$= \$305,826K + \$62,283K = \$368,109K$$

$$\text{EBITDA \% Margin} = \frac{\$368,109K}{\$6,779,511K} = \mathbf{5.43\%}$$

### Note on D&A Selection
The cash flow statement also lists amortization of streaming content assets ($3,405,382K) and DVD content assets ($79,380K) [Source 4: NETFLIX_2015_10K.pdf, Page 42]. These are **excluded** from the traditional EBITDA D&A add-back, as they represent content-specific amortization already captured within cost of revenues on the income statement — not conventional property, equipment & intangibles depreciation.

---

**Bottom line**: Netflix's FY2015 unadjusted EBITDA margin was **5.43%**, derived from EBITDA of $368,109K on revenues of $6,779,511K.
```

### V1 retrieved chunks (top 5 of 5 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 40] NETFLIX, INC NETFLIX, INC CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share data) Year ended December 31, 2015 2014 2013Revenues $6,779,511 $5,504,656 $4,374,562Cost of revenues 4,591,476 3,752,760 3,117,203Marketing 824,092 607,186 469,942Technology and development 650,788 472,321 378,769General and administrative 407,329 269,741 180,301Operating income 305,826 402,648 228,347Other income (expense): Interest expense (132,716) (50,219) (29,142)Interest and other income (expense) (31,225 ) (3,060 ) (3,002 )Loss on extinguishment of debt — — (25,129)Income before income taxes 141,885 349,369 171,074Provision for income taxes 19,244 82,570 58,671 Net income $122,641 $266,799 $112,403Earnings per share: Basic $0.29 $0.63 $0.28 Diluted $0.28 $0.62 $0.26 Weight...
```

**Chunk 2:**
```
[10K | Page 61] Table of Contents The following tables represent segment information for the year ended December 31, 2015: As of/Year ended December 31, 2015 Domestic Streaming InternationalStreaming DomesticDVD Consolidated (in thousands) Total memberships at end of period (1)44,738 30,024 4,904 — Revenues$ 4,180,339 $1,953,435 $645,737 $6,779,511Cost of revenues2,487,193 1,780,375 323,908 4,591,476Marketing317,646 506,446 — 824,092 Contribution profit (loss)$ 1,375,500 $(333,386) $321,829 $1,363,943Other operating expenses 1,058,117Operating income 305,826 Other income (expense) (163,941 )Provision for income taxes 19,244 Net income $122,641 As of/Year ended December 31, 2015 Domestic Streaming InternationalStreaming DomesticDVD Consolidated (in thousands) Amortization of content assets1...
```

**Chunk 3:**
```
[10K | Page 19] ationsThe following represents our consolidated performance highlights:  As of/ Year Ended December 31,  Change   2015 2014 2013 2015 vs. 2014 2014 vs ationsThe following represents our consolidated performance highlights:  As of/ Year Ended December 31,  Change   2015 2014 2013 2015 vs. 2014 2014 vs 2013  (in thousands, except revenue per membership and percentages) Global streaming memberships 74,762 57,391 44,350 30 % 29%Global streaming average monthly revenue per paying membership $8.15 $8.20 $8.03 (1)% 2%Revenues $6,779,511 $5,504,656 $4,374,562 23 % 26%Operating income $305,826 $402,648 $228,347 (24)% 76%Net income $122,641 $266,799 $112,403 (54)% 137%Consolidated revenues for 2015 and 2014 increased as compared to prior years due to growth in global streaming averag...
```

**Chunk 4:**
```
[10K | Page 42] NETFLIX, INC NETFLIX, INC CONSOLIDATED STATEMENTS OF CASH FLOWS(in thousands) Year Ended December 31, 2015 2014 2013Cash flows from operating activities: Net income $122,641 $266,799 $112,403Adjustments to reconcile net income to net cash (used in) provided by operating activities: Additions to streaming content assets (5,771,652) (3,773,019) (3,030,701)Change in streaming content liabilities 1,162,413 593,125 673,785Amortization of streaming content assets 3,405,382 2,656,279 2,121,981Amortization of DVD content assets 79,380 71,491 71,325Depreciation and amortization of property, equipment and intangibles 62,283 54,028 48,374Stock-based compensation expense 124,725 115,239 73,100Excess tax benefits from stock-based compensation (80,471) (89,341) (81,663)Other non-cash ite...
```

**Chunk 5:**
```
[10K | Page 62] 1, 2016 Domestic Streaming InternationalStreaming DomesticDVD Consolidated (in thousands) Amortization of content assets$ 2,337,950 $2,450,548 $78,952 1, 2016 Domestic Streaming InternationalStreaming DomesticDVD Consolidated (in thousands) Amortization of content assets$ 2,337,950 $2,450,548 $78,952 $4,867,450The following tables represent segment information for the year ended December 31, 2015 : As of/Year ended December 31, 2015 Domestic Streaming InternationalStreaming DomesticDVD Consolidated (in thousands) Total memberships at end of period (1)44,738 30,024 4,904 — Revenues$ 4,180,339 $1,953,435 $645,737 $6,779,511Cost of revenues2,487,193 1,780,375 323,908 4,591,476Marketing317,646 506,446 — 824,092Contribution profit (loss)$ 1,375,500 $(333,386) $321,829 1,363,943O...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `netflix`  (display: Netflix)
- **Auto target_fiscal_year:** `2015`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=netflix; override if wrong)

**TARGET_YEAR:** `OK` (auto=2015; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Netflix FY2015 operating income.
2. Netflix FY2015 depreciation and amortization from the cash flow statement.
3. Netflix FY2015 total revenue.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 26 of 75  —  `diag_026`  **[FAILING]**  audit=DATASET_SUSPECT

**fb_id:** `financebench_id_01328`
**company:** PepsiCo
**doc:** PEPSICO_2022_10K
**question_type:** domain-relevant

### Question

What is the quantity of restructuring costs directly outlined in Pepsico's income statements for FY2022? If restructuring costs are not explicitly outlined then state 0.

### Gold answer

> Pepsico's restructuring costs in FY2022 amounted to $411 million .

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the provided context, I need to determine what restructuring costs are **explicitly outlined in PepsiCo's income statements** for FY2022.

From the Consolidated Statement of Cash Flows [Source 1: PEPSICO_2022_10K.pdf, Page 64], restructuring and impairment charges of **$411 million** are listed as a line item. This figure is corroborated by the 2019 Productivity Plan summary [Source 2: PEPSICO_2022_10K.pdf, Page 78], which breaks down the $411 million across cost of sales ($33M) and SG&A ($347M) and other pension/retiree medical ($31M).

However, the question specifically asks about the **income statement** (not the cash flow statement). The income statement itself does not appear to have a standalone "restructuring costs" line item — rather, restructuring charges are embedded within **Cost of Sales** and **Selling, General and Administrative Expenses** on the face of the income statement, and are only separately identified in supplemental/non-GAAP reconciliation tables [Source 2, Source 5].

Since restructuring costs are **not presented as a separately labeled line item on the face of PepsiCo's income statement** for FY2022, but are instead embedded within other line item

[... truncated, total 1460 chars]
```

### V1 retrieved chunks (top 5 of 5 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 64] Table of Contents
Consolidated Statement of Cash Flows
PepsiCo, Inc. and Subsidiaries
Fiscal years ended December 31, 2022, December 25, 2021 and December 26, 2020
(in millions)
2022 2021 2020
Operating Activities
Net income $ 8,978 $ 7,679 $ 7,175
Depreciation and amortization 2,763 2,710 2,548
Gain associated with the Juice Transaction (3,321) — —
Impairment and other charges 3,618 — —
Operating lease right-of-use asset amortization 517 505 478
Share-based compensation expense 343 301 264
Restructuring and impairment charges 411 247 289
Cash payments for restructuring charges (224) (256) (255)
Acquisition and divestiture-related charges 80 (4) 255
Cash payments for acquisition and divestiture-related charges (46) (176) (131)
Pension and retiree medical plan expense...
```

**Chunk 2:**
```
[FY2022 10K | Page 78] rments (all non-cash) resulting from plant closures and related actions and 35%
for other costs associated with the implementation of our initiatives. The total plan pre-tax charges are expected to be incurred by division approximately as follows:
FLNA QFNA PBNA LatAm Europe AMESA APAC Corporate
Expected pre-tax charges 15 % 1 % 25 % 10 % 25 % 5 % 4 % 15 %
A summary of our 2019 Productivity Plan charges is as follows:
2022 2021 2020
Cost of sales $ 33 $ 29 $ 30
Selling, general and administrative expenses 347 208 239
Other pension and retiree medical benefits expense 31 10 20
Total restructuring and impairment charges $ 411 $ 247 $ 289
After-tax amount $ 334 $ 206 $ 231
Impact on net income attributable to PepsiCo per common share $ (0.24) $ (0.15) $ (0.17)
76
```

**Chunk 3:**
```
[FY2022 10K | Page 49] Table of Contents
2021
Cost ofsales Grossprofit
Selling, generaland administrativeexpenses Operatingprofit
Other pensionand retireemedicalbenefitsincome
Net interestexpense andother
Provision forincometaxes
Net incomeattributable tononcontrollinginterests
Net incomeattributable toPepsiCo
Reported, GAAP Measure $ 37,075 $ 42,399 $ 31,237 $ 11,162 $ 522 $ (1,863) $ 2,142 $ 61 $ 7,618
Items Affecting Comparability
Mark-to-market net impact (39) 39 20 19 — — 5 — 14
Restructuring and impairmentcharges (29) 29 (208) 237 10 — 41 1 205
Acquisition and divestiture-relatedcharges (1) 1 5 (4) — — 23 — (27)
Pension and retiree medical-relatedimpact — — — — 12 — 1 — 11
Charge related to cash tenderoffers — — — — — 842 165 — 677
Tax expense related to the TCJ Act — — — — — — (190)...
```

**Chunk 4:**
```
[FY2023 10K | Page 13] e
Provision
for income
taxes(b)
Net
income
attributable
to PepsiCo
Net income
attributable to
PepsiCo per
common share
- diluted
Effective
tax rate(c) Reported, GAAP Measure $ 7,433 $ 8,767 $ 6,580  (3,322)  242 $ 5,267 $ 134 $ 888 $ 4,261 $ 3.06  17.2 %
Items Affecting Comparability
Mark-to-market net impact  33  (33)  79  —  —  (112)  —  (26)  (86)  (0.06)  (0.1)
Restructuring and impairment charges  (5)  5  (22)  —  —  27  —  6  21  0.02  —
Acquisition and divestiture-related charges  —  —  (50)  —  —  50  6  9  47  0.03  —
Gain associated with the Juice Transaction  —  —  —  3,322  —  (3,322)  —  (452)  (2,870)  (2.06)  4.5
Impairment and other charges/credits  (140)  140  (100)  —  (242)  482  —  48  434  0.31  (1.0)
Pension and retiree medical-related impact  —...
```

**Chunk 5:**
```
[FY2022 10K | Page 49] latedimpact — — — — 12 — 1 — 11
Charge related to cash tenderoffers — — — — — 842 165 — 677
Tax expense related to the TCJ Act — — — — — — (190) — 190 Core, Non-GAAP Measure $ 37,006 $ 42,468 $ 31,054 $ 11,414 $ 544 $ (1,021) $ 2,187 $ 62 $ 8,688
(a) Provision for income taxes is the expected tax charge/benefit on the underlying item based on the tax laws and income tax rates applicable to the underlying item in its corresponding taxjurisdiction.
2022 2021 Change
Net income attributable to PepsiCo per common share – diluted, GAAP measure$ 6.42 $ 5.49 17 %
Mark-to-market net impact 0.03 0.01
Restructuring and impairment charges 0.24 0.15
Acquisition and divestiture-related charges 0.05 (0.02)
Gain associated with the Juice Transaction (2.08) —
Impairment and other cha...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `pepsico`  (display: PepsiCo)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=pepsico; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** The $411M and embedded-line-item discussion are supported by the cash flow and restructuring-note chunks.

---
## Record 27 of 75  —  `diag_027`  **[PASSING]**

**fb_id:** `financebench_id_04700`
**company:** Microsoft
**doc:** MICROSOFT_2016_10K
**question_type:** metrics-generated

### Question

What is the FY2016 COGS for Microsoft? Please state answer in USD millions. Provide a response to the question by primarily using the statement of income.

### Gold answer

> $32780.00

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the income statement provided, Microsoft's FY2016 Cost of Revenue (COGS) is broken down as follows:

| Category | Amount (USD millions) |
|---|---|
| Product | $17,880 |
| Service and other | $14,900 |
| **Total Cost of Revenue** | **$32,780** |

[Source: MICROSOFT_2016_10K.pdf, Page 52]

**Bottom line:** Microsoft's total COGS (Cost of Revenue) for FY2016 (year ended June 30, 2016) was **$32,780 million**.
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[Company: Microsoft Inc. | 10K | Page 52] Table of Contents
PART IIItem 8
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
INCOME STATEMENTS
(In millions, except per share amounts)
Year Ended June 30,   2016  2015  2014
Revenue:
Product   $  61,502   $  75,956   $  72,948  Service and other    23,818    17,624    13,885
Total revenue    85,320    93,580    86,833
Cost of revenue:
Product    17,880    21,410    16,681  Service and other    14,900    11,628    10,397
Total cost of revenue    32,780    33,038    27,078
Gross margin    52,540    60,542    59,755  Research and development    11,988    12,046    11,381  Sales and marketing    14,697    15,713    15,811  General and administrative    4,563    4,611    4,677  Impairment, integration, and restructuring    1,110    10,011    127
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `microsoft`  (display: Microsoft)
- **Auto target_fiscal_year:** `2016`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=microsoft; override if wrong)

**TARGET_YEAR:** `OK` (auto=2016; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 28 of 75  —  `diag_028`  **[PASSING]**

**fb_id:** `financebench_id_02608`
**company:** Best Buy
**doc:** BESTBUY_2017_10K
**question_type:** metrics-generated

### Question

In agreement with the information outlined in the income statement, what is the FY2015 - FY2017 3 year average net profit margin (as a %) for Best Buy? Answer in units of percents and round to one decimal place.

### Gold answer

> 2.8%

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Answer

Based on the income statement data from Best Buy's 10-K filings, here are the confirmed figures:

| Fiscal Year | Net Earnings Attributable to Best Buy Shareholders | Total Revenue | Net Profit Margin |
|---|---|---|---|
| FY2015 | $1,233M | $40,339M | 3.057% |
| FY2016 | $897M | $39,528M | 2.270% |
| FY2017 | $1,228M | $39,403M | 3.116% |

[Source: BESTBUY_2017_10K.pdf, Page 56 & Page 26]

**Computation:**

- FY2015: $1,233 / $40,339 = 3.057%
- FY2016: $897 / $39,528 = 2.270%
- FY2017: $1,228 / $39,403 = 3.116%

**3-Year Average** = (3.057% + 2.270% + 3.116%) / 3 = **2.8%**

---

**Bottom line:** Best Buy's FY2015–FY2017 three-year average net profit margin was **2.8%**, based on net earnings attributable to Best Buy Co., Inc. shareholders divided by total revenue for each year. [Source: BESTBUY_2017_10K.pdf, Pages 26 & 56]
```

### V1 retrieved chunks (top 5 of 6 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 26] lysis of Financial Condition and Results of Operations , and Item 8,  Financial Statements and Supplementary Data , of this Annual Report on Form 10-K lysis of Financial Condition and Results of Operations , and Item 8,  Financial Statements and Supplementary Data , of this Annual Report on Form 10-K Five-Year Financial Highlights$ in millions, except per share amountsFiscal Year2019 (1) 2018 (2)(3) 2017 (4) 2016 (5) 2015 (6)Consolidated Statements of Earnings Data Revenue$ 42,879 $42,151 $39,403 $39,528 $40,339Operating income1,900 1,843 1,854 1,375 1,450Net earnings from continuing operations1,464 999 1,207 807 1,246Gain (loss) from discontinued operations— 1 21 90 (11 )Net earnings including noncontrolling interests1,464 1,000 1,228 897 1,235Net earnings attributable to ...
```

**Chunk 2:**
```
[10K | Page 81] Table of Contents The following table presents a reconciliation of the numerators and denominators of basic and diluted earnings per share from continuing operations attributable toBest Buy Co., Inc. in fiscal 2017 , 2016 and 2015 ($ and shares in millions, except per share amounts): 2017 2016 2015Numerator (in millions): Net earnings from continuing operations attributable to Best Buy Co., Inc., shareholders$ 1,207 $807 $1,246Denominator (in millions): Weighted-average common shares outstanding318.5 346.5 349.5Effect of potentially dilutive securities: Stock options and other4.1 4.2 4.1Weighted-average common shares outstanding, assuming dilution322.6 350.7 353.6Net earnings per share from continuing operations attributable to Best Buy Co., Inc.shareholders Basic$ 3.79 $2....
```

**Chunk 3:**
```
[10K | Page 26] lysis of Financial Condition and Results of Operations , and Item 8,  Financial Statements and Supplementary Data , of this Annual Report on Form 10-K lysis of Financial Condition and Results of Operations , and Item 8,  Financial Statements and Supplementary Data , of this Annual Report on Form 10-K Five-Year Financial Highlights$ in millions, except per share amounts 12-Month 11-MonthFiscal Year 2017 (1) 2016 (2) 2015 (3) 2014 (4) 2013 (5)(6)Consolidated Statements of Earnings Data Revenue $39,403 $39,528 $40,339 $40,611 $38,252Operating income 1,854 1,375 1,450 1,144 90Net earnings (loss) from continuing operations 1,207 807 1,246 695 (259)Gain (loss) from discontinued operations 21 90 (11) (172) (161)Net earnings (loss) including noncontrolling interests 1,228 897 1,235...
```

**Chunk 4:**
```
[10K | Page 57] Table of Contents
Consolidated Statements of Comprehensive Income$ in millionsFiscal Years Ended  January 28, 2017 January 30, 2016 January 31, 2015Net earnings including noncontrolling interests  $1,228 $897 $1,235Foreign currency translation adjustments  10 (44) (103)Unrealized loss on available-for-sale investments  — — (3)Reclassification of foreign currency translations adjustments into earnings due to sale of business  (2) (67) —Reclassification of gains on available-for-sale investments into earnings  — — (4)Comprehensive income including noncontrolling interests  1,236 786 1,125Comprehensive income attributable to noncontrolling interests  — — (2)Comprehensive income attributable to Best Buy Co., Inc. shareholders  $1,236 $786 $1,123See Notes to Consolidated Financi...
```

**Chunk 5:**
```
[10K | Page 56] 0)Earnings from continuing operations before income tax expense 1,816 1,310 1,387Income tax expense 609 503 141Net earnings from continuing operations 0)Earnings from continuing operations before income tax expense 1,816 1,310 1,387Income tax expense 609 503 141Net earnings from continuing operations 1,207 807 1,246Gain (loss) from discontinued operations (Note 2), net of tax expense of $7, $1 and $0 21 90 (11)Net earnings including noncontrolling interests 1,228 897 1,235Net earnings from discontinued operations attributable to noncontrolling interests — — (2)Net earnings attributable to Best Buy Co., Inc. shareholders $1,228 $897 $1,233 Basic earnings (loss) per share attributable to Best Buy Co., Inc. shareholders Continuing operations $3.79 $2.33 $3.57Discontinued opera...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `best_buy`  (display: Best Buy)
- **Auto target_fiscal_year:** `2017`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=best_buy; override if wrong)

**TARGET_YEAR:** `OK` (auto=2017; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Best Buy FY2015 net earnings and revenue.
2. Best Buy FY2016 net earnings and revenue.
3. Best Buy FY2017 net earnings and revenue.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 29 of 75  —  `diag_029`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_00476`
**company:** American Express
**doc:** AMERICANEXPRESS_2022_10K
**question_type:** domain-relevant

### Question

Which debt securities are registered to trade on a national securities exchange under American Express' name as of 2022?

### Gold answer

> There are none

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the provided context, the chunk from the 2022 10-K (Page 125) contains only a table of long-term debt details (maturities, rates, balances) for American Express and its subsidiaries. It does **not** contain information about which debt securities are registered to trade on a national securities exchange.

**I don't have enough information to answer this question.**

The answer to this question would typically be found in the cover page or Exhibit 4 of the 10-K filing (which lists securities registered under Section 12 of the Exchange Act), neither of which is present in the provided context.
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 125] 2033 1,250 4.42 — — — —
Fixed Rate Subordinated Notes 2024 574 3.63 5.46 599 3.63 1.38
Fixed-to-Floating Rate Subordinated Notes 2033 750 4.99 — — — — American Express Credit Corporation
Fixed Rate Senior Notes 2027 328 3.30 — 2,078 2.80 1.32
Floating Rate Senior Notes — — — 300 0.87 —
Lending Trust
Fixed Rate Senior Notes 2023 - 2025 10,499 2.81 — 8,199 2.01 1.82
Floating Rate Senior Notes 2023 2,125 4.67 — 3,325 0.49 —
Fixed Rate Subordinated Notes — — — 212 2.72 —
Floating Rate Subordinated Notes 2023 61 4.89 — 79 0.68 —
Charge Trust
Floating Rate Conduit Borrowings — — — 2,000 0.40 —
Other
Finance Leases 2023 - 2024 3 5.76 — 14 5.49 —
Floating Rate Borrowings 2023 - 2025 254 0.41 — % 297 0.42 — %
Unamortized Underwriting Fees (84) (52)
Total Long-Term Debt $ 42,...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `american_express`  (display: American Express)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=american_express; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Retrieved chunk lacks exchange-registration information; refusal is grounded.

---
## Record 30 of 75  —  `diag_030`  **[PASSING]**

**fb_id:** `financebench_id_00720`
**company:** American Express
**doc:** AMERICANEXPRESS_2022_10K
**question_type:** domain-relevant

### Question

What drove gross margin change as of the FY2022 for American Express? If gross margin is not a useful metric for a company like this, then please state that and explain why.

### Gold answer

> Performance is not measured through gross margin

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Gross Margin for American Express (FY2022)

**Gross margin is not a useful or meaningful metric for American Express.** Here is why:

### Why Gross Margin Doesn't Apply

American Express is a **financial services and payments network company**, not a manufacturer or retailer. Its revenues consist of:

- **Discount revenue** (fees charged to merchants)
- **Net interest income** (earned on card member loans)
- **Net card fees** (annual membership fees)
- **Other fees and commissions**

Because American Express does not produce or purchase physical goods for resale, there is **no "Cost of Goods Sold" (COGS)** line item in the traditional sense. Without a meaningful COGS, gross profit — and therefore gross margin — is either undefined or becomes an arbitrary figure depending on how one chooses to classify operating expenses.

### What Metrics Actually Matter for American Express

Industry analysts and management focus on the following profitability and efficiency metrics instead:

| Metric | Why It's Relevant |
|---|---|
| **Net Interest Margin (NIM)** | Measures profitability of lending/card balances |
| **Provision for Credit Losses** | Reflects credit risk and loan quality |
| **

[... truncated, total 2005 chars]
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```

```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `american_express`  (display: American Express)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=american_express; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. American Express FY2022 revenue structure and whether COGS/gross profit is reported.
2. American Express management profitability metrics used instead of gross margin.

**HALLU_GROUNDED:** `N`  (one of: Y, N, PARTIAL)

**NOTES:** Retrieved chunks are empty, but the answer asserts detailed business-model and metric claims.

---
## Record 31 of 75  —  `diag_031`  **[PASSING]**

**fb_id:** `financebench_id_04302`
**company:** Nike
**doc:** NIKE_2018_10K
**question_type:** metrics-generated

### Question

We need to calculate a reasonable approximation (or exact number if possible) of a financial metric. Basing your judgment by information plainly provided in the statement of income, what is Nike's three year average of cost of goods sold as a % of revenue from FY2016 to FY2018? Answer in units of percents and round to one decimal place.

### Gold answer

> 55.1%

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Nike's Three-Year Average COGS as % of Revenue (FY2016–FY2018)

All figures sourced directly from the Consolidated Statements of Income [Source 1: NIKE_2018_10K.pdf, Page 46]:

| Fiscal Year | Revenue ($M) | Cost of Sales ($M) | COGS % of Revenue |
|---|---|---|---|
| FY2016 | $32,376 | $17,405 | 53.8% |
| FY2017 | $34,350 | $19,038 | 55.4% |
| FY2018 | $36,397 | $20,441 | 56.2% |

**Three-Year Average:**
(53.8% + 55.4% + 56.2%) / 3 = 165.4% / 3 = **55.1%**

---

**Bottom line:** Nike's three-year average Cost of Goods Sold as a percentage of Revenue from FY2016 to FY2018 was **55.1%**, reflecting a consistent upward trend from 53.8% to 56.2% over the period.
```

### V1 retrieved chunks (top 3 of 3 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 46] NIKE, Inc NIKE, Inc Consolidated Statements of Income Year Ended May 31, (In millions, except per share data) 2018 2017 2016Revenues $36,397 $34,350 $32,376Cost of sales 20,441 19,038 17,405 Gross profit 15,956 15,312 14,971 Demand creation expense 3,577 3,341 3,278 Operating overhead expense 7,934 7,222 7,191 Total selling and administrative expense 11,511 10,563 10,469 Interest expense (income), net 54 59 19 Other expense (income), net 66 (196 ) (140 )Income before income taxes 4,325 4,886 4,623 Income tax expense 2,392 646 863 NET INCOME $1,933 $4,240 $3,760 Earnings per common share: Basic $1.19 $2.56 $2.21 Diluted $1.17 $2.51 $2.16 Dividends declared per common share $0.78 $0.70 $0.62 The accompanying Notes to the Consolidated Financial Statements are an integral part ...
```

**Chunk 2:**
```
[10K | Page 32] fic & Latin America5,254 5,166 2 %13 %4,7379 %10 %Global Brand Divisions (2) 42 88 -52 %-53 %7321 %12 %TOTAL NIKE BRAND37,218 34,485 8 %11 %32,2337 %5 fic & Latin America5,254 5,166 2 %13 %4,7379 %10 %Global Brand Divisions (2) 42 88 -52 %-53 %7321 %12 %TOTAL NIKE BRAND37,218 34,485 8 %11 %32,2337 %5 fic & Latin America5,254 5,166 2 %13 %4,7379 %10 %Global Brand Divisions (2) 42 88 -52 %-53 %7321 %12 %TOTAL NIKE BRAND37,218 34,485 8 %11 %32,2337 %5 %Converse1,906 1,886 1 %3 %2,042-8 %-11 %Corporate (3)(7 )26— — 75 — — TOTAL NIKE, INC
```

**Chunk 3:**
```
[10K | Page 52] Table of Contents NIKE, INC.CONSOLIDATED STATEMENTS OF INCOME YEAR ENDED MAY 31, (In millions, except per share data)2019 2018 2017 Revenues$ 39,117$36,397$34,350Cost of sales21,643 20,441 19,038 Gross profit17,474 15,956 15,312 Demand creation expense3,753 3,577 3,341 Operating overhead expense8,949 7,934 7,222 Total selling and administrative expense12,702 11,511 10,563 Interest expense (income), net49 54 59 Other (income) expense, net(78 )66 (196 )Income before income taxes4,801 4,325 4,886 Income tax expense772 2,392 646 NET INCOME$ 4,029$1,933$4,240Earnings per common share: Basic$ 2.55$1.19$2.56Diluted$ 2.49$1.17$2.51Weighted average common shares outstanding: Basic1,579.7 1,623.8 1,657.8 Diluted1,618.4 1,659.1 1,692.0 The accompanying Notes to the Consolidated Financ...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `nike`  (display: Nike)
- **Auto target_fiscal_year:** `2018`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=nike; override if wrong)

**TARGET_YEAR:** `OK` (auto=2018; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Nike FY2016 revenue and cost of sales.
2. Nike FY2017 revenue and cost of sales.
3. Nike FY2018 revenue and cost of sales.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 32 of 75  —  `diag_032`  **[FAILING]**  audit=PASS_NUMERIC_ROUNDING

**fb_id:** `financebench_id_00585`
**company:** Boeing
**doc:** BOEING_2022_10K
**question_type:** novel-generated

### Question

How does Boeing's effective tax rate in FY2022 compare to FY2021?

### Gold answer

> Effective tax rate in FY2022 was 0.62%, compared to  -14.76% in FY2021.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Boeing's Effective Tax Rate: FY2022 vs. FY2021

### Summary Figures

| Metric | FY2022 | FY2021 | Change |
|---|---|---|---|
| Effective Tax Rate | **(0.6)%** | **14.8%** | **−15.4 pp** |
| Pre-tax Loss | ($5,022M) | ($5,033M) | ~flat |
| Income Tax Expense/(Benefit) | $31M expense | ($743M) benefit | swing of $774M |

[Source: BOEING_2022_10K.pdf, Page 24 & Page 27]

---

### What Drove the Deterioration?

Boeing swung from receiving a **meaningful tax benefit** in FY2021 (reducing its net loss) to incurring a **small net tax expense** in FY2022 — despite nearly identical pre-tax losses in both years. The key drivers from the tax reconciliation table are [Source: BOEING_2022_10K.pdf, Page 77]:

1. **Valuation allowance** (largest driver): The drag worsened significantly — **(23.9)%** rate impact in FY2022 vs. **(10.2)%** in FY2021, reflecting Boeing adding $1,199M to valuation allowances vs. $512M the prior year. This signals reduced confidence in realizing deferred tax assets.

2. **Audit settlements** (one-time FY2022 item): A $587M charge (+4.1% rate impact) appeared **only in FY2022** with no comparable item in FY2021, further eroding the benefit.

3. **R&D credits** (parti

[... truncated, total 1755 chars]
```

### V1 retrieved chunks (top 5 of 5 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 24] Table of Contents
Consolidated Results of Operations
The following table summarizes key indicators of consolidated results of operations:
(Dollars in millions, except per share data)
Years ended December 31, 2022 2021 2020
Revenues $66,608 $62,286 $58,158
GAAP
Loss from operations ($3,547) ($2,902) ($12,767)
Operating margins (5.3)% (4.7)% (22.0)%
Effective income tax rate (0.6)% 14.8 % 17.5 %
Net loss attributable to Boeing Shareholders ($4,935) ($4,202) ($11,873)
Diluted loss per share ($8.30) ($7.15) ($20.88)
Non-GAAP
Core operating loss ($4,690) ($4,075) ($14,150)
Core operating margins (7.0 %) (6.5 %) (24.3 %)
Core loss per share ($11.06) ($9.44) ($23.25)
These measures exclude certain components of pension and other postretirement benefit expense. See pages 45 ...
```

**Chunk 2:**
```
[FY2022 10K | Page 27] Table of Contents
Other Earnings Items
(Dollars in millions)
Years ended December 31, 2022 2021 2020
Loss from operations ($3,547) ($2,902) ($12,767)
Other income, net 1,058 551 447
Interest and debt expense (2,533) (2,682) (2,156)
Loss before income taxes (5,022) (5,033) (14,476)
Income tax (expense)/benefit (31) 743 2,535
Net loss from continuing operations (5,053) (4,290) (11,941)
Less: net loss attributable to noncontrolling interest (118) (88) ($68)
Net loss attributable to Boeing Shareholders ($4,935) ($4,202) ($11,873)
Non-operating pension income included in Other income, net was $881 million in 2022, $528 million in 2021, and $340 million in 2020. The
```

**Chunk 3:**
```
[FY2022 10K | Page 55] expense, net (2,852) (2,249) (2,476)
Gain on dispositions, net 6 277 202
Loss from operations (3,547) (2,902) (12,767)
Other income, net 1,058 551 447 Interest and debt expense (2,533) (2,682) (2,156)
Loss before income taxes (5,022) (5,033) (14,476)
Income tax (expense)/benefit (31) 743 2,535
Net loss (5,053) (4,290) (11,941)
Less: net loss attributable to noncontrolling interest (118) (88) (68)
Net loss attributable to Boeing Shareholders ($4,935) ($4,202) ($11,873)
Basic loss per share ($8.30) ($7.15) ($20.88)
Diluted loss per share ($8.30) ($7.15) ($20.88)
See Notes to the Consolidated Financial Statements on pages 59 - 114.
53
```

**Chunk 4:**
```
[FY2022 10K | Page 77] Table of Contents
The following is a reconciliation of the U.S. federal statutory tax to actual income tax (benefit)/expense:
Years ended December 31, 2022 2021 2020
Amount Rate Amount Rate Amount Rate
U.S. federal statutory tax ($1,054) 21.0 % ($1,057) 21.0 % ($3,039) 21.0 %
Valuation allowance 1,199 (23.9) 512 (10.2) 2,603 (18.0)
Research and development credits (204) 4.1 (189) 3.8 (284) 2.0
State income tax provision, net of effects on U.S.
federal tax (90) 1.8 (94) 1.9 (168) 1.2
Tax on non-U.S. activities 64 (1.3) 47 (0.9) 7 (0.1)
Impact of CARES Act (5) 0.1 3 (0.1) (1,175) 8.1
Other provision adjustments 121 (2.4) 35 (0.8) 108 (0.8)
Audit settlements (587) 4.1
Income tax expense/(benefit) $31 (0.6)% ($743) 14.7 % ($2,535) 17.5 %
```

**Chunk 5:**
```
[FY2022 10K | Page 76] Table of Contents
Note 4 – Income Taxes
The components of Loss before income taxes were:
Years ended December 31, 2022 2021 2020
U.S. ($5,457) ($5,475) ($14,882)
Non-U.S. 435 442 406 
Total ($5,022) ($5,033) ($14,476)
Income tax (benefit)/expense consisted of the following:
Years ended December 31, 2022 2021 2020
Current tax (benefit)/expense
U.S. federal ($58) ($89) ($3,968)
Non-U.S. 142 147 148 
U.S. state (42) 42 21 
Total current 42 100 (3,799)
Deferred tax (benefit)/expense
U.S. federal (62) (855) 652 
Non-U.S. (3) (12)  
U.S. state 54 24 612 
Total deferred (11) (843) 1,264 
Total income tax expense/(benefit) $31 ($743) ($2,535)
Net income tax (refunds)/payments were ($1,317), ($1,480) and $37 in 2022, 2021 and 2020, respectively.
72
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `boeing`  (display: Boeing)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=boeing; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Boeing FY2022 effective tax rate.
2. Boeing FY2021 effective tax rate.
3. Boeing FY2022 versus FY2021 tax expense or benefit and tax-rate drivers.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 33 of 75  —  `diag_033`  **[PASSING]**

**fb_id:** `financebench_id_00552`
**company:** Microsoft
**doc:** MICROSOFT_2023_10K
**question_type:** domain-relevant

### Question

Has Microsoft increased its debt on balance sheet between FY2023 and the FY2022 period?

### Gold answer

> No. Microsoft decreased its debt by $2.5bn in FY 2023 vs FY 2022.

### V1 system answer (for HALLU_GROUNDED labeling)

```
**No — Microsoft did not increase its total debt between FY2022 and FY2023; it decreased.**

According to Microsoft's FY2023 10-K, total debt on the balance sheet moved as follows:

| Item | FY2023 | FY2022 | Change |
|---|---|---|---|
| Total face value | $52,866M | $55,511M | −$2,645M |
| Unamortized discount & issuance costs | ($438M) | ($471M) | |
| Hedge fair value adjustments | ($106M) | ($68M) | |
| Premium on debt exchange | ($5,085M) | ($5,191M) | |
| **Total debt** | **$47,237M** | **$49,781M** | **−$2,544M** |
| Current portion of long-term debt | $5,247M | $2,749M | |
| Long-term debt | $41,990M | $47,032M | |

[Source: MICROSOFT_2023_10K.pdf, Page 81]

This is corroborated by the balance sheet, which shows long-term debt declining from $47,032M to $41,990M, and the current portion rising from $2,749M to $5,247M — reflecting debt maturities coming due rather than new borrowing. [Source: MICROSOFT_2023_10K.pdf, Page 60]

---

**Bottom line:** Microsoft's total debt **decreased by ~$2.5 billion (~5.1%)**, from $49,781M in FY2022 to $47,237M in FY2023 — driven primarily by a reduction in total face value outstanding.
```

### V1 retrieved chunks (top 5 of 6 — for HALLU_GROUNDED)

**Chunk 1:**
```
[Company: Microsoft Inc. | FY2023 10K | Page 81] f $
2.3
billion
2042
3.50
%
3.57
%
454
1,204
2013
issuance of $
5.2
billion
2023
–
2043
3.63
%
–
4.88
%
3.73
%
–
4.92
%
1,814
2,814
2013
issuance of € 4.1
billion
2028
–
2033
2.63
%
–
3.13
%
2.69
%
–
3.22
%
2,509
2,404
2015
issuance of $
23.8
billion
2025
–
2055
2.70
%
–
4.75
%
2.77
%
–
4.78
%
9,805
10,805
2016
issuance of $
19.8
billion
2023
–
2056
2.00
%
–
3.95
%
2.10
%
–
4.03
%
9,430
9,430
2017
issuance of $
17.0
billion
2024
–
2057
2.88
%
–
4.50
%
3.04
%
–
4.53
%
8,945
8,945
2020
issuance of $
10.0
billion
2050
–
2060
2.53
%
–
2.68
%
2.53
%
–
2.68
%
10,000
10,000
2021
issuance of $
8.2
billion
2052
–
2062
2.92
%
–
3.04
%
2.92
%
–
3.04
%
8,185
8,185
Total face value
52,866
55,511
Unamortized discount and issuance costs
(
438
)
(
471
)
Hed...
```

**Chunk 2:**
```
[Company: Microsoft Inc. | FY2023 10K | Page 60] sets, net
9,366
11,298
Other long-term assets
30,601
21,897
Total assets
$
411,976
$
364,840
Liabilities and stockholders’ equity
Current liabilities: Accounts payable
$
18,095
$
19,000
Current portion of long-term debt
5,247
2,749
Accrued compensation
11,009
10,661
Short-term income taxes
4,152
4,067
Short-term unearned revenue
50,901
45,538
Other current liabilities
14,745
13,067
Total current liabilities
104,149
95,082
Long-term debt
41,990
47,032
Long-term income taxes
25,560
26,069
Long-term unearned revenue
2,912
2,870
Deferred income taxes
433
230
Operating lease liabilities
12,728
11,489
Other long-term liabilities
17,981
15,526
Total liabilities
205,753
198,298
Commitments and contingencies
Stockholders’ equity:
Common stock and pai...
```

**Chunk 3:**
```
[Company: Microsoft Inc. | FY2023 10K | Page 81] m on debt exchange
(
5,085
)
(
5,191
)
Total debt
47,237
49,781
Current portion of long-term debt
(
5,247
)
(
2,749
)
Long-term debt
$
41,990
$
47,032 (a)
Refer to Note 5 – Derivatives for further information on the interest rate swaps related to fixed-rate debt.
As of June 30, 2023 and 2022, the estimated fair value of long-term debt, including the current portion, was $
46.2
billion and $
50.9
billion, respectively.
The estimated fair values are based on Level 2 inputs.
Debt in the table above is comprised of senior unsecured obligations and ranks equally with our other outstanding obligations. Interest is paid semi-
annually, except for the Euro-denominated debt, which is paid annually. Cash paid for interest on our debt for fiscal years ...
```

**Chunk 4:**
```
[Company: Microsoft Inc. | FY2023 10K | Page 51]  June 30, 2023:
(In millions)
2024
Thereafter
Total
Long-term debt:
Principal payments
$
5,250
$
47,616
$
52,866
Interest payments
1,379
19,746
21,125 Construction commitments
12,237
1,218
13,455
Operating and finance leases, including imputed interest
5,988
73,852
79,840
Purchase commitments
64,703
3,115
67,818
Total
$
89,557
$
145,547
$
235,104
(a)
Refer to Note 11 – Debt of the Notes to Financial Statements (Part II, Item 8 of this Form 10-K).
(b)
Refer to Note 7 – Property and Equipment of the Notes to Financial Statements (Part II, Item 8 of this Form 10-K).
(c)
Refer to Note 14 – Leases of the Notes to Financial Statements (Part II, Item 8 of this Form 10-K).
(d)
Purchase commitments primarily relate to datacenters and include open pur...
```

**Chunk 5:**
```
[Company: Microsoft Inc. | FY2023 10K | Page 72]  2
498
1
(
24
)
475
0
475
0
Mortgage- and asset-
backed securities
Level 2
824
1
(
39
)
786
0
786
0
Corporate notes and bonds
Level 2
10,809
8
(
583
) 10,234
0
10,234
0
Corporate notes and bonds
Level 3
120
0
0
120
0
120
0
Municipal securities
Level 2
285
1
(
18
)
268
7
261
0
Municipal securities
Level 3
103
0
(
16
)
87
0
87
0
Total debt investments
$
99,869
$
13
$
(
4,550
)
$
95,332
$
18,780
$
76,552
$
0
Changes in Fair Value
Recorded in Net Income
Equity investments
Level 1
$
10,138
$
7,446
$
0
$
2,692
Equity investments
Other
7,187
0
0
7,187
Total equity investments
$
17,325
$
7,446
$
0
$
9,879
Cash
$
8,478
$
8,478
$
0
$
0
Derivatives, net
6
0
6
0
Total
$
121,141
$
34,704
$
76,558
$
9,879
72
(a)
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `microsoft`  (display: Microsoft)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=microsoft; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Microsoft FY2023 total debt.
2. Microsoft FY2022 total debt.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 34 of 75  —  `diag_034`  **[PASSING]**

**fb_id:** `financebench_id_01491`
**company:** Johnson & Johnson
**doc:** JOHNSON_JOHNSON_2023_8K_dated-2023-08-30
**question_type:** novel-generated

### Question

What is the amount of the cash proceeds that JnJ realised from the separation of Kenvue (formerly Consumer Health business segment), as of August 30, 2023?

### Gold answer

> JnJ realised $13.2 billion in cash proceeds from the separation of Kenvue.

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the provided context, Johnson & Johnson generated **$13.2 billion in cash proceeds** from the Kenvue debt offering and initial public offering (IPO) as a result of the separation of its Consumer Health business.

[Source: JOHNSON_JOHNSON_2023_8K_dated-2023-08-30.pdf, Page 6]

Additionally, Johnson & Johnson retained a **9.5% equity stake** in Kenvue common stock following the transaction, which the Company intended to monetize in a tax-efficient manner within the next year. [Source: JOHNSON_JOHNSON_2023_8K_dated-2023-08-30.pdf, Page 6]

**Bottom line:** As of August 30, 2023, J&J realized **$13.2 billion in cash proceeds** from the separation of Kenvue (formerly its Consumer Health business segment), comprising proceeds from both the Kenvue debt offering and its initial public offering.
```

### V1 retrieved chunks (top 4 of 4 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 8K | Page 4] c., formerly Johnson &
Johnson’s Consumer Health business. As a result of the completion of the exchange offer, Johnson & Johnson will now present its Consumer Health business financial results as discontinued operations, including a gain of approximately $20 billion in the third quarter of
2023.
```

**Chunk 2:**
```
[FY2023 8K | Page 4] are count by approximately 191 million; 2023 guidance reflects only a partial-year benefitof approximately 73.5 million shares or $0.28 benefit to EPS • Company secured $13.2 billion in cash proceeds from the Kenvue debt offering and initial public offering and maintains 9.5%
of equity stake in Kenvue
• Company maintains its quarterly dividend of $1.19 per share
New Brunswick, N.J. (August 30, 2023) – Johnson & Johnson (NYSE: JNJ) (“the Company”) today announced updates to its financials and
2023 guidance which reflect its operations as a company focused on transformational innovation in Pharmaceutical and MedTech. The
Company has published a recorded webinar for investors to provide additional context behind the updated financials and 2023 guidance
found in this relea...
```

**Chunk 3:**
```
[FY2023 8K | Page 6] ll Year 2023 Projected Average Shares Outstanding (Diluted) only reflects impact from the Kenvue exchange offerNote: percentages may have been rounded Following completion of the Kenvue exchange offer, the Company has reduced its outstanding share count by the approximately 191 million
shares of common stock accepted in the exchange offer.
The weighted average shares outstanding used in the calculation of the August 2023 Guidance for Adjusted Diluted EPS reflects the net
reduction of approximately 73.5 million shares of Johnson & Johnson outstanding common stock as a result of the Kenvue exchange offer.
Because this net reduction occurred on August 23, 2023, Johnson & Johnson will recognize only a partial-year benefit of $0.28 to its full-year
2023 Adjusted Diluted EPS...
```

**Chunk 4:**
```
[FY2023 8K | Page 6] ted EPS.
The Company generated $13.2 billion in cash proceeds as result of the Kenvue debt offering and initial public offering. Additionally, Johnson & Johnson maintains a 9.5% stake in Kenvue common stock, which provides the Company the opportunity to monetize the retained stake in
a tax efficient manner in the next year, subject to a
6
1,2,5
2,5
3,5
2,4
3,4
8 7
1
2
3
4
5
6
7
8
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `johnson_johnson`  (display: Johnson & Johnson)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=johnson_johnson; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 35 of 75  —  `diag_035`  **[FAILING]**  audit=WRONG_DIRECTION

**fb_id:** `financebench_id_00499`
**company:** 3M
**doc:** 3M_2022_10K
**question_type:** domain-relevant

### Question

Is 3M a capital-intensive business based on FY2022 data?

### Gold answer

> No, the company is managing its CAPEX and Fixed Assets pretty efficiently, which is evident from below key metrics:
CAPEX/Revenue Ratio: 5.1%
Fixed assets/Total Assets: 20%
Return on Assets= 12.4%

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Is 3M a Capital-Intensive Business? (FY2022 Analysis)

### Key Capital Metrics from FY2022

| Metric | FY2022 | FY2021 |
|--------|--------|--------|
| Purchases of PP&E (Capex) | $1,749M | $1,603M |
| Net cash from operating activities | $5,591M | $7,454M |
| Free cash flow | $3,842M | $5,851M |
| Net income attributable to 3M | $5,777M | $5,921M |
| Free cash flow conversion | 66% | 99% |

[Source: 3M_2022_10K.pdf, Page 41]

### Supporting Evidence

- **Capex as % of Operating Cash Flow**: $1,749M / $5,591M = **~31%** — a meaningful but not extreme ratio.
- **Environmental capex alone** was ~$317M in FY2022, with $646M projected for 2023–2024 in aggregate [Source: 3M_2022_10K.pdf, Page 7].
- **2023 capital spending guidance** of **$1.5B–$1.8B** signals continued significant investment [Source: 3M_2022_10K.pdf, Page 39].
- 3M explicitly states that investing in the business (R&D, capex, commercialization) is its **first priority** for capital deployment [Source: 3M_2022_10K.pdf, Page 37].

### Assessment

3M exhibits **moderate capital intensity** — not at the extreme end (e.g., utilities or heavy industrials), but clearly requires substantial ongoing investment. The ~31% capex

[... truncated, total 1700 chars]
```

### V1 retrieved chunks (top 4 of 4 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 39] ses and proceeds from maturities and sale of marketable securities and investments, net
11
204
Proceeds from sale of businesses, net of cash sold
13
— Cash payment from Food Safety business split-off, net of divested cash
478
—
Other — net
1
31
Net cash provided by (used in) investing activities
$
(1,046)
$
(1,317)
Investments in property, plant and equipment enable growth across many diverse markets, helping to meet product demand and increasing manufacturing efficiency. The
Company expects 2023 capital spending to be approximately $1.5 billion to $1.8 billion as 3M continues to invest in growth, productivity and sustainability.
3M records capital-related government grants earned as reductions to the cost of property, plant and equipment; and associated unpaid liabi...
```

**Chunk 2:**
```
[FY2022 10K | Page 7]  approximately $317 million on capital projects for environmental purposes as defined below. Capital projects for environmental purposes include waste reduction and pollution control programs such as, water usage reduction and water quality improvement equipment, scrubbers, containment structures, solvent recovery units
and thermal oxidizers. Capital expenditures for similar projects are presently expected to approach approximately $646 million for 2023 and 2024 in aggregate.
Although an estimate of certain nearer-term capital expenditures is provided above, 3M cannot predict with certainty whether future costs of compliance with government
regulations (including environmental regulations) will have a material effect on its capital expenditures, earnings or competitiv...
```

**Chunk 3:**
```
[FY2022 10K | Page 37] T
able of
Contents
FINANCIAL CONDITION AND LIQUIDITY
The strength and stability of 3M’s business model and strong free cash flow capability, together with proven capital markets access, provide financial flexibility to deploy
capital in accordance with the Company's stated priorities and meet needs associated with contractual commitments and other obligations. Investing in 3M’s business to drive
organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and
commercialization capability. The Company also continues to actively manage its portfolio through acquisitions and divestitures to maximize value for shareholders. 3M
```

**Chunk 4:**
```
[FY2022 10K | Page 41]  components of the calculation of free cash flow. Refer to the preceding “Results of Operations” section for discussion of items that impacted the net income attributable to 3M component of the calculation of free cash flow conversion.
Year ended December 31, (Millions)
2022
2021
Major GAAP Cash Flow Categories
Net cash provided by (used in) operating activities
$
5,591
$
7,454
Net cash provided by (used in) investing activities
(1,046)
(1,317)
Net cash provided by (used in) financing activities
(5,350)
(6,145)
Free Cash Flow (non-GAAP measure)
Net cash provided by (used in) operating activities
$
5,591
$
7,454
Purchases of property, plant and equipment
(1,749)
(1,603)
Free cash flow
3,842
5,851
Net income attributable to 3M
$
5,777
$
5,921
Free cash flow conversion
...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `3m`  (display: 3M)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=3m; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Capital-intensity conclusion is grounded in retrieved capex, cash-flow, and capital-deployment evidence.

---
## Record 36 of 75  —  `diag_036`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_04417`
**company:** Best Buy
**doc:** BESTBUY_2019_10K
**question_type:** metrics-generated

### Question

What is the year end FY2019 total amount of inventories for Best Buy? Answer in USD millions. Base your judgments on the information provided primarily in the balance sheet.

### Gold answer

> $5409.00

### V1 system answer (for HALLU_GROUNDED labeling)

```
I couldn't find relevant information in the available documents to answer your question.
This could mean the information isn't in the documents I have access to, or the question
may need to be rephrased. Could you try asking in a different way?
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```

```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `best_buy`  (display: Best Buy)
- **Auto target_fiscal_year:** `2019`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=best_buy; override if wrong)

**TARGET_YEAR:** `OK` (auto=2019; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Empty retrieval; refusal is grounded.

---
## Record 37 of 75  —  `diag_037`  **[PASSING]**

**fb_id:** `financebench_id_00464`
**company:** Boeing
**doc:** BOEING_2022_10K
**question_type:** novel-generated

### Question

Is Boeing's business subject to cyclicality?

### Gold answer

> Yes, Boeing's business is subject to cyclicality due to its exposure to the airline industry which is a cyclical industry.

### V1 system answer (for HALLU_GROUNDED labeling)

```
Yes, Boeing's business is explicitly subject to cyclicality. Both the 2022 and 2018 10-K filings consistently describe the airline industry — Boeing's primary commercial customer base — as inherently cyclical.

Specifically, Boeing states: *"the airline industry has been cyclical and very competitive and has experienced significant profit swings and constant challenges to be more cost competitive."* [Source 1: BOEING_2022_10K.pdf, Page 8] [Source 3: BOEING_2018_10K.pdf, Page 7]

Key drivers of this cyclicality include:
- **Macroeconomic conditions** – demand for commercial aircraft is heavily influenced by sustained economic growth and political stability [Source 2: BOEING_2022_10K.pdf, Page 8]
- **Airline profitability** – swings in airline financial health directly affect new aircraft orders [Source 2: BOEING_2022_10K.pdf, Page 8]
- **External shocks** – fuel prices, terrorism, pandemics, epidemics, and trade policies all amplify cyclical swings [Source 2: BOEING_2022_10K.pdf, Page 8]
- **Long backlog exposure** – because Boeing's commercial aircraft backlog spans several years of deliveries, cyclical downturns can affect the business over an extended period [Source 1: BOEING_202

[... truncated, total 1532 chars]
```

### V1 retrieved chunks (top 4 of 4 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 8] lly, the
airline industry has been cyclical and very competitive and has experienced significant profit swings and constant challenges to be more cost competitive. Significant deterioration in the global economic environment, the airline industry generally or the financial stability of one or more of
our major customers could result in fewer new orders for aircraft or services, or could cause customers to seek to postpone or cancel contractual
orders and/or payments to us, which could result in lower revenues, profitability and cash flows and a reduction in our contractual backlog. In
addition, because our commercial aircraft backlog consists of aircraft scheduled for delivery over a period of several years, any of these
macroeconomic, industry or customer impacts cou...
```

**Chunk 2:**
```
[FY2022 10K | Page 8] nique risks.
Market conditions have a significant impact on demand for our commercial aircraft and related services. The commercial aircraft market is predominantly driven by long-term trends in airline passenger and cargo traffic. The principal factors underlying long-term traffic growth are
sustained economic growth and political stability both in developed and emerging markets. Demand for our commercial aircraft is further
influenced by airline profitability, availability of aircraft financing, world trade policies, government-to-government relations, technological
advances, price and other competitive factors, fuel prices, terrorism, pandemics, epidemics and environmental regulations. Historically, the
airline industry has been cyclical and very competitive and ha...
```

**Chunk 3:**
```
[10K | Page 7] conditions
have
a
significant
impact
on
demand
for
our
commercial
aircraft
and
related
services. The  commercial  aircraft  market  ispredominantly  driven  by  long-term  trends  in  airline  passenger  and  cargo  traffic. The  principal  factors  underlying  long-term  traffic  growth  aresustained economic growth and political stability both in developed and emerging markets. Demand for our commercial aircraft is further influencedby airline profitability, availability of aircraft financing, world trade policies, government-to-government relations, technological advances, price andother competitive factors, fuel prices, terrorism, epidemics and environmental regulations. Traditionally, the airline industry has been cyclical andvery  competitive  and  has  experienced  si...
```

**Chunk 4:**
```
[10K | Page 7] has been cyclical andvery  competitive  and  has  experienced  significant  profit  swings  and  constant  challenges  to  be  more  cost  competitive has been cyclical andvery  competitive  and  has  experienced  significant  profit  swings  and  constant  challenges  to  be  more  cost  competitive In  addition,  availability  offinancing to non-U.S. customers depends in part on the Export-Import Bank of the United States being fully operational. Significant deterioration inthe global economic environment, the airline industry generally, or the financial stability of one or more of our major customers could result in fewernew orders for aircraft or services, or could cause customers to seek to postpone or cancel contractual orders and/or payments to us, which couldresult i...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `boeing`  (display: Boeing)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=boeing; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 38 of 75  —  `diag_038`  **[FAILING]**  audit=WRONG_NUMBER

**fb_id:** `financebench_id_04171`
**company:** MGM Resorts
**doc:** MGMRESORTS_2018_10K
**question_type:** metrics-generated

### Question

Basing your judgments off of the balance sheet, what is the year end FY2018 amount of accounts payable for MGM Resorts? Answer in USD millions.

### Gold answer

> $303.00

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the balance sheet provided, the accounts payable figure shown is for **MGM Growth Properties** (a subsidiary/joint venture of MGM Resorts), not MGM Resorts International's consolidated balance sheet.

The accounts payable shown is **$25,758** (in thousands), or approximately **$25.8 million** for the entity reflected in this filing. [Source: MGMRESORTS_2018_10K.pdf, Page 174]

However, this appears to be a subsidiary-level balance sheet (likely MGM Growth Properties LLC), not the consolidated MGM Resorts International balance sheet, as evidenced by the "Members' equity" line item and "Due to MGM Resorts International" line — indicating this is a separate legal entity.

---

**Bottom line (Partial evidence):** The accounts payable on this particular balance sheet is **~$25.8 million** as of FY2018 year-end [Source: MGMRESORTS_2018_10K.pdf, Page 174], but this reflects a subsidiary entity, not MGM Resorts International's consolidated accounts payable figure. The consolidated MGM Resorts International accounts payable is not available in the provided context.
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 174]   24,938  Assets held for sale  –    356,692      Total current assets  363,755   708,909          Property
and
equipment,
net
  6,128,076   6,239,915 Other
assets,
net
39,777    40,559    $6,531,608  $6,989,383 LIABILITIES
AND
MEMBERS'
EQUITY
Current
liabilities
Accounts payable $25,758   $24,950  Construction payable  9,212    36,327  Current portion of long-term debt  18,015    16,000  Current portion of capital lease obligation  4,225    –  Due to MGM Resorts International  82,701    77,006  Other accrued liabilities  207,799   184,454 Liabilities related to assets held for sale  –    9,494       Total current liabilities  347,710   348,231          Long-term
debt,
net
1,729,829   1,545,797 Capital
lease
obligation,
less
current
portion
15,149    –  Other
long-term
obl...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `mgm_resorts`  (display: MGM Resorts)
- **Auto target_fiscal_year:** `2018`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=mgm_resorts; override if wrong)

**TARGET_YEAR:** `OK` (auto=2018; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Answer is grounded in the retrieved subsidiary-level balance sheet and its caveat.

---
## Record 39 of 75  —  `diag_039`  **[FAILING]**  audit=DATASET_SUSPECT

**fb_id:** `financebench_id_00601`
**company:** Ulta Beauty
**doc:** ULTABEAUTY_2023Q4_EARNINGS
**question_type:** novel-generated

### Question

What drove the reduction in SG&A expense as a percent of net sales in FY2023?

### Gold answer

> Lower marketing expenses and leverage of incentive compensation due to higher sales. The answer here assumes FY2023 refers to the 12 months ended on January 28, 2023 (although the company refers to this period as its fiscal 2022.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Drivers of SG&A Expense Reduction as a % of Net Sales in FY2023 (Amcor)

### Key Figures

| Metric | FY2022 | FY2023 | Change |
|---|---|---|---|
| SG&A expense | $(1,284)M | $(1,246)M | −$38M (−3%) |
| Net sales | $14,544M | $14,694M | +$150M (+1.0%) |
| SG&A as % of net sales | (8.8)% | (8.5)% | −0.3 pp improvement |

[Source: AMCOR_2023_10K.pdf, Page 33; AMCOR_2023_10K.pdf, Page 29; AMCOR_2023Q4_EARNINGS.pdf, Page 8]

### Primary Driver

**Exchange rate movements** were the primary driver of the SG&A reduction. As stated directly in the 10-K:

> *"SG&A decreased by $38 million, or 3%, in fiscal year 2023, compared to fiscal year 2022. The decrease was primarily driven by exchange rate movements."*
> [Source: AMCOR_2023_10K.pdf, Page 33]

### Supporting Mechanics

Two factors combined to improve the ratio:
1. **Numerator decline**: Favorable currency translation reduced absolute SG&A by $38M (the primary driver per management).
2. **Denominator growth**: Net sales grew modestly by $150M (+1.0%), which further diluted the SG&A ratio, though this was a secondary effect.

---

**Bottom line**: The 0.3 percentage point improvement in Amcor's SG&A as a percent of net sales (from 8.

[... truncated, total 1425 chars]
```

### V1 retrieved chunks (top 5 of 7 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 10Q | Page 40] enses
Six Months Ended December 31,
($ in millions) 2022 2021
SG&A expenses $ (600) $ (616)
SG&A expenses as a percentage of net sales (8.2 %) (8.9 %) SG&A expenses decreased by $16 million, or by 3%, for the six months ended December 31, 2022, compared to the six months ended
December 31, 2021. The decrease was primarily driven by currency movements during the six months ended December 31, 2022, partially offset
by inflationary impacts on labor costs.
Consolidated Restructuring and Related Activities, Net
Six Months Ended December 31,
($ in millions) 2022 2021
Restructuring and related activities, net $ 212 $ (18)
Restructuring and related activities, net, as a percentage of net sales 2.9 % (0.3 %)
```

**Chunk 2:**
```
[FY2023 10K | Page 33]  Administrative ("SG&A") Expenses
($ in millions) 2023 2022
SG&A expenses $ (1,246) $ (1,284)
SG&A expenses as a percentage of net sales (8.5)% (8.8)% SG&A decreased by $38 million, or 3%, in fiscal year 2023, compared to fiscal year 2022. The decrease was primarily driven by exchange
rate movements.
Consolidated Restructuring, Impairment and Other Related Activities, Net
($ in millions) 2023 2022
Restructuring, impairment, and other related activities, net $ 104 $ (234)
Restructuring, impairment, and other related activities, net, as a percentage of net sales 0.7 % (1.6)%
Restructuring, impairment, and other related activities, net decreased by $338 million, or 144%, in fiscal year 2023, compared to fiscal year
2022. The decrease in net expense was mainly a result o...
```

**Chunk 3:**
```
[FY2023 10K | Page 2]  and administrative (SG&A) expenses increased 17.3% to $762.7
million compared to $650.0 million in the fourth quarter of fiscal 2021. As a percentage of net sales, SG&A expenses decreased to 23.6% compared to 23.8% in the fourth
quarter of fiscal 2021, primarily due to leverage of marketing expenses and incentive
compensation due to higher sales, partially offset by deleverage of store payroll and
benefits due to wage investments and deleverage in corporate overhead due to
strategic investments.
Operating income increased 19.2% to $447.6 million, or 13.9% of net sales, compared
to $375.6 million, or 13.8% of net sales, in the fourth quarter of fiscal 2021.
The tax rate increased to 24.6% compared to 22.9% in the fourth quarter of fiscal
2021.
Net income increased 17....
```

**Chunk 4:**
```
[FY2023 10K | Page 2] les increased 15.6% compared to an increase of 37.9% in fiscal 2021,
driven by a 10.8% increase in transactions and a 4.3% increase in average ticket. Gross profit increased 20.1% to $4.0 billion compared to $3.4 billion in fiscal 2021. As
a percentage of net sales, gross profit increased to 39.6% compared to 39.0% in fiscal
2021, primarily due to leverage of fixed costs, strong growth in other revenue, and
favorable channel mix shifts, partially offset by higher inventory shrink and lower
merchandise margin.
SG&A expenses increased 16.2% to $2.4 billion compared to $2.1 billion in fiscal
2021. As a percentage of net sales, SG&A expenses decreased to 23.5% compared to
23.9% in fiscal 2021, primarily due to lower marketing expenses and leverage of
incentive compensatio...
```

**Chunk 5:**
```
[FY2023 10K | Page 33] ry pressures.
Consolidated Gross Profit
($ in millions) 2023 2022
Gross profit $ 2,725 $ 2,820
Gross profit as a percentage of net sales 18.5 % 19.4 % Gross profit decreased by $95 million, or 3%, in fiscal year 2023, compared to fiscal year 2022. Excluding negative currency impacts of $78
million, the negative impact from disposed and ceased operations of $73 million, the remaining variation in gross profit for fiscal year 2023 was
an increase of $56 million, reflecting favorable operating cost performance. Gross profit as a percentage of sales decreased to 18.5% in fiscal
year 2023, mainly from the impact on the calculation from the pass-through of higher raw material costs during the current fiscal period and the
impact of disposed operations.
Consolidated Selling...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `ulta_beauty`  (display: Ulta Beauty)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=ulta_beauty; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Ulta Beauty FY2023 SG&A expense as a percent of net sales.
2. Ulta Beauty prior-year SG&A expense as a percent of net sales.
3. Management discussion of drivers of SG&A expense leverage or reduction.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** The answer is grounded in the retrieved Amcor chunks, even though retrieval/entity selection is wrong for the Ulta question.

---
## Record 40 of 75  —  `diag_040`  **[FAILING]**  audit=PASS_OTHER

**fb_id:** `financebench_id_00215`
**company:** Verizon
**doc:** VERIZON_2022_10K
**question_type:** domain-relevant

### Question

Is Verizon a capital intensive business based on FY 2022 data?

### Gold answer

> Yes. Verizon's capital intensity ratio was approximately 2.774729. This means that it took approximately $2.77 of assets to generate $1 of revenue and thus, Verizon can be considered capital intensive.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Is Verizon a Capital-Intensive Business? (FY2022 Analysis)

Yes, Verizon is clearly a capital-intensive business. Here is the supporting evidence:

### Key FY2022 Financial Metrics

| Metric | FY2022 | FY2021 |
|---|---|---|
| Operating Revenues | $136,835M | $133,613M |
| Cash Flows from Operations | $37,141M | $39,539M |
| Capital Expenditures (CapEx) | $23,087M | $20,286M |
| Free Cash Flow | $14,054M | $19,253M |

[Source: VERIZON_2022_10K.pdf, Pages 21 & 42]

### Key Ratios Indicating Capital Intensity

- **CapEx as % of Revenue**: $23,087M ÷ $136,835M = **~16.9%** — a high ratio indicative of capital-intensive industries
- **CapEx as % of Operating Cash Flow**: $23,087M ÷ $37,141M = **~62.2%** — meaning nearly two-thirds of operating cash flow was consumed by capital expenditures
- **Free Cash Flow Conversion**: Free cash flow of $14,054M represents only ~38% of operating cash flow, with the remainder absorbed by CapEx

### Additional Context
- Verizon also recorded **$1.7 billion in capitalized interest** related to wireless licenses in 2022 alone [Source: VERIZON_2022_10K.pdf, Page 39], further underscoring the scale of capital deployment required to maintain and expand 

[... truncated, total 1670 chars]
```

### V1 retrieved chunks (top 3 of 3 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 39] of the previously expected December 2023 timeframe. During 2022, Verizon made payments of
approximately $310 million associated with these agreements. During 2022 and 2021, we recorded capitalized interest related to wireless licenses of $1.7 billion and $1.6 billion, respectively.
During 2022 and 2021, we entered into and completed various other wireless license acquisitions for cash consideration of an
insignificant amount and $95 million, respectively.
Cash Received (Paid) Related to Acquisitions of Businesses, Net of Cash Acquired
In September 2020, we entered into a purchase agreement to acquire TracFone, a provider of prepaid and value mobile services
in the U.S. The transaction closed on November 23, 2021 (the Acquisition Date). The aggregate cash consideratio...
```

**Chunk 2:**
```
[FY2022 10K | Page 42] ed by operating activities $ 37,141 $ 39,539
Less Capital expenditures (including capitalized software) 23,087 20,286
Free cash flow $ 14,054 $ 19,253 The decrease in free cash flow during 2022 is a reflection of the decrease in operating cash flows, as well as the increase in
capital expenditures, both of which are discussed above.
Verizon 2022 Annual Report on Form 10-K                                42
```

**Chunk 3:**
```
[FY2022 10K | Page 21] urth-generation (4G)
and fifth-generation (5G) wireless networks. We expect that our next-generation multi-use platform, which we call the Intelligent Edge Network, will simplify operations by eliminating legacy network elements, speed the deployment of 5G wireless technology
and create new opportunities in the business market in a cost efficient manner. Our network leadership is the hallmark of our
brand and the foundation for the connectivity, platforms and solutions upon which we build our competitive advantage.
Highlights of Our 2022 Financial Results
(dollars in millions)
Operating Revenues
$136,835 $133,613
2022 2021
Operating Income
$30,467
$32,448
2022 2021
Net Income
$21,748 $22,618
2022 2021
Cash Flows from
Operations
$37,141 $39,539
2022 2021
Capital Expen...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `verizon`  (display: Verizon)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=verizon; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 41 of 75  —  `diag_041`  **[FAILING]**  audit=PARTIAL_ANSWER

**fb_id:** `financebench_id_01107`
**company:** CVS Health
**doc:** CVSHEALTH_2022_10K
**question_type:** domain-relevant

### Question

Has CVS Health reported any materially important ongoing legal battles from 2022, 2021 and 2020?

### Gold answer

> Yes, CVS Health has been involved in multiple ongoing legal battles. Some notable legal dispute areas for CVS are: (1) usual and customary pricing litigation: where it's claimed that CVSâs retail pharmacies overcharged for prescription drugs; (2) PBM litigation and investigations: where it's claimed that that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products; and (3) controlled substances litigation: legal matters around opioids for which CVS has agreed to pay up to $4.3 billion to claimants in remediation and $625 million to attorneys and fees

### V1 system answer (for HALLU_GROUNDED labeling)

```
# CVS Health: Materially Important Ongoing Legal Battles (2020–2022)

Yes. CVS Health's FY2022 10-K explicitly discloses multiple ongoing legal matters described as potentially having **"a material effect on the Company's business, financial condition, operating results and/or cash flows"** [Source: CVSHEALTH_2022_10K.pdf, Page 175]. Below is a structured summary:

---

## 1. Opioid Litigation (Most Significant Category)

| Matter | Year | Status / Amount |
|---|---|---|
| Ohio federal court judgment | Nov 2021 verdict / Aug 2022 judgment | **$651M** jointly against 3 defendants, payable over 15 years; CVS **appealing**, **no liability accrued** |
| Florida state settlement | March 2022 | **$484M** over 18 years; **$484M liability recorded** in Q1 2022 |
| New Mexico state settlement | August 2022 | Agreement reached; terms not specified in filing |
| West Virginia state settlement | September 2022 | Agreement reached; terms not specified in filing |
| Cherokee Nation settlement | September 2022 | Agreement reached; terms not specified in filing |
| DOJ/DEA administrative subpoena | January 2020 | Seeking documents on opioid/controlled substance practices; potential CSA & False Cla

[... truncated, total 3540 chars]
```

### V1 retrieved chunks (top 5 of 7 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 174] al U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas,
CIDs, and other requests for information. In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; in August 2022, the court issued a
judgment jointly against the three defendants in the amount of $651 million to be paid over 15 years, and also ordered certain injunctive relief. The Company is
appealing the judgment and has not accrued a liability for this matter. In March 2022, CVS Health Corporation and CVS Pharmacy, Inc. entered into a
settlement agreement with the State of Florida to resolve claims related to opioid medications dating back more than a decade. Under the terms of the
settlement...
```

**Chunk 2:**
```
[FY2022 10K | Page 174] t agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $484 million, which is to be paid over a period of 18 years. During the three months ended March 31, 2022, the Company recorded a $484 million liability associated with this legal
settlement. In August 2022, CVS Pharmacy, Inc. entered into an agreement with the State of New Mexico to settle all opioid claims against it and its parents
and subsidiaries by the State of New Mexico and participating subdivisions. In September 2022, CVS Pharmacy, Inc. entered into an agreement with the State
of West Virginia to settle all opioid claims against it and its parents and subsidiaries by the State of West Virginia and participating subdivisions. Also in
Sep...
```

**Chunk 3:**
```
[FY2022 10K | Page 175] escription did not exist and that
these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims. U.S. ex rel. Gill et al. v. CVS Health Corp. et al. (U.S. District Court for the Northern District of Illinois). In July 2022, the Delaware Attorney General’s Office
moved for partial intervention as to allegations under the Delaware false claims act related to not escheating alleged overpayments in this previously sealed qui
tam case. The federal government and the remaining states declined to intervene on other additional theories in the relator’s complaint. The Company is
defending itself against all of the claims.
In July 2017, the Company also received a subpoena from the California Department of Insurance reques...
```

**Chunk 4:**
```
[FY2022 10K | Page 177] th prejudice in February 2021. Plaintiffs appealed that decision to the First Circuit after their motion for reconsideration was denied, and in August 2022 the First Circuit affirmed the dismissal. In re CVS Health Corp. Securities Act Litigation (formerly known as Waterford) and In re CVS Health Corp.
Securities Litigation (formerly known as City of Warren and Freundlich) have been stayed pending the outcome of the First Circuit appeal. Plaintiffs in both
cases have since filed amended complaints, which the Company has moved to dismiss.
In August and September 2020, two class actions under the Employee Retirement Income Security Act of 1974 (“ERISA”) were filed in the U.S. District Court
for the District of Connecticut against CVS Health, Aetna, and several current...
```

**Chunk 5:**
```
[FY2022 10K | Page 175] s and assertions that have merit, the Company is not able to reasonably estimate the range of ultimate possible loss for all opioid-related litigation matters at this time. The outcome of these legal matters could have a material effect on the Company’s business, financial condition, operating results and/or
cash flows.
In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to
prescription opioids and other controlled substances at CVS pharmacy locations concerning potential violations of the federal Controlled Substances Act and
the federal False Claims Act. In January 2022, the DOJ served the Company with a CID regarding similar subjects, and the Company is providing documents...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `cvs_health`  (display: CVS Health)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=cvs_health; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Shown legal-matter claims are supported by the CVS legal-proceedings chunks.

---
## Record 42 of 75  —  `diag_042`  **[FAILING]**  audit=WRONG_NUMBER

**fb_id:** `financebench_id_03856`
**company:** Adobe
**doc:** ADOBE_2017_10K
**question_type:** metrics-generated

### Question

What is the FY2017 operating cash flow ratio for Adobe? Operating cash flow ratio is defined as: cash from operations / total current liabilities. Round your answer to two decimal places. Please utilize information provided primarily within the balance sheet and the cash flow statement.

### Gold answer

> 0.83

### V1 system answer (for HALLU_GROUNDED labeling)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Adobe FY2017 Operating Cash Flow Ratio

### Confirmed Data Points

| Item | Value | Source |
|------|-------|--------|
| Cash from Operations (FY2017) | $2,912.9 million | [Source 4: ADOBE_2017_10K.pdf, Page 49] |
| Total Current Liabilities (FY2017 year-end) | **Not directly retrieved** from FY2017 10K balance sheet | — |
| Total Current Liabilities (FY2016 year-end) | $2,811.635 million | [Source 3: ADOBE_2016_10K.pdf, Page 61] |

### Key Limitation

The FY2017 10K balance sheet was **not retrieved** in the available chunks. The only balance sheet data available is from [Source 3: ADOBE_2016_10K.pdf, Page 61], which shows **FY2016 year-end** total current liabilities of **$2,811,635 thousand** — this would appear as the *prior-year comparative* column on the FY2017 10K balance sheet, not the FY2017 ending figure.

### Best-Available Computation

Using the FY2016 year-end current liabilities as the closest available proxy (with explicit caveat):

$$\text{Operating Cash Flow Ratio} = \frac{\$2,912.9M}{\$2,811.6M} = \mathbf{1.04}$$

---

**Bottom line (partial

[... truncated, total 1685 chars]
```

### V1 retrieved chunks (top 5 of 6 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 40] o increases in Creative Cloud team and individual
subscriptions, and new contracts and the timing of renewals for our Adobe Experience Cloud services. • Cost of revenue of $1.01 billion increased by $190.6 million, or 23%, during fiscal 2017, from $819.9 million in fiscal
2016. The increase was primarily due to increases in media costs associated with our Advertising Cloud offerings, data
center and hosting costs and increased headcount.
• Operating expenses of $4.12 billion increased by $582.0 million, or 16%, during fiscal 2017, from $3.54 billion in
fiscal 2016. The increase was primarily due to increased headcount and stock based compensation expense.
• Net income of $1.69 billion increased by $525.2 million, or 45%, during fiscal 2017 from $1.17 billion in fiscal 2016
...
```

**Chunk 2:**
```
[10K | Page 49] ds from participation
in the employee stock purchase plan. Other uses of cash include our stock repurchase program, which is described below, business acquisitions and purchases of property and equipment.
Cash Flows from Operating Activities
For fiscal 2017, net cash provided by operating activities of $2.91 billion was primarily comprised of net income plus the
net effect of non-cash items. The primary working capital sources of cash were net income coupled with increases in deferred
revenue and accrued expenses. The increase in deferred revenue was primarily due to increased subscriptions for our Creative
Cloud offerings and increases in Digital Marketing hosted services. The increase in accrued expenses is primarily due to the
increase in accruals for compensation costs ...
```

**Chunk 3:**
```
[10K | Page 61] sets 149,758 159,832
Total assets $ 12,707,114 $ 11,726,472
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Trade payables $ 88,024 $ 93,307 Accrued expenses 739,630 679,884
Income taxes payable 38,362 6,165
Deferred revenue 1,945,619 1,434,200
Total current liabilities 2,811,635 2,213,556
Long-term liabilities:
Debt and capital lease obligations 1,902,068 1,907,231
Deferred revenue 69,131 51,094
Income taxes payable 184,381 256,129
Deferred income taxes 217,660 208,209
Other liabilities 97,404 88,673
Total liabilities 5,282,279 4,724,892
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value; 2,000 shares authorized; none issued — —
Common stock, $0.0001 par value; 900,000 shares authorized; 600,834 shares issued;
494,254 and 497,8...
```

**Chunk 4:**
```
[10K | Page 49] ,720.4 $ 3,028.1
Stockholders’ equity $ 8,459.9 $ 7,424.8
A summary of our cash flows is as follows:
(in millions)
Fiscal
2017
Fiscal
2016
Fiscal
2015 Net cash provided by operating activities $ 2,912.9 $ 2,199.7 $ 1,469.5
Net cash used for investing activities (442.9) (960.0) (1,488.4)
Net cash used for financing activities (1,183.7) (1,090.7) (200.7)
Effect of foreign currency exchange rates on cash and cash
equivalents 8.5 (14.2) (21.2)
Net increase (decrease) in cash and cash equivalents $ 1,294.8 $ 134.8 $ (240.8)
Our primary source of cash is receipts from revenue. The primary uses of cash are payroll related expenses, general operating
expenses including marketing, travel and office rent, and cost of revenue. Other sources of cash are proceeds from participation
in t...
```

**Chunk 5:**
```
[FY2022 10K | Page 57]  and
assumed liabilities:
Trade receivables, net  (198)  (430)  106
Prepaid expenses and other assets  (94)  (475)  (288)
Trade payables  66  (20)  96 Accrued expenses and other liabilities  7  162  86
Income taxes payable  19  2  (72)
Deferred revenue  536  1,053  258
Net cash provided by operating activities  7,838  7,230  5,727
Cash flows from investing activities:
Purchases of short-term investments  (909)  (1,533)  (1,071)
Maturities of short-term investments  683  877  915
Proceeds from sales of short-term investments  270  191  167
Acquisitions, net of cash acquired  (126)  (2,682)  —
Purchases of property and equipment  (442)  (348)  (419)
Purchases of long-term investments, intangibles and other assets  (46)  (42)  (15)
Proceeds from sales of long-term inves...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `adobe`  (display: Adobe)
- **Auto target_fiscal_year:** `2017`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=adobe; override if wrong)

**TARGET_YEAR:** `OK` (auto=2017; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Adobe FY2017 cash from operations.
2. Adobe FY2017 total current liabilities.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Answer is grounded in retrieved cash-flow and FY2016 balance-sheet evidence, with caveats about missing FY2017 liabilities.

---
## Record 43 of 75  —  `diag_043`  **[FAILING]**  audit=PASS_NUMERIC_ROUNDING

**fb_id:** `financebench_id_00283`
**company:** Pfizer
**doc:** Pfizer_2023Q2_10Q
**question_type:** novel-generated

### Question

How much does Pfizer expect to pay to spin off Upjohn in the future in USD million?

### Gold answer

> 77.78

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the provided context, Pfizer expected to incur **total costs of approximately $700 million** in connection with separating Upjohn.

As of the most recent data point available:
- By **December 31, 2021**: approximately **75%** had already been incurred [Source: PFIZER_2021_10K.pdf, Page 32], implying ~$175 million remained.
- By **Q2 2023**: approximately **90%** had been incurred [Source: Pfizer_2023Q2_10Q.pdf, Page 41], implying ~**$70 million** remained to be paid in the future.

**Bottom line:** As of Q2 2023, Pfizer expected to pay approximately **$70 million** more in future Upjohn separation costs (i.e., the remaining ~10% of the total ~$700 million estimate). [Source: Pfizer_2023Q2_10Q.pdf, Page 41]
```

### V1 retrieved chunks (top 5 of 5 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 10Q | Page 41] le that extend and significantly improve their lives. In 2023, we are making additional investments in both R&D and SI&A to support Pfizer’s near- and longer-term growth plans, including to support anticipated new launches, commercial launch of COVID-19 products, potential pipeline programs and recently
acquired assets. We manage our commercial operations through a global structure consisting of two operating segments: Biopharma and Business Innovation.
Biopharma is the only reportable segment. See Note 13A.
We expect to incur costs of approximately $700 million in connection with separating Upjohn, of which approximately 90% has been incurred since inception
and through the second quarter of 2023. These charges include costs and expenses related to separation of leg...
```

**Chunk 2:**
```
[FY2021 10K | Page 32] ximately $700 million in connection with separating Upjohn, of which, approximately 75% has been incurred since inception and through December31, 2021 ximately $700 million in connection with separating Upjohn, of which, approximately 75% has been incurred since inception and through December31, 2021 These charges include costs and expenses related to separation of legal entities and transaction costs.Transforming to a More Focused Company: We have undertaken efforts to ensure our cost base and support model align appropriately with our new operating structure. While certain direct costs transferred to the Consumer Healthcare JV and to the Upjohn Business in connection with the spin-off, there are indirect costs which did not transfer. We aretaking steps to restructu...
```

**Chunk 3:**
```
[FY2021 10K | Page 32]  commercial operations through a new globalstructure consisting of two operating segments: Biopharma and PC1. Biopharma is the only reportable segment  commercial operations through a new globalstructure consisting of two operating segments: Biopharma and PC1. Biopharma is the only reportable segment On December 31, 2021, we completed the sale of our Meridiansubsidiary, and beginning in the fourth quarter of 2021, the financial results of Meridian are reflected as discontinued operations for all periods presented. Beginning in the fourthquarter of 2020, the financial results of the Upjohn Business and the Mylan-Japan collaboration were reflected as discontinued operations for all periods presented. Prior-periodinformation has been restated to reflect our current orga...
```

**Chunk 4:**
```
[FY2021 10K | Page 76] ative medicines and vaccines. We have undertaken efforts to ensure our cost base and support model align appropriately with our new operatingstructure ative medicines and vaccines. We have undertaken efforts to ensure our cost base and support model align appropriately with our new operatingstructure While certain direct costs transferred to the Consumer Healthcare JV and to the Upjohn Business in connection with the spin-off, there are indirect costs which did nottransfer. This program is primarily composed of the following three initiatives:•We are taking steps to restructure our corporate enabling functions to appropriately support our business, R&D and PGS platform functions. We expect costs, primarily related torestructuring our corporate enabling functions, to ...
```

**Chunk 5:**
```
[FY2021 10K | Page 71] ed, as-converted and as-exercised basis. The Transactions aregenerally expected to be tax free to Pfizer and Pfizer stockholders for U.S. tax purposes ed, as-converted and as-exercised basis. The Transactions aregenerally expected to be tax free to Pfizer and Pfizer stockholders for U.S. tax purposes Beginning November 16, 2020, Viatris operates both the Upjohn Business and Mylan as anindependent publicly traded company, which is traded under the symbol “VTRS” on the NASDAQ.In connection with the Transactions, in June 2020, Upjohn Inc. and Upjohn Finance B.V. completed privately placed debt offerings of $7.45 billion and €3.60 billion aggregate principalamounts, respectively, (approximately $11.4 billion) of senior unsecured notes and entered into other financing arr...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `pfizer`  (display: Pfizer)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=pfizer; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 44 of 75  —  `diag_044`  **[PASSING]**

**fb_id:** `financebench_id_00995`
**company:** AMD
**doc:** AMD_2022_10K
**question_type:** domain-relevant

### Question

What are the major products and services that AMD sells as of FY22?

### Gold answer

> AMD sells server microprocessors (CPUs) and graphics processing units (GPUs), data processing units (DPUs), Field Programmable Gate Arrays (FPGAs), and Adaptive System-on-Chip (SoC) products for data centers; CPUs, accelerated processing units (APUs) that integrate CPUs and GPUs, and chipsets for desktop and notebook personal computers; discrete GPUs, and semi-custom SoC products and development services; and embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## AMD's Major Products and Services (FY2022)

Based on AMD's FY2022 10-K, the company offers a broad portfolio across four primary categories:

### 1. Data Center Products
- Server microprocessors: **AMD EPYC processors** [Source 1: AMD_2022_10K.pdf, Page 11]
- Data center GPUs: **Radeon Instinct, Radeon PRO V-series, AMD Instinct accelerators** [Source 1: AMD_2022_10K.pdf, Page 11]
- **Data Processing Units (DPUs)** [Source 2: AMD_2022_10K.pdf, Page 4]
- **FPGAs and Adaptive SoC (System-on-Chip) products** (added via Xilinx acquisition, Feb 2022) [Source 3: AMD_2022_10K.pdf, Page 43]

### 2. Client / PC Products
- Desktop & notebook CPUs: **AMD Ryzen, AMD Ryzen PRO, Ryzen Threadripper, Ryzen Threadripper PRO, AMD Athlon, AMD Athlon PRO, AMD PRO A-Series** [Source 6: AMD_2022_10K.pdf, Page 11]
- **Accelerated Processing Units (APUs)** integrating CPUs and GPUs [Source 2: AMD_2022_10K.pdf, Page 4]
- **Chipsets** [Source 2: AMD_2022_10K.pdf, Page 4]

### 3. Graphics Products
- Consumer graphics: **AMD Radeon graphics** [Source 1: AMD_2022_10K.pdf, Page 11]
- Professional graphics: **AMD Radeon PRO graphics** [Source 1: AMD_2022_10K.pdf, Page 11]
- Embedded graphics: **AMD Embedded R

[... truncated, total 2358 chars]
```

### V1 retrieved chunks (top 5 of 8 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 11] Threadripper, RyzenThreadripper PRO, AMD Athlon, AMD Athlon PRO, and AMD PRO A-Series. These products service desktop and notebook personal computers. Our product brand for the consumer graphics market is AMD Radeon graphics, and AMD Embedded Radeon graphics is our product brand for the embeddedgraphics market.
Our product brand for professional graphics products are AMD Radeon PRO graphics.
Our product brands for data center graphics are Radeon Instinct, Radeon PRO V-series, and AMD Instinct accelerators for servers. We also market and sell ourchipsets under AMD trademarks.
Our product brand for server microprocessors is AMD EPYC processors.
We also sell low-power versions of our AMD Athlon, as well as AMD Geode™, AMD Ryzen, AMD EPYC, AMD R-Series and G-Series proce...
```

**Chunk 2:**
```
[FY2022 10K | Page 4] rt or detailed in our other Securities and Exchange Commission(SEC) reports and filings. We assume no obligation to update forward-looking statements. References in this Annual Report on Form 10-K to “AMD,” “we,” “us,” “management,” “our” or the “Company” mean Advanced Micro Devices, Inc. and ourconsolidated subsidiaries.
Overview
We are a global semiconductor company primarily offering:
• server microprocessors (CPUs) and graphics processing units (GPUs), data processing units (DPUs), Field Programmable Gate Arrays (FPGAs), andAdaptive System-on-Chip (SoC) products for data centers;
• CPUs, accelerated processing units (APUs) that integrate CPUs and GPUs, and chipsets for desktop and notebook personal computers;
• discrete GPUs, and semi-custom SoC products and devel...
```

**Chunk 3:**
```
[FY2022 10K | Page 43] nancial Condition and Results of Operations” in Part II, Item 7 ofour Annual Report on Form 10-K for the fiscal year ended December 25, 2021.
Overview 2022 was a transformative year for AMD as we took several major steps that scaled and reshaped our business. In February 2022, we completed our strategicacquisition of Xilinx, Inc. (Xilinx) which expanded our technology and product portfolio to include adaptable hardware platforms that enable hardwareacceleration and rapid innovation across a variety of technologies and established AMD in multiple embedded markets where we have traditionally not had asignificant presence. We now offer Field Programmable Gate Arrays (FPGAs), Adaptive SoCs, and Adaptive Compute Acceleration Platform (ACAP) products.With the acquisition o...
```

**Chunk 4:**
```
[FY2022 10K | Page 8] es mobile processors, built on “Zen 3+” architecture and AMD Ryzen 5000 Series mobile processors, which arepowered with our “Zen 3” core architecture. Commercial CPUs. We offer enterprise-class desktop and mobile PC solutions sold as AMD PRO Mobile and AMD PRO desktop processors with Radeon™graphics for the commercial market. AMD Ryzen PRO, AMD Threadripper™ PRO and AMD Athlon PRO processors solutions are designed to provideenterprise customers with the performance, security capabilities and business features such as enhanced security and manageability, platform longevity andextended image stability. Our AMD Ryzen Threadripper PRO 5000 WX-Series processors provide full-spectrum performance across multiple workstationworkloads due to the performance and efficiency of t...
```

**Chunk 5:**
```
[FY2022 10K | Page 11] low-power versions of our AMD Athlon, as well as AMD Geode™, AMD Ryzen, AMD EPYC, AMD R-Series and G-Series processors as embeddedprocessor solutions. Our FPGA product brands are Virtex-6, Virtex-7, Virtex UltraScale+, Kintex-7, Kintex UltraScale, Kintex UltraScale+, Artix-7, Artix UltraScale+, Spartan-6 andSpartan-7.
Our product brands for Adaptive SoCs are Zynq-7000, Zynq UltraScale+ MPSoC, Zynq UltraScale+ RFSoCs, Versal HBM, Versal Premium, Versal Prime,Versal AI Core, Versal AI Edge, Vitis and Vivado.
Our compute and network acceleration board products are sold under the Alveo brand.
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `amd`  (display: AMD)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=amd; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 45 of 75  —  `diag_045`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_00605`
**company:** Ulta Beauty
**doc:** ULTABEAUTY_2023Q4_EARNINGS
**question_type:** novel-generated

### Question

What percent of Ulta Beauty's total spend on stock repurchases for FY 2023 occurred in Q4 of FY2023?

### Gold answer

> 36%. The answer here assumes FY2023 refers to the 12 months ended on January 28, 2023 (although the company refers to this period as its fiscal 2022.

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the available evidence, I can confirm the FY 2023 full-year stock repurchase total but cannot compute the requested percentage.

**What is confirmed:**
- **FY 2023 total stock repurchases: $900,033 thousand (~$900.0M)** [Source: ULTABEAUTY_2023Q4_EARNINGS.pdf, Page 8]

**What is missing:**
- The Q4 FY2023-specific repurchase figure is **not present** in the retrieved chunks. The cash flow statement provided covers the full fiscal year only. To isolate Q4 spending, one would need either:
  - The Q3 FY2023 year-to-date cumulative repurchase figure (to subtract from the annual total), or
  - A quarterly breakdown from the Q4 earnings press release's share repurchase table.

Neither of those figures appears in the available context.

---

**Bottom line (Partial evidence):** The FY 2023 full-year repurchase spend of **$900,033K** is confirmed [Source: ULTABEAUTY_2023Q4_EARNINGS.pdf, Page 8], but the Q4-specific portion is unavailable in the provided context — the percentage cannot be calculated without the Q3 cumulative or Q4 standalone repurchase figure.
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 10K | Page 8]  expenses and other current assets
(19,432
)
(3,412
)
Income taxes
(45,182
)
(35,652
)
Accounts payable
8,309
66,156
Accrued liabilities
48,249
58,598 Deferred revenue
41,098
79,196
Operating lease liabilities
(324,500
)
(303,914
)
Other assets and liabilities
(7,731
)
12,392
Net cash provided by operating activities
1,481,915
1,059,265
Investing activities
Capital expenditures
(312,126
)
(172,187
)
Other investments
(2,458
)
(4,297
)
Net cash used in investing activities
(314,584
)
(176,484
)
Financing activities
Repurchase of common shares
(900,033
)
(1,521,925
)
Stock options exercised
46,011
40,386
Purchase of treasury shares
(6,992
)
(15,677
)
Net cash used in financing activities
(861,014
)
(1,497,216
)
Effect of exchange rate changes on cash and cash equivalent...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `ulta_beauty`  (display: Ulta Beauty)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=ulta_beauty; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Ulta Beauty FY2023 total stock repurchases.
2. Ulta Beauty Q4 FY2023 stock repurchases.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Partial refusal is grounded because the full-year repurchase amount is shown but Q4-specific repurchases are not.

---
## Record 46 of 75  —  `diag_046`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_00799`
**company:** Amcor
**doc:** AMCOR_2023_10K
**question_type:** domain-relevant

### Question

Has AMCOR's quick ratio improved or declined between FY2023 and FY2022? If the quick ratio is not something that a financial analyst would ask about a company like this, then state that and explain why.

### Gold answer

> The quick ratio has slightly improved from 0.67 times to 0.69 times between FY 2023 and FY 2022.(3.4% jump)

### V1 system answer (for HALLU_GROUNDED labeling)

```
## AMCOR Quick Ratio: FY2023 vs. FY2022

### Data Availability Problem

The full consolidated balance sheet figures needed to compute AMCOR's quick ratio for **FY2023 (year ended June 30, 2023)** and **FY2022 (year ended June 30, 2022)** are **not present in the retrieved context**. Specifically, the following required inputs are missing:

| Required Input | FY2023 | FY2022 |
|---|---|---|
| Consolidated current assets | ❌ Not found | ❌ Not found |
| Consolidated inventories | ❌ Not found | ❌ Not found |
| Consolidated current liabilities | ❌ Not found | ❌ Not found |

The only balance sheet data retrieved is from the **Obligor Group sub-consolidation** (a subset of AMCOR's legal entity structure), as of **December 31, 2022 and June 30, 2022** — neither of which corresponds to the FY2023 full-year endpoint, and neither of which breaks out inventory [Source: AMCOR_2023Q2_10Q.pdf, Page 45]. These figures **cannot be used** as a proxy for the consolidated quick ratio comparison requested.

---

### Is the Quick Ratio Even a Relevant Metric for AMCOR?

This is a fair and important qualifier. AMCOR is a **global capital-intensive packaging manufacturer**. For companies of this type:

- 

[... truncated, total 3012 chars]
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 10Q | Page 45] subsidiaries outside the Obligor Group 3
Total net sales 545
Gross profit 87
Net income $ (244)
Net income attributable to non-controlling interests — Net income attributable to Obligor Group $ (244)
Balance Sheets for Obligor Group
($ in millions) December 31, 2022 June 30, 2022
Assets
Current assets - external $ 859 $ 1,254
Current assets - due from subsidiaries outside the Obligor Group 122 83
Total current assets 981 1,337
Non-current assets - external 1,394 1,396
Non-current assets - due from subsidiaries outside the Obligor Group 10,179 10,978
Total non-current assets 11,573 12,374
Total assets $ 12,554 $ 13,711
Liabilities
Current liabilities - external $ 1,279 $ 2,014
Current liabilities - due to subsidiaries outside the Obligor Group 30 23
Total current liab...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `amcor`  (display: Amcor)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=amcor; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. AMCOR FY2023 quick assets and total current liabilities.
2. AMCOR FY2022 quick assets and total current liabilities.
3. Whether quick ratio is a relevant liquidity metric for AMCOR.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Obligor-group data and missing consolidated inputs are grounded; general relevance/business-model discussion is unsupported.

---
## Record 47 of 75  —  `diag_047`  **[PASSING]**

**fb_id:** `financebench_id_01858`
**company:** 3M
**doc:** 3M_2023Q2_10Q
**question_type:** novel-generated

### Question

Does 3M maintain a stable trend of dividend distribution?

### Gold answer

> Yes, not only they distribute the dividends on a routine basis, 3M has also been increasing the per share dividend for consecutive 65 years

### V1 system answer (for HALLU_GROUNDED labeling)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## 3M's Dividend Distribution Trend

Yes, 3M demonstrates a remarkably stable and consistently **growing** dividend distribution trend, supported by evidence spanning multiple decades.

### Historical Dividend Per Share Data

| Year | Cash Dividends Declared Per Share | YoY Growth |
|------|----------------------------------|------------|
| 2014 | $3.59 | — |
| 2015 | $3.075 | — |
| 2016 | $4.44 | ~44% |
| 2017 | $4.70 | ~6% |
| 2018 | $5.44 | ~16% |
| 2021 | $5.92 ($1.48/qtr) | — |
| 2022 | $5.96 ($1.49/qtr) | ~1% |
| 2023 | $6.00 ($1.50/qtr) | ~1% |

[Source: 3M_2018_10K.pdf, Page 14; 3M_2022_10K.pdf, Page 18; 3M_2023Q2_10Q.pdf, Page 73]

### Key Supporting Evidence

1. **Unbroken payment history**: 3M has paid dividends continuously **since 1916** [Source: 3M_2018_10K.pdf, Page 48; 3M_2022_10K.pdf, Page 41]

2. **Consecutive annual increases**: By Q1 2019, 3M had achieved **61 consecutive years** of dividend increases [Source: 3M_2018_10K.pdf, Page 48], growing to **65 consecutive years** by early 2023 [Source: 3M_2022_10K.pdf, Page 41]

3. **Total dividends 

[... truncated, total 1851 chars]
```

### V1 retrieved chunks (top 5 of 8 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 26] 
when comparing 2017 to 2016. Refer to the section entitled “Financial Condition and Liquidity” later in MD&A for a discussion of items impacting cash flows. In November 2018, 3M’s Board of Directors authorized the repurchase of up to $10 billion of 3M’s outstanding common stock, which replaced the
Company’s February 2016 repurchase program. This program has no pre-established end date. In 2018, the Company purchased $4.9 billion of its own
stock, compared to purchases of $2.1 billion in 2017 and $3.8 billion in 2016. The Company expects to purchase $2.0 billion to $4.0 billion of its own stock
in 2019. In February 2019, 3M’s Board of Directors declared a first-quarter 2019 dividend of $1.44 per share, an increase of 6 percent. This marked the
61st consecutive year of divid...
```

**Chunk 2:**
```
[FY2022 10K | Page 41] T
able of
Contents
Dividends Paid to Shareholders:
3M has paid dividends since 1916. In February 2023, 3M’s Board of Directors declared a first-quarter 2023 dividend of $1.50 per share, an increase of 1 percent. This is
equivalent to an annual dividend of $6.00 per share and marked the 65th consecutive year of dividend increases.
Other cash flows from financing activities may include various other items, such as cash paid associated with certain derivative instruments, distributions to or sales of
noncontrolling interests, changes in overdraft balances, and principal payments for finance leases.
Free Cash Flow (non-GAAP measure):
```

**Chunk 3:**
```
[10K | Page 48] vidends paid to shareholders totaled $3.193 billion ($5.44 per share) in 2018, $2.803 billion ($4.70 per share) in 2017, and $2.678 billion ($4.44 per share) in 2016. 3M has paid dividends since 1916. In February 2019, 3M’s Board of Directors declared a first-quarter 2019 dividend of $1.44 per share, an
increase of 6 percent. This is equivalent to an annual dividend of $5.76 per share and marked the 61st consecutive year of dividend increases.
48
```

**Chunk 4:**
```
[FY2023 10Q | Page 70] Table of Contents
FINANCIAL CONDITION AND LIQUIDITY The strength and stability of 3M’s business model and strong free cash flow capability, together with proven capital markets access, provide financial flexibility to deploycapital in accordance with the Company's stated priorities and meet needs associated with contractual commitments and other obligations. Investing in 3M’s business to driveorganic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures,and commercialization capability. The Company also continues to actively manage its portfolio through acquisitions and divestitures to maximize value for shareholders. 3Mexpects to continue returning cash to...
```

**Chunk 5:**
```
[FY2023 10Q | Page 73]  extinguishments of short-and long-term debt are described in Note 10 to the Consolidated Financial Statements in3M’s 2022 Annual Report on Form 10-K. Repurchases of common stock are made to support the Company’s stock-based employee compensation plans and for other corporate purposes. In the first six months of 2023,the Company purchased $29 million of its own stock. For more information, refer to the table titled “Issuer Purchases of Equity Securities” in Part II, Item 2. The Companydoes not utilize derivative instruments linked to the Company’s stock.
3M has paid dividends since 1916. In February 2023, 3M’s Board of Directors declared a first-quarter 2023 dividend of $1.50 per share, an increase of 1 percent. This isequivalent to an annual dividend of $6.00 per sh...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `3m`  (display: 3M)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=3m; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Core 65-year dividend-increase claim is grounded, but several historical dividend-per-share figures in the table are not shown in retrieved chunks.

---
## Record 48 of 75  —  `diag_048`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_01935`
**company:** Amcor
**doc:** AMCOR_2022_8K_dated-2022-07-01
**question_type:** novel-generated

### Question

What was the key agenda of the AMCOR's 8k filing dated 1st July 2022?

### Gold answer

> Amcor Finance (USA), Inc. and Amcor Flexibles North America, Inc., entered into supplemental indentures relating to Guaranteed Senior Notes due 2026 and 2028. This involved the substitution of the Substitute Issuer (Amcor Flexibles North America) for the Former Issuer (Amcor Finance) and the assumption of covenants under the indentures. (In essence a novation agreement)

### V1 system answer (for HALLU_GROUNDED labeling)

```
I couldn't find relevant information in the available documents to answer your question.
This could mean the information isn't in the documents I have access to, or the question
may need to be rephrased. Could you try asking in a different way?
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```

```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `amcor`  (display: Amcor)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=amcor; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Empty retrieval; refusal is grounded.

---
## Record 49 of 75  —  `diag_049`  **[FAILING]**  audit=WRONG_NUMBER

**fb_id:** `financebench_id_00540`
**company:** AES Corporation
**doc:** AES_2022_10K
**question_type:** domain-relevant

### Question

Roughly how many times has AES Corporation sold its inventory in FY2022? Calculate inventory turnover ratio for the FY2022; if conventional inventory management is not meaningful for the company then state that and explain why.

### Gold answer

> AES has converted inventory 9.5 times in FY 2022.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Inventory Turnover Ratio — AES Corporation FY2022

### Key Data Points

| Item | Value | Source |
|------|-------|--------|
| Inventory, Dec 31, 2022 | $1,055M | [Source 1: AES_2022_10K.pdf, Page 130] |
| Inventory, Dec 31, 2021 | $604M | [Source 1: AES_2022_10K.pdf, Page 130] |
| Average Inventory (FY2022) | **$829.5M** | Computed |
| COGS (FY2022) | **Not available** in retrieved chunks | — |

---

### Why Conventional Inventory Turnover Is **Not Meaningful** for AES

Even if COGS were available to complete the arithmetic, the resulting ratio would carry **little operational significance** for AES Corporation, for the following reasons:

1. **AES is a power generation and utility company**, not a manufacturer or retailer. It generates and sells **electricity** — a commodity delivered instantaneously upon production. There is no "stock of finished goods" that is manufactured, warehoused, and then sold to customers.

2. **AES's inventory consists of fuel stocks** (coal, natural gas, oil) and **spare parts/maintenance materials** used to operate its power plants. This is confirmed by the $417M increase in inventory on the cash flow statement and the $425M in "Emissions allowance 

[... truncated, total 2288 chars]
```

### V1 retrieved chunks (top 2 of 2 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 130] 128
Consolidated Balance Sheets
December 31, 2022 and 2021
2022 2021
(in millions, except share and per share data)
ASSETS
CURRENT ASSETS
Cash and cash equivalents $ 1,374 $ 943
Restricted cash 536 304
Short-term investments 730 232
Accounts receivable, net of allowance for doubtful accounts of $5 and $5, respectively 1,799 1,418
Inventory 1,055 604
Prepaid expenses 98 142
Other current assets, net of CECL allowance of $2 and $0, respectively 1,533 897
Current held-for-sale assets 518 816
Total current assets 7,643 5,356
NONCURRENT ASSETS
Property, Plant and Equipment:
Land 470 426
Electric generation, distribution assets and other 26,599 25,552
Accumulated depreciation (8,651) (8,486)
Construction in progress 4,621 2,414
Property, plant and equipment, net 23,039 19...
```

**Chunk 2:**
```
[FY2022 10K | Page 135] 132
Consolidated Statements of Cash Flows
Years ended December 31, 2022, 2021, and 2020
2022 2021 2020
OPERATING ACTIVITIES: (in millions)
Net income (loss) $ (505) $ (951) $ 152
Adjustments to net income (loss):
Depreciation and amortization 1,053 1,056 1,068
Loss on disposal and sale of business interests 9 1,683 95
Impairment expense 1,715 1,575 1,066
Deferred income taxes 4 (406) (233)
Reversals of contingencies (1) (10) (186)
Loss on extinguishment of debt 15 78 186
Gain on remeasurement to acquisition date fair value (5) (254) —
Loss of affiliates, net of dividends 111 36 128
Emissions allowance expense 425 337 135
Other 183 120 54
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable (532) (170) 48
(Increase) decrease in inve...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `aes_corporation`  (display: AES Corporation)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=aes_corporation; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. AES FY2022 inventory and FY2021 inventory.
2. AES FY2022 cost of sales or fuel/operations cost comparable to COGS.
3. Whether conventional inventory turnover is meaningful for AES's power generation business.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Inventory values are grounded; business-model and inventory-composition explanations are not fully supported by retrieved chunks.

---
## Record 50 of 75  —  `diag_050`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_07966`
**company:** Activision Blizzard
**doc:** ACTIVISIONBLIZZARD_2019_10K
**question_type:** metrics-generated

### Question

What is the FY2017 - FY2019 3 year average of capex as a % of revenue for Activision Blizzard? Answer in units of percents and round to one decimal place. Calculate (or extract) the answer from the statement of income and the cash flow statement.

### Gold answer

> 1.9%

### V1 system answer (for HALLU_GROUNDED labeling)

```
I don't have enough information to answer this question.

The research agent explicitly flagged that **no evidence chunks were successfully retrieved** from the source documents. All figures presented in the synthesis table were drawn from the agent's general knowledge — not from verified financial statements — and the raw retrieved chunks section is empty.

Presenting those unverified numbers as an answer would risk fabricating or misrepresenting Activision Blizzard's actual reported financials. Per my instructions, I cannot rely on figures that lack a cited source document and page number.

**To answer this question properly**, the following data points need to be extracted directly from Activision Blizzard's 10-K filings:
- **Revenue** (Income Statement): FY2017, FY2018, FY2019
- **Capital Expenditures** (Cash Flow Statement — Investing Activities): FY2017, FY2018, FY2019

Once those six figures are confirmed with source citations, the 3-year average capex % of revenue can be computed reliably.
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```

```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `activision_blizzard`  (display: Activision Blizzard)
- **Auto target_fiscal_year:** `2019`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=activision_blizzard; override if wrong)

**TARGET_YEAR:** `OK` (auto=2019; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Activision Blizzard FY2017, FY2018, and FY2019 revenue.
2. Activision Blizzard FY2017, FY2018, and FY2019 capital expenditures.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Empty retrieval; refusal and requested inputs are grounded.

---
## Record 51 of 75  —  `diag_051`  **[PASSING]**

**fb_id:** `financebench_id_03471`
**company:** General Mills
**doc:** GENERALMILLS_2020_10K
**question_type:** metrics-generated

### Question

By drawing conclusions from the information stated only in the statement of financial position, what is General Mills's FY2020 working capital ratio? Define working capital ratio as total current assets divided by total current liabilities. Round your answer to two decimal places.

### Gold answer

> 0.68

### V1 system answer (for HALLU_GROUNDED labeling)

```
## General Mills FY2020 Working Capital Ratio

### Data from the Consolidated Balance Sheet

| Item | FY2020 (May 31, 2020) |
|---|---|
| Cash and cash equivalents | $1,677.8M |
| Receivables | $1,615.1M |
| Inventories | $1,426.3M |
| Prepaid expenses and other current assets | $402.1M |
| **Total current assets** | **$5,121.3M** |

[Source: GENERALMILLS_2020_10K.pdf, Page 50]

| Current Liability Item | FY2020 (May 31, 2020) |
|---|---|
| Accounts payable | $3,247.7M |
| Current portion of long-term debt | $2,331.5M |
| Notes payable | $279.0M |
| Other current liabilities | $1,633.3M |
| **Total current liabilities (summed)** | **$7,491.5M** |

[Source: GENERALMILLS_2020_10K.pdf, Page 50]

> **Note:** The FY2020 balance sheet does not display an explicit "Total current liabilities" subtotal in the retrieved text, so the figure is derived by summing the four line items. This approach is validated by the FY2019 10-K [Source: GENERALMILLS_2019_10K.pdf, Page 55], which confirms the identical four line items sum to $7,087.1M — matching the labeled subtotal for that year.

### Calculation

$$\text{Working Capital Ratio} = \frac{\$5,121.3M}{\$7,491.5M} = \mathbf{0.68}$$

---

**Bottom 

[... truncated, total 1457 chars]
```

### V1 retrieved chunks (top 2 of 2 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 50] 50
Consolidated Balance Sheets
GENERAL MILLS, INC. AND SUBSIDIARIES
(In Millions, Except Par Value)
May 31, 2020 May 26, 2019
ASSETS
Current assets:
Cash and cash equivalents $ 1,677.8   $ 450.0
Receivables  1,615.1    1,679.7
Inventories  1,426.3    1,559.3
Prepaid expenses and other current assets  402.1    497.5
Total current assets  5,121.3    4,186.5
Land, buildings, and equipment  3,580.6    3,787.2
Goodwill  13,923.2    13,995.8
Other intangible assets  7,095.8    7,166.8
Other assets  1,085.8    974.9
Total assets $ 30,806.7   $ 30,111.2
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable $ 3,247.7   $ 2,854.1
Current portion of long-term debt  2,331.5    1,396.5
Notes payable  279.0    1,468.7
Other current liabilities  1,633.3    1,367.8
```

**Chunk 2:**
```
[10K | Page 55] Consolidated Balance Sheets GENERAL MILLS, INC Consolidated Balance Sheets GENERAL MILLS, INC AND SUBSIDIARIES(In Millions, Except Par Value) May 26, 2019 May 27, 2018 ASSETS Current assets: Cash and cash equivalents $450.0 $399.0 Receivables 1,679.7 1,684.2 Inventories 1,559.3 1,642.2 Prepaid expenses and other current assets 497.5 398.3 Total current assets 4,186.5 4,123.7 Land, buildings, and equipment 3,787.2 4,047.2 Goodwill 13,995.8 14,065.0 Other intangible assets 7,166.8 7,445.1 Other assets 974.9 943.0 Total assets $ 30,111.2 $ 30,624.0 LIABILITIES AND EQUITY Current liabilities: Accounts payable $2,854.1 $2,746.2 Current portion of long-term debt 1,396.5 1,600.1 Notes payable 1,468.7 1,549.8 Other current liabilities 1,367.8 1,445.8 Total current liabilities 7,087...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `general_mills`  (display: General Mills)
- **Auto target_fiscal_year:** `2020`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=general_mills; override if wrong)

**TARGET_YEAR:** `OK` (auto=2020; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. General Mills FY2020 total current assets.
2. General Mills FY2020 total current liabilities.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 52 of 75  —  `diag_052`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_00591`
**company:** Adobe
**doc:** ADOBE_2022_10K
**question_type:** novel-generated

### Question

Does Adobe have an improving Free cashflow conversion as of FY2022?

### Gold answer

> Yes, the FCF conversion (using net income as the denominator) for Adobe has improved by ~13% from 143% in 2021 to 156% in 2022

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Adobe Free Cash Flow Conversion — FY2022 Assessment

### What the Data Confirms

**Operating Cash Flow trend** (the numerator proxy before CapEx):

| Fiscal Year | Operating Cash Flow |
|-------------|-------------------|
| FY2020 | $5,727M |
| FY2021 | $7,230M |
| FY2022 | $7,838M |

[Source: ADOBE_2022_10K.pdf, Page 47]

This represents a **37% cumulative increase** over three years, with consistent year-over-year growth (+26% FY20→FY21, +8.4% FY21→FY22).

---

### What Is Missing

To compute a **true FCF conversion ratio** (Free Cash Flow ÷ Net Income), two additional figures are needed that are **not present in the retrieved context**:

1. **Capital Expenditures** (to derive FCF = Operating Cash Flow − CapEx)
2. **Net Income** for FY2020, FY2021, and FY2022 (the denominator)

Without these, a precise FCF conversion ratio cannot be calculated or confirmed as improving.

---

### Bottom Line

**Partial evidence:** Adobe's operating cash flow shows a clear and consistent upward trend — $5,727M → $7,230M → $7,838M (FY2020–FY2022) — which is a strong directional signal of improving cash generation [Source: ADOBE_2022_10K.pdf, Page 47]. However, a definitive conclusion on **FCF co

[... truncated, total 1418 chars]
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 47] LIQUIDITY AND CAPITAL RESOURCES
Cash Flows
This data should be read in conjunction with our Consolidated Statements of Cash Flows.
As of
(in millions) December 2, 2022 December 3, 2021
Cash and cash equivalents $ 4,236 $ 3,844
Short-term investments $ 1,860 $ 1,954
Working capital $ 868 $ 1,737
Stockholders’ equity $ 14,051 $ 14,797
A summary of our cash flows for fiscal 2022, 2021 and 2020 is as follows:
(in millions) 2022 2021 2020
Net cash provided by operating activities $ 7,838 $ 7,230 $ 5,727
Net cash used for investing activities  (570)  (3,537)  (414)
Net cash used for financing activities  (6,825)  (4,301)  (3,488)
Effect of foreign currency exchange rates on cash and cash equivalents  (51)  (26)  3
Net change in cash and cash equivalents $ 392 $ (634) $ 1,8...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `adobe`  (display: Adobe)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=adobe; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Adobe FY2022 free cash flow and net income.
2. Adobe FY2021 free cash flow and net income.
3. Adobe FY2022 versus FY2021 free-cash-flow conversion trend.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Partial answer is grounded in the retrieved operating-cash-flow trend and missing FCF/net-income inputs.

---
## Record 53 of 75  —  `diag_053`  **[PASSING]**

**fb_id:** `financebench_id_01198`
**company:** AMD
**doc:** AMD_2022_10K
**question_type:** domain-relevant

### Question

What drove revenue change as of the FY22 for AMD?

### Gold answer

> In 2022, AMD reported Higher sales of their EPYC server processors, higher semi-custom product sales, and the inclusion of Xilinx embedded product sales

### V1 system answer (for HALLU_GROUNDED labeling)

```
## AMD FY22 Revenue Change: Key Drivers

AMD's net revenue grew **+$7,167M (+44% YoY)**, from **$16,434M in FY21** to **$23,601M in FY22**. [Source 1: AMD_2022_10K.pdf, Page 54]

---

### Segment-Level Breakdown

| Segment | FY22 Revenue | FY21 Revenue | Change | Primary Driver |
|---|---|---|---|---|
| Data Center | $6.0B | $3.7B | **+64%** | Higher EPYC™ server processor sales |
| Gaming | $6.8B | $5.6B | **+21%** | Higher semi-custom (gaming console SoC) sales |
| Client | $6.2B | $6.9B | **−10%** | PC market weakness; −24% unit shipments |
| Embedded | Significant ↑ | ~$44M op. income | **Large ↑** | Inclusion of Xilinx embedded product sales |

---

### Driver Detail

1. **Data Center (+64%)**: Primarily driven by higher sales of EPYC server processors. Operating income rose from $991M to $1,848M. [Source 5: AMD_2022_10K.pdf, Page 48]

2. **Gaming (+21%)**: Higher semi-custom product sales (gaming console SoCs) drove growth, **partially offset** by lower gaming graphics sales due to soft consumer demand and weakened macroeconomic conditions in H2 2022. [Source 4: AMD_2022_10K.pdf, Page 49]

3. **Client (−10%)**: A 24% decline in unit shipments due to challenging PC market cond

[... truncated, total 2091 chars]
```

### V1 retrieved chunks (top 5 of 7 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 54] Table of Contents
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Advanced Micro Devices, Inc.
Consolidated Statements of Operations
Year Ended
December 31,2022 December 25,2021 December 26,2020
(In millions, except per share amounts)
Net revenue $ 23,601 $ 16,434 $ 9,763 Cost of sales 11,550 8,505 5,416
Amortization of acquisition-related intangibles 1,448 — —
Total cost of sales 12,998 8,505 5,416
Gross profit 10,603 7,929 4,347
Research and development 5,005 2,845 1,983 Marketing, general and administrative 2,336 1,448 995
Amortization of acquisition-related intangibles 2,100 — —
Licensing gain (102) (12) —
Operating income 1,264 3,648 1,369
Interest expense (88) (34) (47)
Other income (expense), net 8 55 (47)
Income before income taxes and equity income 1,184...
```

**Chunk 2:**
```
[FY2022 10K | Page 48] by higher revenue, partially offset by higher operating expenses. Operating expenses increased for the reasons outlined under “Expenses” below.
Client Client net revenue of $6.2 billion in 2022 decreased by 10%, compared to net revenue of $6.9 billion in 2021, primarily driven by a 24% decrease in unitshipment, partially offset by a 19% increase in average selling price. The decrease in unit shipments was due to challenging PC market conditions andsignificant inventory correction across the PC supply chain experienced during the second half of 2022. The increase in average selling price was primarilydriven by a richer mix of Ryzen mobile processor sales.
Client operating income was $1.2 billion in 2022, compared to operating income of $2.1 billion in 2021. The decrea...
```

**Chunk 3:**
```
[FY2022 10K | Page 43] ship compute engines and accelerators to help enable best performance, security, flexibility and total cost ofownership for leading-edge data centers. Our 2022 financial results reflect the strength of our diversified business model despite the challenging PC market conditions in the second half of 2022. Netrevenue for 2022 was $23.6 billion, an increase of 44% compared to 2021 net revenue of $16.4 billion. The increase in net revenue was driven by a 64%increase in Data Center segment revenue primarily due to higher sales of our EPYC™ server processors, a 21% increase in Gaming segment revenueprimarily due to higher semi-custom product sales, and a significant increase in Embedded segment revenue from the prior year period driven by the inclusionof Xilinx embedded pr...
```

**Chunk 4:**
```
[FY2022 10K | Page 49] Table of Contents
Gaming
Gaming net revenue of $6.8 billion in 2022 increased by 21%, compared to net revenue of $5.6 billion in 2021. The increase in net revenue was driven byhigher semi-custom product sales due to higher demand for gaming console SoCs, partially offset by lower gaming graphics sales due to a decrease in unitshipments driven by soft consumer demand given weakened macroeconomic conditions experienced in the second half of 2022.
Gaming operating income was $953 million in 2022, compared to operating income of $934 million in 2021. The increase in operating income was primarilydriven by higher revenue, partially offset by higher operating expenses. Operating expenses increased for the reasons outlined under “Expenses” below.
Embedded
```

**Chunk 5:**
```
[FY2022 10K | Page 48] er $ 1,848 $ 991 Client 1,190 2,088
Gaming 953 934 Embedded 2,252 44
All Other (4,979) (409)
Total operating income (loss) $ 1,264 $ 3,648
Data Center Data Center net revenue of $6 billion in 2022 increased by 64%, compared to net revenue of $3.7 billion in 2021. The increase was primarily driven by highersales of our EPYC server processors.
Data Center operating income was $1.8 billion in 2022, compared to operating income of $991 million in 2021. The increase in operating income was primarilydriven by higher revenue, partially offset by higher operating expenses. Operating expenses increased for the reasons outlined under “Expenses” below.
Client
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `amd`  (display: AMD)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=amd; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. AMD FY2022 and FY2021 revenue by segment.
2. AMD management discussion of Data Center revenue drivers.
3. AMD management discussion of Gaming revenue drivers.
4. AMD management discussion of Embedded/Xilinx revenue contribution.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 54 of 75  —  `diag_054`  **[FAILING]**  audit=DATASET_SUSPECT

**fb_id:** `financebench_id_00080`
**company:** Paypal
**doc:** PAYPAL_2022_10K
**question_type:** domain-relevant

### Question

Does Paypal have positive working capital based on FY2022 data? If working capital is not a useful or relevant metric for this company, then please state that and explain why.

### Gold answer

> Yes. Paypal has a positive working capital of $ 1.6Bn as of FY2022 end.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## PayPal FY2022 Working Capital Analysis

### The Calculation

| Item | FY2022 ($M) |
|---|---|
| Total Current Assets | $57,517 |
| Total Current Liabilities | $45,101 |
| **Working Capital** | **+$12,416** |

**Yes, PayPal has positive working capital of +$12,416 million as of December 31, 2022.** [Source: PAYPAL_2022_10K.pdf, Page 61]

---

### ⚠️ Important Caveat: Working Capital Is a Misleading Metric for PayPal

While the arithmetic is positive, **working capital is not a particularly useful or relevant metric for PayPal** due to a structural feature of its payments business model. The balance sheet reveals a critical distortion:

| Line Item | Amount ($M) | Nature |
|---|---|---|
| Funds receivable and customer accounts *(asset)* | $36,357 | Customer funds held on behalf of users |
| Funds payable and amounts due to customers *(liability)* | $40,107 | Offsetting obligation to return those funds |

These two items — representing **~63% of current assets** and **~89% of current liabilities** — are essentially **pass-through balances**. PayPal holds customer funds in trust and must return them on demand; they are **not liquidity available to the company** for its own operation

[... truncated, total 2200 chars]
```

### V1 retrieved chunks (top 2 of 2 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 61] Table of Contents
PayPal Holdings, Inc.
CONSOLIDATED BALANCE SHEETS
As of December 31,
2022 2021
(In millions, except par value)
ASSETS
Current assets:
Cash and cash equivalents $ 7,776 $ 5,197
Short-term investments 3,092 4,303
Accounts receivable, net 963 800
Loans and interest receivable, net of allowances of $598 and $491 as of December 31, 2022 and 2021,respectively 7,431 4,846
Funds receivable and customer accounts 36,357 36,141
Prepaid expenses and other current assets 1,898 1,287
Total current assets 57,517 52,574
Long-term investments 5,018 6,797
Property and equipment, net 1,730 1,909
Goodwill 11,209 11,454
Intangible assets, net 788 1,332
Other assets 2,455 1,737
Total assets $ 78,717 $ 75,803
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable $ ...
```

**Chunk 2:**
```
[FY2022 10K | Page 61] assets, net 788 1,332
Other assets 2,455 1,737
Total assets $ 78,717 $ 75,803
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable $ 126 $ 197 Funds payable and amounts due to customers 40,107 38,841
Accrued expenses and other current liabilities 4,055 3,755
Income taxes payable 813 236
Total current liabilities 45,101 43,029
Deferred tax liability and other long-term liabilities 2,925 2,998
Long-term debt 10,417 8,049
Total liabilities 58,443 54,076
Commitments and contingencies (Note 13)
Equity:
Common stock, $0.0001 par value; 4,000 shares authorized; 1,136 and 1,168 shares outstanding as ofDecember 31, 2022 and 2021, respectively — —
Preferred stock, $0.0001 par value; 100 shares authorized, unissued — —
Treasury stock at cost, 173 and 132 shares as of De...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `paypal`  (display: Paypal)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=paypal; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. PayPal FY2022 total current assets.
2. PayPal FY2022 total current liabilities.
3. Whether working capital is a relevant metric for PayPal given customer funds balances.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Balance-sheet arithmetic is grounded; explanation about customer funds being pass-through/trust balances is not fully supported by chunks.

---
## Record 55 of 75  —  `diag_055`  **[FAILING]**  audit=PASS_NUMERIC_ROUNDING

**fb_id:** `financebench_id_06655`
**company:** Amazon
**doc:** AMAZON_2017_10K
**question_type:** metrics-generated

### Question

What is Amazon's FY2017 days payable outstanding (DPO)? DPO is defined as: 365 * (average accounts payable between FY2016 and FY2017) / (FY2017 COGS + change in inventory between FY2016 and FY2017). Round your answer to two decimal places. Address the question by using the line items and information shown within the balance sheet and the P&L statement.

### Gold answer

> 93.86

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Amazon FY2017 Days Payable Outstanding (DPO)

### Source Data (from Balance Sheet & P&L)

| Line Item | Value | Source |
|---|---|---|
| FY2016 Accounts Payable | $25,309M | [Source: AMAZON_2017_10K.pdf, Page 40] |
| FY2017 Accounts Payable | $34,616M | [Source: AMAZON_2017_10K.pdf, Page 40] |
| FY2017 Cost of Sales (COGS) | $111,934M | [Source: AMAZON_2017_10K.pdf, Page 38] |
| FY2016 Inventories | $11,461M | [Source: AMAZON_2017_10K.pdf, Page 40] |
| FY2017 Inventories | $16,047M | [Source: AMAZON_2017_10K.pdf, Page 40] |

### Calculation

**Step 1 — Average Accounts Payable:**
= (25,309 + 34,616) / 2 = **$29,962.5M**

**Step 2 — Change in Inventory:**
= 16,047 − 11,461 = **+$4,586M**

> *(Inventory increase represents additional purchases not yet expensed through COGS)*

**Step 3 — Purchases Proxy (Denominator):**
= 111,934 + 4,586 = **$116,520M**

**Step 4 — DPO:**
= 365 × 29,962.5 / 116,520
= **93.79 days**

---

**Bottom line:** Amazon's FY2017 DPO was **93.79 days**, calculated using average AP of $29,962.5M and a purchases proxy of $116,520M derived from FY2017 COGS of $111,934M plus the $4,586M inventory build. [Source: AMAZON_2017_10K.pdf, Pages 38 & 40]
```

### V1 retrieved chunks (top 5 of 6 — for HALLU_GROUNDED)

**Chunk 1:**
```
[Company: Amazon Inc. | 10K | Page 40] AMAZON.COM, INC AMAZON.COM, INC CONSOLIDATED BALANCE SHEETS(in millions, except per share data) December 31, 2016 2017ASSETS Current assets: Cash and cash equivalents$ 19,334 $20,522Marketable securities6,647 10,464Inventories11,461 16,047Accounts receivable, net and other8,339 13,164Total current assets45,781 60,197Property and equipment, net29,114 48,866Goodwill3,784 13,350Other assets4,723 8,897 Total assets$ 83,402 $131,310LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable$ 25,309 $34,616Accrued expenses and other13,739 18,170Unearned revenue4,768 5,097 Total current liabilities43,816 57,883Long-term debt7,694 24,743Other long-term liabilities12,607 20,975Commitments and contingencies (Note 7) Stockholders’ equity: Preferre...
```

**Chunk 2:**
```
[Company: Amazon Inc. | 10K | Page 37] ities: Inventories(3,583 ) (1,314) (3,278)Accounts receivable, net and other(4,780 ) (4,615) (7,681)Accounts payable7,100 3,263 8,193 Accrued expenses ities: Inventories(3,583 ) (1,314) (3,278)Accounts receivable, net and other(4,780 ) (4,615) (7,681)Accounts payable7,100 3,263 8,193 Accrued expenses ities: Inventories(3,583 ) (1,314) (3,278)Accounts receivable, net and other(4,780 ) (4,615) (7,681)Accounts payable7,100 3,263 8,193 Accrued expenses and other283 472 (1,383)Unearned revenue738 1,151 1,711 Net cash provided by (used in) operating activities18,365 30,723 38,514 INVESTING ACTIVITIES: Purchases of property and equipment(11,955 ) (13,427) (16,861)Proceeds from property and equipment sales and incentives1,897 2,104 4,172 Acquisitions, net of ...
```

**Chunk 3:**
```
[Company: Amazon Inc. | 10K | Page 37] nd liabilities: Inventories(2,187 ) (1,426) (3,583)Accounts receivable, net and other(1,755 ) (3,367) (4,786)Accounts payable4,294 5,030 7,175 Accrued nd liabilities: Inventories(2,187 ) (1,426) (3,583)Accounts receivable, net and other(1,755 ) (3,367) (4,786)Accounts payable4,294 5,030 7,175 Accrued nd liabilities: Inventories(2,187 ) (1,426) (3,583)Accounts receivable, net and other(1,755 ) (3,367) (4,786)Accounts payable4,294 5,030 7,175 Accrued expenses and other913 1,724 283 Unearned revenue1,292 1,955 738 Net cash provided by (used in) operating activities12,039 17,272 18,434 INVESTING ACTIVITIES: Purchases of property and equipment, including internal-use software and website development(5,387 ) (7,804) (11,955)Proceeds from property and equipm...
```

**Chunk 4:**
```
[Company: Amazon Inc. | 10K | Page 37] AMAZON.COM, INC AMAZON.COM, INC CONSOLIDATED STATEMENTS OF CASH FLOWS(in millions) Year Ended December 31, 2015 2016 2017CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD$ 14,557 $15,890 $19,334OPERATING ACTIVITIES: Net income596 2,371 3,033 Adjustments to reconcile net income to net cash from operating activities: Depreciation of property and equipment, including internal-use software and website development, andother amortization, including capitalized content costs6,281 8,116 11,478Stock-based compensation2,119 2,975 4,215 Other operating expense, net155 160 202 Other expense (income), net250 (20 ) (292 )Deferred income taxes81 (246 ) (29 )Changes in operating assets and liabilities: Inventories(2,187 ) (1,426) (3,583)Accounts receivable, net and othe...
```

**Chunk 5:**
```
[Company: Amazon Inc. | 10K | Page 38] AMAZON.COM, INC AMAZON.COM, INC CONSOLIDATED STATEMENTS OF OPERATIONS(in millions, except per share data) Year Ended December 31, 2015 2016 2017Net product sales$ 79,268 $94,665 $118,573Net service sales27,738 41,322 59,293Total net sales107,006 135,987 177,866Operating expenses: Cost of sales71,651 88,265 111,934Fulfillment13,410 17,619 25,249Marketing5,254 7,233 10,069Technology and content12,540 16,085 22,620General and administrative1,747 2,432 3,674 Other operating expense, net171 167 214 Total operating expenses104,773 131,801 173,760Operating income2,233 4,186 4,106 Interest income50 100 202 Interest expense(459 ) (484) (848 )Other income (expense), net(256 ) 90 346 Total non-operating income (expense)(665 ) (294) (300 )Income before income tax...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `amazon`  (display: Amazon)
- **Auto target_fiscal_year:** `2017`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=amazon; override if wrong)

**TARGET_YEAR:** `OK` (auto=2017; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Amazon FY2017 and FY2016 accounts payable.
2. Amazon FY2017 cost of sales.
3. Amazon FY2017 and FY2016 inventories.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 56 of 75  —  `diag_056`  **[FAILING]**  audit=PASS_OTHER

**fb_id:** `financebench_id_01028`
**company:** American Express
**doc:** AMERICANEXPRESS_2022_10K
**question_type:** domain-relevant

### Question

What are the geographies that American Express primarily operates in as of 2022?

### Gold answer

> United States, EMEA, APAC, and LACC

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the 2022 10-K, American Express operates across a broad global footprint. The primary geographies include:

**United States (Headquarters & Key Operations)**
- Phoenix, AZ; Sunrise, FL; Greensboro, NC; Sandy, UT (AENB headquarters) [Source: AMERICANEXPRESS_2022_10K.pdf, Page 40]

**Key International Markets**
- **Europe**: United Kingdom (London), Spain (Madrid), France, Italy, Germany, Poland, Austria, Czech Republic, Sweden, Netherlands, Ireland [Source: AMERICANEXPRESS_2022_10K.pdf, Pages 253–254]
- **Asia-Pacific**: India (Gurgaon), Japan (Tokyo), Philippines (Manila), Malaysia (Kuala Lumpur), Australia (Sydney), China, Hong Kong, Taiwan, Thailand, Indonesia [Source: AMERICANEXPRESS_2022_10K.pdf, Pages 40, 253–254]
- **Americas**: Canada (Toronto), Mexico (Mexico City), Brazil, Argentina, Chile [Source: AMERICANEXPRESS_2022_10K.pdf, Pages 40, 252, 254]
- **Middle East**: Bahrain [Source: AMERICANEXPRESS_2022_10K.pdf, Page 253]
- **Other**: Switzerland, Jersey, Netherlands Antilles [Source: AMERICANEXPRESS_2022_10K.pdf, Pages 252–253]

The company specifically highlights the **UK, EU, Australia, Japan, Canada, and Mexico** as the most significant regions for billed busi

[... truncated, total 1700 chars]
```

### V1 retrieved chunks (top 5 of 8 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 40] owned or leased principal locations include American Express offices in Phoenix, Arizona, Sunrise, Florida, Gurgaon, India, Brighton, England, Manila, Philippines, Tokyo, Japan, Kuala Lumpur, Malaysia and Sydney, Australia; the American Express data centers in Phoenix, Arizona and Greensboro, North
Carolina; the headquarters for AENB in Sandy, Utah; the headquarters for American Express Services Europe Limited in London, England; the headquarters
for American Express Europe, S.A. in Madrid, Spain; the headquarters for Amex Bank of Canada and Amex Canada Inc. in Toronto, Ontario, Canada; and the
headquarters for American Express Bank (Mexico) S.A. Institucion de Banca Multiple and American Express Company (Mexico) S.A. de C.V. in Mexico City,
Mexico. We also lease and...
```

**Chunk 2:**
```
[FY2022 10K | Page 254]  Co., Ltd. Japan Japan
American Express Payment Services Limited United Kingdom England and Wales
American Express Payments Europe, S.L.U. Spain Spain American Express Services India Private Limited India India
American Express Swiss Holdings GmbH Switzerland Switzerland
Swisscard AECS GmbH* Switzerland Switzerland
American Express TLS HK Limited China Hong Kong
American Express Travel Holdings Netherlands Cooperatief U.A. Netherlands Netherlands
Amex General Insurance Agency, Inc. China Taiwan
Pocket Concierge Inc. Japan Japan
American Express Netherlands Holdings B.V. Netherlands Netherlands
American Express Brasil Assessoria Empresarial Ltda. Brazil Brazil
PT American Express Indonesia Indonesia Indonesia
American Express Marketing & Development Corp. United Stat...
```

**Chunk 3:**
```
[FY2022 10K | Page 253] American Express Business Solutions (India) Private Limited India India
American Express (Thai) Company Limited Thailand Thailand
American Express Asia Network Consulting (Beijing) Limited Company China China
American Express Continental, LLC United States Delaware
American Express Australia Limited Australia Victoria
Centurion Finance Limited New Zealand New Zealand
American Express Dutch Capital, LLC United States Delaware
American Express Holdings Limited United Kingdom England and Wales
American Express Services Europe Limited United Kingdom England and Wales
American Express de Espana, S.A. (Sociedad Unipersonal) Spain Spain
Amex Asesores de Seguros, S.A. (Sociedad Unipersonal) Spain Spain
American Express Europe, S.A. Spain Spain
American Express Italia S.r.l....
```

**Chunk 4:**
```
[FY2022 10K | Page 254] American Express Holdings 2 Limited United Kingdom England and Wales
American Express Europe LLC United States Delaware
American Express International (Taiwan), Inc. China Taiwan
American Express International Holdings, LLC United States Delaware
American Express Argentina S.A. Argentina Argentina
American Express Holdings (France) SAS France France
American Express France SAS France France
American Express Canada Holdings B.V. Netherlands Netherlands
American Express Holding AB Sweden Sweden
Amex Agenzia Assicurativa S.r.l. Italy Italy
Amex Canada Inc. Canada Ontario
American Express Carte France SA France France
American Express Japan Co., Ltd. Japan Japan
American Express Payment Services Limited United Kingdom England and Wales
American Express Payments Europe, ...
```

**Chunk 5:**
```
[FY2022 10K | Page 5] ion of our billed business outside of the United States
include the United Kingdom (UK), the European Union (EU), Australia, Japan, Canada and Mexico. For the year ended December 31, 2022, worldwide billed business (spending on American Express cards issued by us) was $1,338 billion and at December 31,
2022, we had 76.7 million proprietary cards-in-force worldwide.
Merchant Acquiring Business
Our GMNS reportable operating segment builds and manages relationships with millions of merchants around the world that choose to accept American
Express cards. This includes signing new merchants to accept our cards, agreeing on the discount rate (a fee charged to the merchant for accepting our cards)
and handling servicing for merchants. We also build and maintain relationships...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `american_express`  (display: American Express)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=american_express; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 57 of 75  —  `diag_057`  **[FAILING]**  audit=WRONG_DIRECTION

**fb_id:** `financebench_id_00790`
**company:** CVS Health
**doc:** CVSHEALTH_2022_10K
**question_type:** domain-relevant

### Question

Is CVS Health a capital-intensive business based on FY2022 data?

### Gold answer

> Yes, CVS Health requires an extensive asset base to operate, which is evident from its ROA of only 1.82% in 2022 and 3.39% in 2021, though it should be noted that a significant portion of this asset base is goodwill, and CVS's fixed assets/total assets ratio is on the lower side of 5.6%.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## CVS Health Capital Intensity Analysis – FY2022

### Key Metrics

| Metric | FY2022 Value | Source |
|--------|-------------|--------|
| Gross Capital Expenditures | ~$2.7 billion | [Source 2: CVSHEALTH_2022_10K.pdf, Page 89] |
| Property & Equipment, net | $12,873 million | [Source 1: CVSHEALTH_2022_10K.pdf, Page 110] |
| Total Assets | $228,275 million | [Source 1: CVSHEALTH_2022_10K.pdf, Page 110] |

### Analysis

**Capital Expenditure as % of Total Assets:**
- $2.7B ÷ $228.3B ≈ **~1.2%** — relatively low

**PP&E as % of Total Assets:**
- $12.9B ÷ $228.3B ≈ **~5.6%** — modest

**Asset Composition Context:**
CVS Health's balance sheet is dominated by **non-physical assets**:
- Goodwill: $78.2B (34% of total assets)
- Intangible assets: $24.8B (11%)
- Accounts receivable: $27.3B (12%)
- Long-term investments: $21.1B (9%)

These figures reflect CVS's nature as a **healthcare services and insurance company** (post-Aetna acquisition), not a heavy industrial firm.

**CapEx Mix (FY2022):** ~73% directed toward technology/digital/strategic initiatives and only ~27% toward physical store/facility expansion [Source 2: CVSHEALTH_2022_10K.pdf, Page 89], further underscoring a shift away f

[... truncated, total 1688 chars]
```

### V1 retrieved chunks (top 2 of 2 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 110] Index to Consolidated Financial Statements
Consolidated Balance Sheets
At December 31,
In millions, except per share amounts 2022 2021
Assets:
Cash and cash equivalents $ 12,945 $ 9,408
Investments 2,778 3,117
Accounts receivable, net 27,276 24,431
Inventories 19,090 17,760
Assets held for sale 908 —
Other current assets 2,685 5,292
Total current assets 65,682 60,008
Long-term investments 21,096 23,025
Property and equipment, net 12,873 12,896
Operating lease right-of-use assets 17,872 19,122
Goodwill 78,150 79,121
Intangible assets, net 24,754 29,026
Separate accounts assets 3,228 5,087
Other assets 4,620 4,714
Total assets $ 228,275 $ 232,999
Liabilities:
Accounts payable $ 14,838 $ 12,544
Pharmacy claims and discounts payable 19,423 17,330
Health care costs payab...
```

**Chunk 2:**
```
[FY2022 10K | Page 89] oceeds from the divestitures of PayFlex and bswift, largely offset by a reduction in restricted cash as a result of the sale of health savings account funds held on behalf of customers in conjunction with the sale of PayFlex. In addition, cash used in investing activities reflected the following activity:
• Gross capital expenditures remained relatively consistent at approximately $2.7 billion and $2.5 billion in 2022 and 2021, respectively. During
2022, approximately 73% of the Company’s total capital expenditures were for technology, digital and other strategic initiatives and 27% were for
store, fulfillment and support facilities expansion and improvements.
• Net cash used in financing activities decreased to $10.5 billion in 2022 compared to $11.4 billion in 2021...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `cvs_health`  (display: CVS Health)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=cvs_health; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Balance-sheet and capex metrics are grounded; some business-model characterization is not explicitly supported by retrieved chunks.

---
## Record 58 of 75  —  `diag_058`  **[FAILING]**  audit=DATASET_SUSPECT

**fb_id:** `financebench_id_00651`
**company:** Johnson & Johnson
**doc:** JOHNSON_JOHNSON_2022Q4_EARNINGS
**question_type:** novel-generated

### Question

Is growth in JnJ's adjusted EPS expected to accelerate in FY2023?

### Gold answer

> No, rate of growth in adjusted EPS is expected to decelerate slightly from 3.6% in FY2022 to 3.5% in FY2023.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Johnson & Johnson: Adjusted EPS Growth Acceleration in FY2023

### Comparing Guidance vs. Prior Year Actuals

| Metric | FY2022 Actual | FY2023 Guidance (Updated, post-Kenvue) |
|---|---|---|
| Adjusted EPS | $10.15 | $10.00 – $10.10 |
| Adjusted EPS Growth | +3.6% | ~12.5% at midpoint (Adjusted Reported EPS) |
| Adjusted Operational EPS | ~$10.15 | $9.90 – $10.00, ~11.5% growth at midpoint |

**Sources:**
- FY2022 adjusted EPS of $10.15 growing 3.6% [Source: JOHNSON_JOHNSON_2022Q4_EARNINGS.pdf, Page 1]
- FY2023 updated guidance of Adjusted Reported EPS $10.00–$10.10 reflecting **12.5% growth at midpoint**, and Adjusted Operational EPS $9.90–$10.00 reflecting **11.5% growth at midpoint** [Source: JOHNSON_JOHNSON_2023_8K_dated-2023-08-30.pdf, Page 4]

### Key Context
The FY2023 guidance was updated following the **Kenvue separation**, which reduced the outstanding share count by ~191 million shares, providing an EPS tailwind of approximately **$0.28** (partial-year benefit of ~73.5 million shares) [Source: JOHNSON_JOHNSON_2023_8K_dated-2023-08-30.pdf, Page 4]. This share count reduction is a meaningful driver of the accelerated EPS growth.

---

**Bottom line:** Yes, adjusted EPS

[... truncated, total 1431 chars]
```

### V1 retrieved chunks (top 5 of 6 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 8K | Page 4] Exhibit 99.1
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the KenvueSeparation
• Company expects increased 2023 Reported Sales Growth of 7.0% - 8.0%, Operational Sales Growth of 7.5% - 8.5%, and
Adjusted Operational Sales Growth of 6.2% - 7.2%; Figures exclude the COVID-19 Vaccine
• Company expects 2023 Adjusted Reported Earnings Per Share (EPS) of $10.00 - $10.10, reflecting increased growth of
12.5% at the mid-point and Adjusted Operational EPS of $9.90 - $10.00, reflecting increased growth of 11.5% at the mid-point
• Company reduced outstanding share count by approximately 191 million; 2023 guidance reflects only a partial-year benefitof approximately 73.5 million shares or $0.28 benefit to EPS
```

**Chunk 2:**
```
[FY2023 10K | Page 1] FOR IMMEDIATE RELEASE
• 2023 Second-Quarter reported sales growth of 6.3% to $25.5 Billion with operational growth of 7.5%* and
adjusted operational growth of 6.2%*. Operational growth excluding COVID-19 Vaccine of 8.9%*
• Earnings per share (EPS) of $1.96 increasing 8.9% and adjusted EPS of $2.80 increasing by 8.1%*
• Company is increasing 2023 full -year guidance midpoints for adjusted operational sales  excluding
COVID-19 Vaccine and adjusted operational EPS
• Johnson & Johnson intends to "split off" Kenvue shares through an exchange offer as the form of its
next step in the separation, subject to market conditions
New Brunswick, N.J. (July 20, 2023) – Johnson & Johnson (NY SE: JNJ) today announced results for second-
```

**Chunk 3:**
```
[FY2022 10K | Page 1] ge. Operational growth of 6.1%*
• 2022 Full -Year earnings per share (EPS) of $ 6.73 decreasing 13.8% and adju sted EPS of $ 10.15
increasing by 3.6%* __________________________________________________________________________________________
• Company guides 2023 adjusted operational sales growth excluding COVID-19 Vaccine of 4.0%* and
adjusted operational EPS of $10.50, reflecting growth of 3.5%*
New Brunswick, N.J. (January 24, 2023) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-
quarter and full year 2022 . “Our full year 2022 results reflect the continued strength and stability of our three
business segments, despite macroeconomic challenges ,” said Joaquin Duato, Chairman of the Board and Chief
Executive Officer. “I am inspired by our employe...
```

**Chunk 4:**
```
[FY2023 10K | Page 1]  the separation, subject to market conditions
New Brunswick, N.J. (July 20, 2023) – Johnson & Johnson (NY SE: JNJ) today announced results for second- quarter 2023. “Our robust performance in the second quarter and first half of 2023 is a testament to the hard work
and commitment of our colleagues around the world ,” said Joaquin Duato, Chairman of the Board and Chief
Executive Officer. “We are entering the back half of the year from a position of strength with numerous catalysts,
including becoming a two-sector company focused on Pharmaceutical and MedTech innovation.”
OVERALL FINANCIAL RESULTS
Q2
($ in Millions, except EPS) 2023 2022 % Change
Reported Sales $25,530 $24,020 6.3%
Net Earnings/(Loss) $5,144 $4,814 6.9%
EPS (diluted) $1.96 $1.80 8.9%
Q2
Non-GAAP* ($ in ...
```

**Chunk 5:**
```
[FY2023 8K | Page 17] Johnson & Johnson and Subsidiaries
Reconciliation of Non-GAAP Financial Measure
Adjusted Operational Sales Growth
2023 ACTUAL vs. 2022 ACTUAL
Q1 Q2 SIX MONTHS
WW As Reported 5.3 % 6.5 % 5.9 %
U.S. 9.4 % 10.9 % 10.2 %
International 1.3 % 1.6 % 1.5 %
WW Currency (3.2) (1.0) (2.1)
U.S. — — —
International (6.4) (2.2) (4.3)
WW Operational 8.5 % 7.5 % 8.0 %
U.S. 9.4 % 10.9 % 10.2 %
International 7.7 % 3.8 % 5.8 %
Abiomed (1.6) (1.6) (1.6)
U.S. (2.7) (2.6) (2.6)
International (0.6) (0.6) (0.6)
All Other Acquisitions and Divestitures 0.0 0.1 0.0
U.S. 0.0 0.0 0.0
International 0.1 0.2 0.2
WW Adjusted Operational 6.9 % 6.0 % 6.4 %
U.S. 6.7 % 8.3 % 7.6 %
International 7.2 % 3.4 % 5.4 %
Note: Percentages are based on actual, non-rounded figures and may not sum
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `johnson_johnson`  (display: Johnson & Johnson)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=johnson_johnson; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Johnson & Johnson FY2022 adjusted EPS growth.
2. Johnson & Johnson FY2023 adjusted EPS growth guidance.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 59 of 75  —  `diag_059`  **[PASSING]**

**fb_id:** `financebench_id_00669`
**company:** Johnson & Johnson
**doc:** JOHNSON_JOHNSON_2022_10K
**question_type:** domain-relevant

### Question

What drove gross margin change as of FY2022 for JnJ? If gross margin is not a useful metric for a company like this, then please state that and explain why.

### Gold answer

> For FY22, JnJ had changes in gross margin due to: One-time COVID-19 vaccine manufacturing exit related costs, Currency impacts in the Pharmaceutical segment, Commodity inflation in the MedTech and Consumer Health segments, partially offset by Supply chain benefits in the Consumer Health segment.

### V1 system answer (for HALLU_GROUNDED labeling)

```
# J&J Gross Margin Analysis: FY2022 vs. FY2021

## Headline Numbers

| Metric | FY2022 | FY2021 | Change |
|---|---|---|---|
| Sales | $94,943M | $93,775M | +$1,168M (+1.3%) |
| Cost of Products Sold | $31,089M | $29,855M | +$1,234M (+4.1%) |
| Gross Profit | $63,854M | $63,920M | −$66M (−0.1%) |
| **Gross Margin %** | **67.3%** | **68.2%** | **−0.9 pp** |
| COGS as % of Sales | 32.7% | 31.8% | +0.9 pp |

[Source: JOHNSON_JOHNSON_2022Q4_EARNINGS.pdf, Page 11; JOHNSON_JOHNSON_2022_10K.pdf, Page 47]

---

## Drivers of the −0.9 pp Gross Margin Compression

Management explicitly identified the following factors causing COGS to increase as a percent of sales [Source: JOHNSON_JOHNSON_2022_10K.pdf, Page 34]:

### Headwinds (margin-compressing):
1. **One-time COVID-19 vaccine manufacturing exit related costs** — J&J wound down its COVID vaccine operations, incurring non-recurring exit charges embedded in COGS
2. **Currency impacts in the Pharmaceutical segment** — USD strength reduced the translated value of international revenues while some costs remained in local currencies, pressuring margins [Source: JOHNSON_JOHNSON_2022_10K.pdf, Page 36]
3. **Commodity inflation in the MedTech and Co

[... truncated, total 3455 chars]
```

### V1 retrieved chunks (top 5 of 8 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 47] JOHNSON & JOHNSON AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
(Dollars and Shares in Millions Except Per Share Amounts) (Note 1)
2022 2021 2020
Sales to customers $ 94,943 93,775 82,584
Cost of products sold 31,089 29,855 28,427
Gross profit 63,854 63,920 54,157
Selling, marketing and administrative expenses 24,765 24,659 22,084
Research and development expense 14,603 14,714 12,159
In-process research and development (Note 5) 783 900 181
Interest income (490) (53) (111)
Interest expense, net of portion capitalized (Note 4) 276 183 201
Other (income) expense, net 1,871 489 2,899
Restructuring (Note 20) 321 252 247
Earnings before provision for taxes on income 21,725 22,776 16,497
Provision for taxes on income (Note 8) 3,784 1,898 1,783
Net earnings $ 17,941 2...
```

**Chunk 2:**
```
[FY2022 10K | Page 11] Johnson & Johnson and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited; in Millions Except Per Share Figures)
Percent
Percent Percent Increase
Amount to Sales Amount to Sales (Decrease)
Sales to customers 94,943$   100.0       93,775$   100.0       1.3
Cost of products sold 31,089     32.7         29,855     31.8         4.1
Gross Profit 63,854     67.3         63,920     68.2         (0.1)
Selling, marketing and administrative expenses 24,765     26.1         24,659     26.3         0.4
Research and development expense 14,603     15.4         14,714     15.7         (0.8)
In-process research and development 783          0.8           900          1.0
Interest (income) expense, net (214)         (0.2)         130          0.1
```

**Chunk 3:**
```
[FY2022 10K | Page 36]  related costs of $1.5 billion in 2022
• Unfavorable changes in the fair value of securities ($0.7 billion loss in 2022 vs. $0.5 billion gain in 2021) • An IPR&D charge of $0.8 billion in 2022 related to bermekimab (JnJ-77474462), an investigational drug for the treatment of Atopic Dermatitis
(AD) and Hidradenitis Suppurativa (HS)
• Lower divestiture gains of $0.1 billion in 2022 versus $0.6 billion related to two pharmaceutical brands outside the U.S. in fiscal 2021
• Currency impacts in Cost of Products Soldpartially offset by:
```

**Chunk 4:**
```
[FY2022 10K | Page 10] Johnson & Johnson and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited; in Millions Except Per Share Figures)
Percent
Percent Percent Increase
Amount to Sales Amount to Sales (Decrease)
Sales to customers 23,706$   100.0       24,804$   100.0       (4.4)
Cost of products sold 7,765       32.8         7,955       32.1         (2.4)
Gross Profit 15,941     67.2         16,849     67.9         (5.4)
Selling, marketing and administrative expenses 6,512       27.4         7,154       28.9         (9.0)
Research and development expense 3,841       16.2         4,720       19.0         (18.6)
In-process research and development 173          0.7           0 0.0
Interest (income) expense, net (77)           (0.3)         47            0.2
```

**Chunk 5:**
```
[FY2022 10K | Page 34] ncreased as a percent to sales driven by:
• One-time COVID-19 vaccine manufacturing exit related costs• Currency impacts in the Pharmaceutical segment • Commodity inflation in the MedTech and Consumer Health segmentspartially offset by• Supply chain benefits in the Consumer Health segmentThe intangible asset amortization expense included in cost of products sold was $4.3 billion and $4.7 billion for the fiscal years 2022 and 2021,respectively.
28
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `johnson_johnson`  (display: Johnson & Johnson)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=johnson_johnson; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Johnson & Johnson FY2022 gross margin and FY2021 gross margin.
2. Johnson & Johnson management-stated drivers of FY2022 cost of products sold change.
3. Whether gross margin is a relevant metric for Johnson & Johnson.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 60 of 75  —  `diag_060`  **[PASSING]**

**fb_id:** `financebench_id_04103`
**company:** General Mills
**doc:** GENERALMILLS_2019_10K
**question_type:** metrics-generated

### Question

What is the FY2019 cash conversion cycle (CCC) for General Mills? CCC is defined as: DIO + DSO - DPO. DIO is defined as: 365 * (average inventory between FY2018 and FY2019) / (FY2019 COGS). DSO is defined as: 365 * (average accounts receivable between FY2018 and FY2019) / (FY2019 Revenue). DPO is defined as: 365 * (average accounts payable between FY2018 and FY2019) / (FY2019 COGS + change in inventory between FY2018 and FY2019). Round your answer to two decimal places. Address the question by using the line items and information shown within the income statement and the balance sheet.

### Gold answer

> -3.7

### V1 system answer (for HALLU_GROUNDED labeling)

```
## FY2019 Cash Conversion Cycle — General Mills

### Source Data (verified from filings)

| Line Item | FY2019 | FY2018 | Source |
|---|---|---|---|
| Inventories | $1,559.3M | $1,642.2M | [Source 1: GENERALMILLS_2019_10K.pdf, Page 55]; [Source 4: Page 103] |
| Receivables | $1,679.7M | $1,684.2M | [Source 1: GENERALMILLS_2019_10K.pdf, Page 55] |
| Accounts Payable | $2,854.1M | $2,746.2M | [Source 1: GENERALMILLS_2019_10K.pdf, Page 55] |
| Net Sales (Revenue) | $16,865.2M | — | [Source 3: GENERALMILLS_2019_10K.pdf, Page 53] |
| Cost of Sales (COGS) | $11,108.4M | — | [Source 3: GENERALMILLS_2019_10K.pdf, Page 53] |

---

### Step-by-Step Computation

**Averages:**
- Avg. Inventory = (1,559.3 + 1,642.2) / 2 = **$1,600.75M**
- Avg. Receivables = (1,679.7 + 1,684.2) / 2 = **$1,681.95M**
- Avg. Accounts Payable = (2,854.1 + 2,746.2) / 2 = **$2,800.15M**
- Change in Inventory = 1,559.3 − 1,642.2 = **−$82.9M**

---

**DIO** = 365 × 1,600.75 / 11,108.4
= 584,273.75 / 11,108.4
= **52.60 days**

**DSO** = 365 × 1,681.95 / 16,865.2
= 613,911.75 / 16,865.2
= **36.40 days**

**DPO** = 365 × 2,800.15 / (11,108.4 + (−82.9))
= 1,022,054.75 / 11,025.5
= **92.70 days**

---

**CCC = DIO + DSO − DP

[... truncated, total 1522 chars]
```

### V1 retrieved chunks (top 4 of 4 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 55] Consolidated Balance Sheets GENERAL MILLS, INC Consolidated Balance Sheets GENERAL MILLS, INC AND SUBSIDIARIES(In Millions, Except Par Value) May 26, 2019 May 27, 2018 ASSETS Current assets: Cash and cash equivalents $450.0 $399.0 Receivables 1,679.7 1,684.2 Inventories 1,559.3 1,642.2 Prepaid expenses and other current assets 497.5 398.3 Total current assets 4,186.5 4,123.7 Land, buildings, and equipment 3,787.2 4,047.2 Goodwill 13,995.8 14,065.0 Other intangible assets 7,166.8 7,445.1 Other assets 974.9 943.0 Total assets $ 30,111.2 $ 30,624.0 LIABILITIES AND EQUITY Current liabilities: Accounts payable $2,854.1 $2,746.2 Current portion of long-term debt 1,396.5 1,600.1 Notes payable 1,468.7 1,549.8 Other current liabilities 1,367.8 1,445.8 Total current liabilities 7,087...
```

**Chunk 2:**
```
[10K | Page 50] 50
Consolidated Balance Sheets
GENERAL MILLS, INC. AND SUBSIDIARIES
(In Millions, Except Par Value)
May 31, 2020 May 26, 2019
ASSETS
Current assets:
Cash and cash equivalents $ 1,677.8   $ 450.0
Receivables  1,615.1    1,679.7
Inventories  1,426.3    1,559.3
Prepaid expenses and other current assets  402.1    497.5
Total current assets  5,121.3    4,186.5
Land, buildings, and equipment  3,580.6    3,787.2
Goodwill  13,923.2    13,995.8
Other intangible assets  7,095.8    7,166.8
Other assets  1,085.8    974.9
Total assets $ 30,806.7   $ 30,111.2
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable $ 3,247.7   $ 2,854.1
Current portion of long-term debt  2,331.5    1,396.5
Notes payable  279.0    1,468.7
Other current liabilities  1,633.3    1,367.8
```

**Chunk 3:**
```
[10K | Page 53] Consolidated Statements of Earnings GENERAL MILLS, INC Consolidated Statements of Earnings GENERAL MILLS, INC AND SUBSIDIARIES(In Millions, Except per Share Data) Fiscal Year 2019 2018 2017 Net sales $ 16,865.2 $ 15,740.4 $ 15,619.8 Cost of sales 11,108.4 10,304.8 10,052.0 Selling, general, and administrative expenses 2,935.8 2,850.1 2,888.8 Divestitures loss 30.0 - 6.5 Restructuring, impairment, and other exit costs 275.1 165.6 180.4 Operating profit 2,515.9 2,419.9 2,492.1 Benefit plan non-service income (87.9) (89.4) (74.3) Interest, net 521.8 373.7 295.1 Earnings before income taxes and after-tax earnings from joint ventures 2,082.0 2,135.6 2,271.3 Income taxes 367.8 57.3 655.2 After-tax earnings from joint ventures 72.0 84.7 85.0 Net earnings, including earnings attrib...
```

**Chunk 4:**
```
[10K | Page 103]  27,2018 Land, buildings, and equipment:    United States  $2,872.8   $3,031.7 Non-United States   914.4    1,015.5 Total  $3,787.2   $4,047.2 NOTE 17  27,2018 Land, buildings, and equipment:    United States  $2,872.8   $3,031.7 Non-United States   914.4    1,015.5 Total  $3,787.2   $4,047.2 NOTE 17 SUPPLEMENTAL INFORMATIONThe components of certain Consolidated Balance Sheet accounts are as follows: In Millions  May 26, 2019   May 27, 2018 Receivables:          Customers   $    1,708.5     $    1,712.6  Less allowance for doubtful accounts   (28.8)    (28.4) Total   $    1,679.7     $    1,684.2   In Millions  May 26, 2019   May 27, 2018 Inventories:          Raw materials and packaging  $434.9    $400.0  Finished goods   1,245.9     1,364.2  Grain   92.0     91.2  Excess...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `general_mills`  (display: General Mills)
- **Auto target_fiscal_year:** `2019`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=general_mills; override if wrong)

**TARGET_YEAR:** `OK` (auto=2019; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. General Mills FY2019 and FY2018 inventory balances.
2. General Mills FY2019 and FY2018 accounts receivable balances.
3. General Mills FY2019 and FY2018 accounts payable balances.
4. General Mills FY2019 revenue and COGS.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 61 of 75  —  `diag_061`  **[PASSING]**

**fb_id:** `financebench_id_02024`
**company:** Verizon
**doc:** VERIZON_2021_10K
**question_type:** novel-generated

### Question

As of FY 2021, how much did Verizon expect to pay for its retirees in 2024?

### Gold answer

> The estimated pension benefits were $1097 million, and the estimated health care and life insurance benefits were $862 million.

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the provided context, Verizon expected to pay the following amounts to retirees in 2024:

- **Pension Benefits**: $1,097 million
- **Health Care and Life**: $862 million
- **Total**: $1,959 million

[Source: VERIZON_2021_10K.pdf, Page 94]

**Bottom line**: As of FY2021, Verizon expected to pay a combined **$1,959 million** ($1,097M in pension benefits + $862M in health care and life) to retirees in 2024.
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2021 10K | Page 94] mated to be approximately $860 million in 2022.
Estimated Future Benefit Payments
The benefit payments to retirees are expected to be paid as follows: (dollars in millions)
Year Pension Benefits Health Care and Life
2022 $ 2,049 $ 906
2023 1,648 883
2024 1,097 862
2025 1,066 850
2026 1,034 840
2027 to 2031 5,097 4,139
Savings Plan and Employee Stock Ownership Plans
We maintain four leveraged employee stock ownership plans (ESOP). We match a certain percentage of eligible employee contributions to
certain savings plans with shares of our common stock from this ESOP. At December 31, 2021, the number of allocated shares of common
stock in this ESOP was 44 million. There were no unallocated shares of common stock in this ESOP at December 31, 2021. All leveraged
ESOP shar...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `verizon`  (display: Verizon)
- **Auto target_fiscal_year:** `2021`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=verizon; override if wrong)

**TARGET_YEAR:** `OK` (auto=2021; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 62 of 75  —  `diag_062`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_02416`
**company:** Pfizer
**doc:** PFIZER_2021_10K
**question_type:** novel-generated

### Question

What are three main companies acquired by Pfizer mentioned in this 10K report?

### Gold answer

> Trillium, Array, and Therachon

### V1 system answer (for HALLU_GROUNDED labeling)

```
Based on the provided context chunks, I cannot identify three main companies **acquired** by Pfizer. The context from pages 133 and 137 of Pfizer's FY2021 10K only contains **lists of subsidiaries** (legal entities owned by or affiliated with Pfizer), not a discussion of acquisitions or deal history.

Some notable subsidiary names that suggest historical acquisitions include:

- **Pharmacia & Upjohn** (multiple entities listed, e.g., Pharmacia & Upjohn Company LLC, Pharmacia & Upjohn LLC) [Source 2: PFIZER_2021_10K.pdf, Page 133]
- **Wyeth** (referenced in "PFE Wyeth-Ayerst (Asia) LLC") [Source 2: PFIZER_2021_10K.pdf, Page 133]
- **Rinat Neuroscience Corp.** (listed as a subsidiary) [Source 1: PFIZER_2021_10K.pdf, Page 137]

However, these are inferences from subsidiary names — the context does **not** explicitly describe acquisition transactions, deal terms, or confirm these as "main" acquisitions.

---

**Bottom line (Partial evidence):** The context confirms subsidiary entities bearing the names of historically acquired companies (Pharmacia & Upjohn, Wyeth-Ayerst, Rinat Neuroscience), but the 10K pages provided do not contain a dedicated acquisitions section to definitively answ

[... truncated, total 1217 chars]
```

### V1 retrieved chunks (top 2 of 2 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2021 10K | Page 137] anyIreland Pfizer Zona Franca, S.A.Costa Rica Pfizer, Inc.Philippines Pfizer, S.A.Costa Rica Pfizer, S.A. de C.V.Mexico Pfizer, S.L.Spain Pfizer, spol anyIreland Pfizer Zona Franca, S.A.Costa Rica Pfizer, Inc.Philippines Pfizer, S.A.Costa Rica Pfizer, S.A. de C.V.Mexico Pfizer, S.L.Spain Pfizer, spol s r.o.Czech Republic Pharmacia & Upjohn Company LLCDelaware Pharmacia & Upjohn LLCDelaware Pharmacia Brasil Ltda.Brazil Pharmacia Hepar LLCDelaware Pharmacia Inter-American LLCPennsylvania Pharmacia International B.V.Netherlands Pharmacia LimitedUnited Kingdom Pharmacia LLCDelaware PHIVCO Corp.Delaware PHIVCO Holdco S.à r.l.Luxembourg PIMB OFG Spain Holding, S.L.Spain PRISM Holdings B.V.Netherlands PT. Pfizer IndonesiaIndonesia Purepac Pharmaceutical Holdings LLCDelawar...
```

**Chunk 2:**
```
[FY2021 10K | Page 133] uticals, LLCTennessee MTG Divestitures LLCDelaware Neusentis LimitedUnited Kingdom PAH USA IN8 LLCDelaware Parke Davis LimitedHong Kong Parke, Davis & uticals, LLCTennessee MTG Divestitures LLCDelaware Neusentis LimitedUnited Kingdom PAH USA IN8 LLCDelaware Parke Davis LimitedHong Kong Parke, Davis & uticals, LLCTennessee MTG Divestitures LLCDelaware Neusentis LimitedUnited Kingdom PAH USA IN8 LLCDelaware Parke Davis LimitedHong Kong Parke, Davis & Company LLCMichigan Parkedale Pharmaceuticals, Inc.Michigan PBG Puerto Rico LLCPuerto Rico P-D Co., LLCDelaware Peak Enterprises LLCDelaware PF Argentum Acquisition ULCCanada PF Consumer Healthcare Holdings LLCDelaware PF Consumer Healthcare Holdings US Inc.Delaware PF Czech Republic Holdings B.V.Netherlands PF Finland Ho...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `pfizer`  (display: Pfizer)
- **Auto target_fiscal_year:** `2021`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=pfizer; override if wrong)

**TARGET_YEAR:** `OK` (auto=2021; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Subsidiary names are grounded, but the historical-acquisition inference is not directly supported by the shown chunks.

---
## Record 63 of 75  —  `diag_063`  **[FAILING]**  audit=WRONG_NUMBER

**fb_id:** `financebench_id_06247`
**company:** Walmart
**doc:** WALMART_2018_10K
**question_type:** metrics-generated

### Question

What is FY2018 days payable outstanding (DPO) for Walmart? DPO is defined as: 365 * (average accounts payable between FY2017 and FY2018) / (FY2018 COGS + change in inventory between FY2017 and FY2018). Round your answer to two decimal places. Please base your judgments on the information provided primarily in the statement of financial position and the P&L statement.

### Gold answer

> 42.69

### V1 system answer (for HALLU_GROUNDED labeling)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## Walmart FY2018 Days Payable Outstanding (DPO)

### Key Inputs Required

| Item | Value | Source |
|------|-------|--------|
| AP, Jan 31, 2018 (FY2018 end) | $41,433M | Walmart FY2018 10-K Balance Sheet |
| AP, Jan 31, 2017 (FY2017 end) | $37,408M | Walmart FY2018 10-K Balance Sheet |
| Average AP | $39,420.5M | Computed |
| FY2018 COGS | $373,396M | Walmart FY2018 10-K Income Statement |
| Inventory, Jan 31, 2018 | $43,783M | Walmart FY2018 10-K Balance Sheet |
| Inventory, Jan 31, 2017 | $43,046M | Walmart FY2018 10-K Balance Sheet |
| Change in Inventory | +$737M | Computed |

**Important caveat**: The retrieved chunks do not directly include the FY2018 balance sheet or income statement pages. The AP balances, COGS, and inventory figures above are drawn from standard Walmart FY2018 10-K disclosures. The cash flow statement [Source 2: WALMART_2018_10K.pdf, Page 62] provides partial corroboration: it shows FY2018 inventory change of −$140M (cash outflow, meaning inventory increased) and AP change of +$4,086M, which are broadly consistent with the balance she

[... truncated, total 1827 chars]
```

### V1 retrieved chunks (top 4 of 4 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 52] Walmart
Inc.
Consolidated
Statements
of
Cash
Flows  Fiscal
Years
Ended
January
31, (Amounts in millions) 2019 2018 2017Cash
flows
from
operating activities:      Consolidated net income $7,179  $10,523  $14,293 Adjustments to reconcile consolidated net income to net cash provided by operating activities:      Depreciation and amortization 10,678  10,529  10,080 Unrealized (gains) and losses 3,516  —  — (Gains) and losses for disposal of business operations 4,850  —  — Deferred income taxes (499 ) (304 ) 761 Loss on extinguishment of debt —  3,136  — Other operating activities 1,734  1,210  206 Changes in certain assets and liabilities, net of effects of acquisitions:      Receivables, net (368 ) (1,074 ) (402 )Inventories (1,311 ) (140 ) 1,021 Accounts payable 1,831  4,086 ...
```

**Chunk 2:**
```
[10K | Page 62] Walmart Inc. Consolidated Statements of Cash Flows Fiscal Years Ended January 31, (Amounts in millions) 2018 2017 2016Cash flows from operating activities: Consolidated net income $10,523 $14,293 $15,080Adjustments to reconcile consolidated net income to net cash provided by operating activities: Depreciation and amortization 10,529 10,080 9,454 Deferred income taxes (304 ) 761 (672 )Loss on extinguishment of debt 3,136 — — Other operating activities 1,210 206 1,410 Changes in certain assets and liabilities, net of effects of acquisitions: Receivables, net (1,074 ) (402 ) (19 )Inventories (140 ) 1,021 (703 )Accounts payable 4,086 3,942 2,008 Accrued liabilities 928 1,280 1,466 Accrued income taxes (557 ) 492 (472 )Net cash provided by operating activities 28,337 31,673 27,5...
```

**Chunk 3:**
```
[10K | Page 56] Walmart Inc. Consolidated Statements of Cash Flows Fiscal Years Ended January 31, (Amounts in millions) 2020 2019 2018Cash flows from operating activities: Consolidated net income $15,201 $7,179 $10,523Adjustments to reconcile consolidated net income to net cash provided by operating activities: Depreciation and amortization 10,987 10,678 10,529 Unrealized (gains) and losses (1,886 ) 3,516 — (Gains) and losses for disposal of business operations 15 4,850 — Asda pension contribution (1,036 ) — — Deferred income taxes 320 (499 ) (304 )Loss on extinguishment of debt — — 3,136 Other operating activities 1,981 1,734 1,210 Changes in certain assets and liabilities, net of effects of acquisitions: Receivables, net 154 (368 ) (1,074 )Inventories (300 ) (1,311 ) (140 )Accounts payab...
```

**Chunk 4:**
```
[10K | Page 53] Walmart Inc. Consolidated Balance Sheets As of January 31, (Amounts in millions) 2020 2019ASSETS Current assets: Cash and cash equivalents $9,465 $7,722 Receivables, net 6,284 6,283 Inventories 44,435 44,269 Prepaid expenses and other 1,622 3,623 Total current assets 61,806 61,897 Property and equipment, net 105,208 104,317Operating lease right-of-use assets 17,424 — Finance lease right-of-use assets, net 4,417 — Property under capital lease and financing obligations, net — 7,078 Goodwill 31,073 31,181 Other long-term assets 16,567 14,822 Total assets $236,495 $219,295 LIABILITIES AND EQUITY Current liabilities: Short-term borrowings $575 $5,225 Accounts payable 46,973 47,060 Accrued liabilities 22,296 22,159 Accrued income taxes 280 428 Long-term debt due within one year 5...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `walmart`  (display: Walmart)
- **Auto target_fiscal_year:** `2018`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=walmart; override if wrong)

**TARGET_YEAR:** `OK` (auto=2018; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Walmart FY2018 and FY2017 accounts payable.
2. Walmart FY2018 cost of sales.
3. Walmart FY2018 and FY2017 inventories.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Final DPO inputs are mostly drawn from outside the retrieved chunks; only cash-flow corroboration is shown.

---
## Record 64 of 75  —  `diag_064`  **[PASSING]**

**fb_id:** `financebench_id_00684`
**company:** Amcor
**doc:** AMCOR_2023_10K
**question_type:** domain-relevant

### Question

Does AMCOR have an improving gross margin profile as of FY2023? If gross margin is not a useful metric for a company like this, then state that and explain why.

### Gold answer

> No. For AMCOR there has been a slight decline in gross margins by 0.8%.

### V1 system answer (for HALLU_GROUNDED labeling)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## AMCOR Gross Margin Profile: FY2021–FY2023

### Data (from [Source 2: AMCOR_2023_10K.pdf, Page 50])

| Fiscal Year | Net Sales | Gross Profit | Gross Margin |
|-------------|-----------|--------------|--------------|
| FY2021 | $12,861M | $2,732M | **21.2%** |
| FY2022 | $14,544M | $2,820M | **19.4%** |
| FY2023 | $14,694M | $2,725M | **18.5%** |

**YoY change FY2021→FY2022:** −1.8 pp
**YoY change FY2022→FY2023:** −0.9 pp

---

### Answer

**No — AMCOR does not have an improving gross margin profile.** Gross margin has declined consistently over three years: from 21.2% in FY2021 to 19.4% in FY2022 to 18.5% in FY2023, a cumulative deterioration of **−2.7 percentage points** [Source 2: AMCOR_2023_10K.pdf, Page 50].

---

### Is Gross Margin Even the Right Metric Here?

Gross margin is **partially useful but potentially misleading** for a company like AMCOR. Here's why:

- AMCOR is a large-scale, capital-intensive **packaging manufacturer** whose primary inputs are commodity raw materials — resins, aluminum foil, films, etc.
- These businesses typically operate u

[... truncated, total 2665 chars]
```

### V1 retrieved chunks (top 3 of 3 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 10Q | Page 5] Part I - Financial Information
Item 1. Financial Statements (unaudited)
Amcor plc and Subsidiaries
Condensed Consolidated Statements of Income
(Unaudited)
Three Months Ended December 31,Six Months Ended December 31,
($ in millions, except per share data) 2022 2021 2022 2021
Net sales $ 3,642 $ 3,507 $ 7,354 $ 6,927
Cost of sales (2,980) (2,862) (6,024) (5,632)
Gross profit 662 645 1,330 1,295
Selling, general, and administrative expenses (298) (303) (600) (616)
Research and development expenses (24) (23) (49) (48)
Restructuring and other related activities, net 213 (10) 212 (18)
Other income, net 6 13 8 5
Operating income 559 322 901 618
Interest income 11 5 20 10
Interest expense (79) (39) (138) (79)
Other non-operating income, net 3 2 3 7
Income before income taxes ...
```

**Chunk 2:**
```
[FY2023 10K | Page 50] Amcor plc and Subsidiaries
Consolidated Statements of Income
($ in millions, except per share data)
For the years ended June 30, 2023 2022 2021
Net sales $ 14,694 $ 14,544 $ 12,861
Cost of sales (11,969) (11,724) (10,129)
Gross profit 2,725 2,820 2,732
Selling, general, and administrative expenses (1,246) (1,284) (1,292)
Research and development expenses (101) (96) (100)
Restructuring, impairment, and other related activities, net 104 (234) (94)
Other income, net 26 33 75
Operating income 1,508 1,239 1,321
Interest income 31 24 14
Interest expense (290) (159) (153)
Other non-operating income, net 2 11 11
Income before income taxes and equity in income of affiliated companies 1,251 1,115 1,193
Income tax expense (193) (300) (261)
Equity in income of affiliated compani...
```

**Chunk 3:**
```
[10K | Page 48] Amcor plc and Subsidiaries
Consolidated Statement of Income
(in millions, except per share data)
For the years ended June 30, 2020 2019 2018
Net sales $ 12,467.5 $ 9,458.2 $ 9,319.1
Cost of sales (9,932.0) (7,659.1) (7,462.3)
Gross profit 2,535.5 1,799.1 1,856.8
Operating expenses:
Selling, general, and administrative expenses (1,384.8) (999.0) (793 .2)
Research and development expenses (97.3) (64.0) (72.7)
Restructuring and related expenses (115.1) (130.8) (40.2)
Other income, net 55.7 186.4 43.2
Operating income 994.0 791.7 993.9
Interest income 22.2 16.8 13.1
Interest expense (206.9) (207.9) (210.0)
Other non-operating income (loss), net 15.9 3.5 (74.1)
Income from continuing operations before income taxes and equity in income (loss) of affiliated companies 825.2 604.1 7...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `amcor`  (display: Amcor)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=amcor; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. AMCOR FY2023 gross profit and net sales.
2. AMCOR FY2022 gross profit and net sales.
3. AMCOR FY2021 gross profit and net sales.
4. Whether gross margin is a relevant metric for AMCOR.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Gross-margin calculations are grounded; business-model/relevance explanation is not fully supported by chunks.

---
## Record 65 of 75  —  `diag_065`  **[FAILING]**  audit=DATASET_SUSPECT

**fb_id:** `financebench_id_01911`
**company:** MGM Resorts
**doc:** MGMRESORTS_2022Q4_EARNINGS
**question_type:** novel-generated

### Question

What was MGM's interest coverage ratio using FY2022 Adjusted EBIT as the numerator and annual Interest Expense as the denominator?

### Gold answer

> As adjusted EBIT is negative, coverage ratio is zero

### V1 system answer (for HALLU_GROUNDED labeling)

```
## MGM Resorts International — FY2022 Interest Coverage Ratio

### Key Figures

| Item | FY2022 Value | Source |
|---|---|---|
| Income (loss) before income taxes | $903,799K | [Source 1: MGMRESORTS_2022_10K.pdf, Page 45] |
| Interest expense, net of amounts capitalized | $594,954K | [Source 2: MGMRESORTS_2022_10K.pdf, Page 83] |
| Operating Income | $1,439,372K | [Source 4: MGMRESORTS_2022Q4_EARNINGS.pdf, Page 11] |

### Calculation

No line item explicitly labeled "Adjusted EBIT" appears in the filings. The most standard financial derivation of EBIT as a coverage ratio numerator is:

**EBIT = Pretax Income + Net Interest Expense**
= $903,799K + $594,954K = **$1,498,753K**

**Interest Coverage Ratio = $1,498,753K / $594,954K ≈ 2.52x**

> *Alternative: Using Operating Income ($1,439,372K) as the numerator yields a ratio of ~2.42x. The difference arises because Operating Income excludes income from unconsolidated affiliates (-$160,213K) and other non-operating items that are added back in the EBIT derivation.*

---

**Bottom line (partial evidence):** MGM's FY2022 interest coverage ratio is approximately **2.52x** using the standard EBIT derivation (pretax income + net interest expe

[... truncated, total 1455 chars]
```

### V1 retrieved chunks (top 4 of 4 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 45] The following table presents a reconciliation of net income (loss) attributable to MGM Resorts International to Adjusted EBITDAR:
Year Ended December 31,
2022 2021 2020
(In thousands)
Net income (loss) attributable to MGM Resorts International $ 1,473,093 $ 1,254,370 $ (1,032,724)
Plus: Net loss attributable to noncontrolling interests (1,266,362) (45,981) (287,183)
Net income (loss) 206,731 1,208,389 (1,319,907)
Provision (benefit) for income taxes 697,068 253,415 (191,572)
Income (loss) before income taxes 903,799 1,461,804 (1,511,479)
Non-operating (income) expense
Interest expense, net of amounts capitalized 594,954 799,593 676,380
Non-operating items from unconsolidated affiliates 23,457 83,243 103,304
Other, net (82,838) (65,941) 89,361
535,573 816,895 869,045
```

**Chunk 2:**
```
[FY2022 10K | Page 83]  MGM China senior notes, due 2025 500,000 500,000
5.875% MGM China senior notes, due 2026 750,000 750,000
4.5% MGP OP senior notes, due 2026 — 500,000 4.625% senior notes, due 2026 400,000 400,000
5.75% MGP OP senior notes, due 2027 — 750,000
5.5% senior notes, due 2027 675,000 675,000
4.75% MGM China senior notes, due 2027 750,000 750,000
4.5% MGP OP senior notes, due 2028 — 350,000
4.75% senior notes, due 2028 750,000 750,000
3.875% MGP OP senior notes, due 2029 — 750,000
7% debentures, due 2036 552 552
8,761,189 12,860,966
Less: Premiums, discounts, and unamortized debt issuance costs, net (41,899) (90,169)
8,719,290 12,770,797
Less: Current portion (1,286,473) (1,000,000)
$ 7,432,817 $ 11,770,797
Interest expense, net consisted of the following:
Year Ended Decemb...
```

**Chunk 3:**
```
[FY2022 10K | Page 42] uant to which the assets and liabilities of MGP were derecognized, which included MGP OP’s
investment in the VICI BREIT Venture.
Non-operating Results Interest expense
The following table summarizes information related to interest expense, net:
Year Ended December 31,
2022 2021 2020
(In thousands)
Total interest incurred $ 595,692 $ 800,156 $ 679,251
Interest capitalized (738) (563) (2,871)
$ 594,954 $ 799,593 $ 676,380
Gross interest expense was $596 million in 2022 compared to $800 million in 2021. The decrease from the prior year period is due primarily to adecrease in debt outstanding as a result of the derecognition of MGP OP’s senior notes in connection with the deconsolidation of MGP, partially offset by an
```

**Chunk 4:**
```
[FY2022 10K | Page 11] 0    1,150,610
3,553,787    2,679,998    11,527,900    7,486,264
Income (loss) from unconsolidated affiliates  (40,325)   (8,047)   (160,213)   84,823 Operating income (loss)  (1,896)   368,847    1,439,372    2,278,699
Non-operating income (expense)
Interest expense, net of amounts capitalized  (137,132)   (201,477)   (594,954)   (799,593)
Non-operating items from unconsolidated affiliates  (1,209)   (15,770)   (23,457)   (83,243)
Other, net  106,160    (4,361)   82,838    65,941
(32,181)   (221,608)   (535,573)   (816,895)
Income (loss) before income taxes  (34,077)   147,239    903,799    1,461,804
Provision for income taxes  (285,937)   (31,152)   (697,068)   (253,415)
Net income (loss)  (320,014)   116,087    206,731    1,208,389
Less: Net loss attributable to n...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `mgm_resorts`  (display: MGM Resorts)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=mgm_resorts; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. MGM Resorts FY2022 adjusted EBIT or adjusted EBITDAR reconciliation.
2. MGM Resorts FY2022 annual interest expense.
3. Appropriate numerator definition for MGM FY2022 interest coverage ratio.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Uses retrieved pre-tax income, interest expense, and operating income with caveats.

---
## Record 66 of 75  —  `diag_066`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_00685`
**company:** Best Buy
**doc:** BESTBUY_2023_10K
**question_type:** domain-relevant

### Question

Are Best Buy's gross margins historically consistent (not fluctuating more than roughly 2% each year)? If gross margins are not a relevant metric for a company like this, then please state that and explain why.

### Gold answer

> Yes, the margins have been consistent, there has been a minor decline of 1.1% in gross margins between FY2022 and FY2023.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Best Buy Gross Margin Analysis

### Is Gross Margin a Relevant Metric for Best Buy?

**Yes, absolutely.** Best Buy is a large-format consumer electronics retailer, and gross margin is a core metric for any retailer. It captures:
- **Pricing power** vs. competitors (Amazon, Walmart, Costco)
- **Vendor negotiation leverage** with suppliers like Apple, Samsung, Sony
- **Product mix shifts** between lower-margin hardware and higher-margin services (Geek Squad, warranties, installation)
- **Promotional intensity** during peak seasons (holiday quarter)

---

### What the Evidence Shows

From the retrieved data, only **FY2017** is confirmed:

| Fiscal Year | Revenue | Gross Profit | Gross Margin |
|-------------|---------|--------------|--------------|
| FY2017 | $39,403M | $9,440M | **23.96%** |

[Source: BESTBUY_2017_10K.pdf, Page 91]

The FY2016 quarterly table is referenced in the same document but the actual FY2016 figures were **not included** in the retrieved text. FY2013–FY2015 data was **not retrieved** at all.

---

### Can Historical Consistency Be Confirmed?

**No — not from the available evidence.** Only one year of data is confirmed, which is insufficient to assess whethe

[... truncated, total 2180 chars]
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 91] 13 13 Quarterly Financial Information (Unaudited)The following tables show selected operating results for each 3-month quarter and full year of fiscal 2017 and 2016 (unaudited) ($ in millions): Quarter 12-Month 1st 2nd 3rd 4th 2017Revenue$ 8,443 $8,533 $8,945 $13,482 $39,403Comparable sales % change (1) (0.1 )% 0.8% 1.8% (0.7)% 0.3%Gross profit (2)$ 2,145 $2,062 $2,203 $3,030 $9,440Operating income (3)372 289 312 881 1,854Net earnings from continuing operations226 182 192 607 1,207Gain from discontinued operations, net of tax3 16 2 — 21Net earnings attributable to Best Buy Co., Inc. shareholders229 198 194 607 1,228Diluted earnings per share (4) Continuing operations$ 0.69 $0.56 $0.60 $1.91 $3.74Discontinued operations0.01 0.05 0.01 — 0.07Diluted earnings per share$ 0.70 $0...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `best_buy`  (display: Best Buy)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=best_buy; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Best Buy FY2023 gross margin.
2. Best Buy FY2022 gross margin.
3. Historical Best Buy gross margin variability and relevance for retail analysis.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** FY2017 margin and insufficiency conclusion are grounded; detailed retail-metric explanation is unsupported.

---
## Record 67 of 75  —  `diag_067`  **[FAILING]**  audit=WRONG_NUMBER

**fb_id:** `financebench_id_04980`
**company:** PepsiCo
**doc:** PEPSICO_2021_10K
**question_type:** metrics-generated

### Question

What is the FY2021 capital expenditure amount (in USD billions) for PepsiCo? Respond to the question by assuming the perspective of an investment analyst who can only use the details shown within the statement of cash flows.

### Gold answer

> $4.60

### V1 system answer (for HALLU_GROUNDED labeling)

```
## PepsiCo FY2021 Capital Expenditure

Based on the cash flow information provided, **PepsiCo's net capital spending in FY2021 was $4.5 billion**.

This figure is referenced in the context of investing activities: *"net cash used for investing activities was $3.3 billion, primarily reflecting **net capital spending of $4.5 billion**, partially offset by maturities of short-term investments with maturities greater than three months of $1.1 billion."* [Source: PEPSICO_2021_10K.pdf, Page 52]

### Key Contextual Notes for an Analyst:
| Item | FY2021 | FY2020 |
|------|--------|--------|
| Net Capital Spending | $4.5B | $4.2B |
| Net Cash Used for Investing | $(3.3B) | $(11.6B) |

- The term used is **"net" capital spending**, which typically implies proceeds from asset disposals have already been netted against gross capex. A strict reading of the statement of cash flows would therefore yield **$4.5B as the reported capex figure**.
- The year-over-year increase of ~$0.3B suggests PepsiCo modestly accelerated investment spending in 2021.

**Bottom line:** PepsiCo's FY2021 capital expenditure, as reported on the statement of cash flows, was **$4.5 billion** (net basis). [Source: PEPSICO_

[... truncated, total 1222 chars]
```

### V1 retrieved chunks (top 2 of 2 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2021 10K | Page 52]  future cash proceeds or payments.
The table below summarizes our cash activity:
2021 2020
Net cash provided by operating activities $ 11,616 $ 10,613 Net cash used for investing activities $ (3,269)$ (11,619)
Net cash (used for)/provided by financing activities $ (10,780)$ 3,819
Operating Activities
In 2021, net cash provided by operating activities was $11.6 billion, compared to $10.6 billion in the prior year. The increase in
operating cash flow primarily reflects favorable working capital comparisons and operating profit performance, partially offset by
higher pre-tax pension and retiree medical plan contributions and higher net cash tax payments in the current year.
Investing Activities
In 2021, net cash used for investing activities was $3.3 billion, primarily ...
```

**Chunk 2:**
```
[FY2021 10K | Page 52]  capital spending of $4.5 billion, partially
offset by maturities of short-term investments with maturities greater than three months of $1.1 billion. In 2020, net cash used for investing activities was $11.6 billion, primarily reflecting net cash paid in connection with our
acquisitions of Rockstar of $3.85 billion, Pioneer Foods of $1.2 billion and Be & Cheery of $0.7 billion, net capital spending of
$4.2 billion, as well as purchases of short-term investments with maturities greater than three months of $1.1 billion.
See Note 1 to our consolidated financial statements for further discussion of capital spending by division; see Note 9 to our
consolidated financial statements for further discussion of our investments in debt securities; and see Note 13 to our consol...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `pepsico`  (display: PepsiCo)
- **Auto target_fiscal_year:** `2021`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=pepsico; override if wrong)

**TARGET_YEAR:** `OK` (auto=2021; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 68 of 75  —  `diag_068`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_00288`
**company:** Best Buy
**doc:** BESTBUY_2024Q2_10Q
**question_type:** novel-generated

### Question

Was there any drop in Cash & Cash equivalents between FY 2023 and Q2 of FY2024?

### Gold answer

> Yes, there was a decline of ~42% between FY2023 and Q2 of FY 2024.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Ulta Beauty: Cash & Cash Equivalents — FY 2023 End vs. Q2 FY 2024

### What the Evidence Confirms

| Period | Cash & Cash Equivalents | Source |
|--------|------------------------|--------|
| End of FY 2023 (Jan 28, 2023) | **$737,877 thousand** | [Source 1: ULTABEAUTY_2023_10K.pdf, Page 57] |
| End of Q2 FY 2024 | **Not available** | — |

### Analysis

Only **one of the two required data points** is present in the retrieved documents:

- **FY 2023 year-end cash** is confirmed at **$737,877 thousand** [Source 1: ULTABEAUTY_2023_10K.pdf, Page 57; Source 2: ULTABEAUTY_2023_10K.pdf, Page 60].
- **Q2 FY 2024 cash** is **not found** in any of the retrieved chunks. No Ulta Beauty Q2 FY 2024 10-Q filing was present in the available evidence.

---

**Bottom line (Partial Evidence):** Ulta Beauty's cash & cash equivalents at the end of FY 2023 stood at **$737,877 thousand** [Source: ULTABEAUTY_2023_10K.pdf, Page 57], but the Q2 FY 2024 figure is unavailable in the provided context — therefore, whether a drop occurred **cannot be determined** from the available evidence alone.
```

### V1 retrieved chunks (top 5 of 10 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 10K | Page 57] vesting activities (314,584) (176,484) (48,751)
Financing activities
Proceeds from long-term debt — — 800,000
Payments on long-term debt — — (800,000) Repurchase of common shares (900,033) (1,521,925) (114,895)
Stock options exercised 46,011 40,386 12,229
Purchase of treasury shares (6,992) (15,677) (3,353)
Debt issuance costs — — (1,915)
Net cash used in financing activities (861,014) (1,497,216) (107,934)
Effect of exchange rate changes on cash and cash equivalents — (56) 56
Net increase (decrease) in cash and cash equivalents 306,317 (614,491) 653,726
Cash and cash equivalents at beginning of year 431,560 1,046,051 392,325
Cash and cash equivalents at end of year $ 737,877 $ 431,560 $ 1,046,051
Supplemental information
Cash paid for interest $ 2,138 $ 2,132 $ 6,98...
```

**Chunk 2:**
```
[FY2023 10K | Page 60] Table of Contents
57
Cash and cash equivalents
Cash equivalents include highly liquid investments such as money market funds and certificates of deposit with an original maturity ofthree months or less from the date of purchase. Cash equivalents also include amounts due from third-party financial institutions for creditcard and debit card transactions. These receivables typically settle in five days or less with little or no default risk.
January 28, January 29,
(In thousands) 2023     2022
Cash $ 651,367 $ 165,122Short-term investments — 199,939Receivables from third-party financial institutions for credit card and debit card transactions 86,510 66,499
Cash and cash equivalents $ 737,877 $ 431,560
Fair value of financial instruments
```

**Chunk 3:**
```
[FY2023 10K | Page 8]  expenses and other current assets
(19,432
)
(3,412
)
Income taxes
(45,182
)
(35,652
)
Accounts payable
8,309
66,156
Accrued liabilities
48,249
58,598 Deferred revenue
41,098
79,196
Operating lease liabilities
(324,500
)
(303,914
)
Other assets and liabilities
(7,731
)
12,392
Net cash provided by operating activities
1,481,915
1,059,265
Investing activities
Capital expenditures
(312,126
)
(172,187
)
Other investments
(2,458
)
(4,297
)
Net cash used in investing activities
(314,584
)
(176,484
)
Financing activities
Repurchase of common shares
(900,033
)
(1,521,925
)
Stock options exercised
46,011
40,386
Purchase of treasury shares
(6,992
)
(15,677
)
Net cash used in financing activities
(861,014
)
(1,497,216
)
Effect of exchange rate changes on cash and cash equivalent...
```

**Chunk 4:**
```
[FY2023 10Q | Page 6] 
Net cash used in financing activities (3,329,536) (2,539,431)
Effect of exchange rate on cash, cash equivalents, and restricted cash (24,393) (1,617) Change in cash and cash equivalents classified as assets held for sale 25,938 (37,232)
Cash, cash equivalents, and restricted cash
Net change for the period (2,106,249) 581,114
Balance, beginning of period 6,036,388 5,203,059
Balance, end of period $ 3,930,139 $ 5,784,173
Supplemental cash flow disclosures
Interest paid, net of amounts capitalized $ 250,469 $ 329,621
Federal, state and foreign income taxes paid (refunds received), net 216,873 (32,736)
Non-cash investing and financing activities
MGM Grand Paradise gaming concession intangible asset $ 226,083 $ —
MGM Grand Paradise gaming concession payment obligation 226...
```

**Chunk 5:**
```
[FY2023 10Q | Page 6]  (maturities greater than 90 days) (1,802) (1,179)
Proceeds from debt (maturities greater than 90 days) 1,107 1
Purchases of treasury stock (29) (773) Proceeds from issuance of treasury stock pursuant to stock option and benefit plans 218 227
Dividends paid to shareholders (1,655) (1,700)
Other — net (9) (22)
Net cash provided by (used in) financing activities (1,519) (3,102)
Effect of exchange rate changes on cash and cash equivalents (43) (64)
Net increase (decrease) in cash and cash equivalents 603 (1,842)
Cash and cash equivalents at beginning of year 3,655 4,564
Cash and cash equivalents at end of period $ 4,258 $ 2,722
The accompanying Notes to Consolidated Financial Statements are an integral part of this statement.
6
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `best_buy`  (display: Best Buy)
- **Auto target_fiscal_year:** `2024`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=best_buy; override if wrong)

**TARGET_YEAR:** `OK` (auto=2024; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Best Buy FY2023 cash and cash equivalents.
2. Best Buy Q2 FY2024 cash and cash equivalents.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Answer is grounded in the retrieved Ulta chunks despite the retrieval/entity mismatch for the Best Buy question.

---
## Record 69 of 75  —  `diag_069`  **[PASSING]**

**fb_id:** `financebench_id_01254`
**company:** MGM Resorts
**doc:** MGMRESORTS_2022_10K
**question_type:** domain-relevant

### Question

Has MGM Resorts paid dividends to common shareholders in FY2022?

### Gold answer

> Yes. MGM maintained 0.01$ per share annual dividend through out FY 2022.

### V1 system answer (for HALLU_GROUNDED labeling)

```
**Yes, MGM Resorts paid dividends to common shareholders in FY2022.**

Specifically, the company declared and paid dividends of **$0.01 per share**, totaling **$4,048 thousand (approximately $4 million)** to common shareholders during FY2022. [Source: MGMRESORTS_2022_10K.pdf, Page 64]

This is consistent with the company's policy noted in the dividend policy disclosure: MGM maintained an annual dividend of $0.01 per share throughout 2022, having reduced it from higher levels in Q2 2020 due to the COVID-19 pandemic's impact on operations. [Source: MGMRESORTS_2022_10K.pdf, Page 32]

The cash flow statement also confirms **$4,048 thousand in dividends paid to common shareholders** in FY2022. [Source: MGMRESORTS_2022_10K.pdf, Page 62]

**Bottom line:** MGM Resorts did pay dividends to common shareholders in FY2022 at a rate of $0.01 per share, totaling ~$4.0 million — a minimal dividend maintained since the COVID-era reduction, which was subsequently suspended in February 2023 in favor of share repurchases.
```

### V1 retrieved chunks (top 5 of 8 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 64]  interest owners — — — — — — (250,910) (250,910)
Dividends declared and paid to common shareholders ($0.01 pershare) — — — (4,789) — (4,789) — (4,789) MGP dividend payable to Class A shareholders — — — — — — (82,294) (82,294)
Repurchases of common stock (43,088) (430) (1,753,079) — — (1,753,509) — (1,753,509)
Adjustment of redeemable noncontrolling interest to redemptionvalue — — (78,298) — — (78,298) — (78,298)
MGP Class A share issuances — — 99,934 — 3,240 103,174 656,361 759,535
Redemption of MGP OP units — — 171,332 — 5,327 176,659 (227,487) (50,828)
MGM Springfield transaction — — (133,844) — — (133,844) 172,749 38,905
Other — — (10,312) — (2,358) (12,670) 2,341 (10,329)
Balances, December 31, 2021 453,804 4,538 1,750,135 4,340,588 (24,616) 6,070,645 4,906,121 1...
```

**Chunk 2:**
```
[FY2022 10K | Page 64] Class A share issuance — — 64,188 — 646 64,834 442,717 507,551
MGM Grand Las Vegas and Mandalay Bay transaction — — (6,503) — (59) (6,562) 8,287 1,725 Redemption of MGP OP units — — 83,859 — 8,773 92,632 (114,924) (22,292)
Other — — (1,724) — (1,018) (2,742) (638) (3,380)
Balances, December 31, 2020 494,318 4,943 3,439,453 3,091,007 (30,677) 6,504,726 4,675,182 11,179,908
Net income (loss) — — — 1,254,370 — 1,254,370 (55,793) 1,198,577
Currency translation adjustment — — — — (13,871) (13,871) (10,784) (24,655)
Cash flow hedges — — — — 13,723 13,723 21,065 34,788
Stock-based compensation — — 59,492 — — 59,492 5,691 65,183
Issuance of common stock pursuant to stock-based compensationawards 2,574 25 (44,543) — — (44,518) — (44,518)
Cash distributions to noncontrolling i...
```

**Chunk 3:**
```
[FY2022 10K | Page 64] 5,711 15,711 12,051 27,762
Cash flow hedges — — — — (44,528) (44,528) (34,837) (79,365)
Stock-based compensation — — 100,907 — — 100,907 6,049 106,956 Issuance of common stock pursuant to stock-based compensationawards 2,031 21 (16,424) — — (16,403) — (16,403)
Cash distributions to noncontrolling interest owners — — — — — — (221,690) (221,690)
Dividends declared and paid to common shareholders ($0.1575 pershare) — — — (77,606) — (77,606) — (77,606)
MGP dividend payable to Class A shareholders — — — — — — (64,086) (64,086)
Issuance of restricted stock units — — 2,142 — — 2,142 — 2,142
Repurchases of common stock (10,861) (109) (353,611) — — (353,720) — (353,720)
Adjustment of redeemable noncontrolling interest to redemptionvalue — — 35,520 — — 35,520 — 35,520
MGP Clas...
```

**Chunk 4:**
```
[FY2022 10K | Page 62] ,089)
Issuance of long-term debt — 749,775 3,550,000
Repayment of long-term debt (1,070,340) — (846,815)
Debt issuance costs (1,367) (18,726) (62,348) Proceeds from issuance of bridge loan facility — — 1,304,625
Issuance of MGM Growth Properties Class A shares, net — 792,851 524,704
Dividends paid to common shareholders (4,048) (4,789) (77,606)
Distributions to noncontrolling interest owners (210,699) (324,190) (286,385)
Repurchases of common stock (2,775,217) (1,753,509) (353,720)
Other (110,907) (159,290) (53,939)
Net cash provided by (used in) financing activities (3,024,302) (2,814,095) 2,103,427
Effect of exchange rate on cash, cash equivalents, and restricted cash 8,926 (1,551) 2,345
Change in cash and cash equivalents classified as assets held for sale (25,938...
```

**Chunk 5:**
```
[FY2022 10K | Page 48] MGP OP paid the following distributions to its partnership unit holders during 2022 and 2021:
• $283 million of distributions paid in 2022, of which we received $117 million and MGP received $166 million, which MGP concurrently paid as a
dividend to its Class A shareholders; and• $545 million of distributions paid in 2021, of which we received $243 million and MGP received $302 million, which MGP concurrently paid as adividend to its Class A shareholders.
Other Factors Affecting Liquidity and Anticipated Uses of Cash
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `mgm_resorts`  (display: MGM Resorts)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=mgm_resorts; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Dividend payment and per-share amount are supported; policy, COVID reduction, and suspension context are not shown in retrieved chunks.

---
## Record 70 of 75  —  `diag_070`  **[PASSING]**

**fb_id:** `financebench_id_07507`
**company:** Adobe
**doc:** ADOBE_2016_10K
**question_type:** metrics-generated

### Question

What is Adobe's year-over-year change in unadjusted operating income from FY2015 to FY2016 (in units of percents and round to one decimal place)? Give a solution to the question by using the income statement.

### Gold answer

> 65.4%

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Adobe's Year-over-Year Change in Unadjusted (GAAP) Operating Income: FY2015 → FY2016

### Key Figures from the Income Statement

| Metric | FY2016 | FY2015 |
|---|---|---|
| Operating Income | $1,493,602K | $903,095K |

[Source: ADOBE_2016_10K.pdf, Page 62] — confirmed by [Source: ADOBE_2017_10K.pdf, Page 58] and [Source: ADOBE_2015_10K.pdf, Page 60]

### Calculation

$$\text{YoY \% Change} = \frac{\$1{,}493{,}602 - \$903{,}095}{\$903{,}095} \times 100 = \frac{\$590{,}507}{\$903{,}095} \times 100 = \textbf{65.4\%}$$

---

**Bottom line**: Adobe's GAAP operating income grew by **+65.4%** year-over-year from FY2015 ($903,095K) to FY2016 ($1,493,602K), driven primarily by a $1.06B increase in total revenue outpacing a $393M rise in total operating expenses.
```

### V1 retrieved chunks (top 4 of 4 — for HALLU_GROUNDED)

**Chunk 1:**
```
[10K | Page 62] Table of Contents
62
ADOBE SYSTEMS INCORPORATED
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
Years Ended
December 2,
2016
November 27,
2015
November 28,
2014
Revenue:
Subscription $ 4,584,833 $ 3,223,904 $ 2,076,584
Product 800,498 1,125,146 1,627,803
Services and support 469,099 446,461 442,678
Total revenue 5,854,430 4,795,511 4,147,065
Cost of revenue:
Subscription 461,860 409,194 335,432
Product 68,917 90,035 97,099
Services and support 289,131 245,088 189,549
Total cost of revenue 819,908 744,317 622,080
Gross profit 5,034,522 4,051,194 3,524,985
Operating expenses:
Research and development 975,987 862,730 844,353
Sales and marketing 1,910,197 1,683,242 1,652,308
General and administrative 577,710 531,919 543,332
```

**Chunk 2:**
```
[10K | Page 62] 
Research and development 975,987 862,730 844,353
Sales and marketing 1,910,197 1,683,242 1,652,308
General and administrative 577,710 531,919 543,332 Restructuring and other charges (1,508) 1,559 19,883
Amortization of purchased intangibles 78,534 68,649 52,424
Total operating expenses 3,540,920 3,148,099 3,112,300
Operating income 1,493,602 903,095 412,685
Non-operating income (expense):
Interest and other income (expense), net 13,548 33,909 7,267
Interest expense (70,442) (64,184) (59,732)
Investment gains (losses), net (1,570) 961 1,156
Total non-operating income (expense), net (58,464) (29,314) (51,309)
Income before income taxes 1,435,138 873,781 361,376
Provision for income taxes 266,356 244,230 92,981
Net income $ 1,168,782 $ 629,551 $ 268,395
Basic net income per s...
```

**Chunk 3:**
```
[10K | Page 58] esearch and development 1,224,059 975,987 862,730
Sales and marketing 2,197,592 1,910,197 1,683,242
General and administrative 624,706 576,202 533,478 Amortization of purchased intangibles 76,562 78,534 68,649
Total operating expenses 4,122,919 3,540,920 3,148,099
Operating income 2,168,095 1,493,602 903,095
Non-operating income (expense):
Interest and other income (expense), net 36,395 13,548 33,909
Interest expense (74,402) (70,442) (64,184)
Investment gains (losses), net 7,553 (1,570) 961
Total non-operating income (expense), net (30,454) (58,464) (29,314)
Income before income taxes 2,137,641 1,435,138 873,781
Provision for income taxes 443,687 266,356 244,230
Net income $ 1,693,954 $ 1,168,782 $ 629,551
Basic net income per share $ 3.43 $ 2.35 $ 1.26
Shares used to comp...
```

**Chunk 4:**
```
[10K | Page 60] 3,468,683
Operating expenses:
Research and development ....................................................................... 862,730 844,353 826,631 Sales and marketing.................................................................................. 1,683,242 1,652,308 1,620,454
General and administrative....................................................................... 531,919 543,332 520,124
Restructuring and other charges ............................................................... 1,559 19,883 26,497
Amortization of purchased intangibles..................................................... 68,649 52,424 52,254
Total operating expenses...................................................................... 3,148,099 3,112,300 3,045,960
Operating income.............
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `adobe`  (display: Adobe)
- **Auto target_fiscal_year:** `2016`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=adobe; override if wrong)

**TARGET_YEAR:** `OK` (auto=2016; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. Adobe FY2016 operating income.
2. Adobe FY2015 operating income.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 71 of 75  —  `diag_071`  **[PASSING]**

**fb_id:** `financebench_id_00917`
**company:** AMD
**doc:** AMD_2022_10K
**question_type:** domain-relevant

### Question

What drove operating margin change as of the FY22 for AMD? If operating margin is not a useful metric for a company like this, then please state that and explain why.

### Gold answer

> The decrease in AMD's operating income was primarily driven by amortization of intangible assets associated with the Xilinx acquisition

### V1 system answer (for HALLU_GROUNDED labeling)

```
# AMD FY22 Operating Margin Analysis

## 1. The Numbers

| Metric | FY21 | FY22 | Change |
|--------|------|------|--------|
| Net Revenue | $16,434M | $23,601M | +$7,167M (+44%) |
| Operating Income | $3,648M | $1,264M | −$2,384M |
| **GAAP Operating Margin** | **22.2%** | **5.4%** | **−16.8 pp** |

[Source: AMD_2022_10K.pdf, Page 54]

---

## 2. What Drove the Decline?

### Primary Driver: Xilinx Acquisition Accounting
The 10-K is unambiguous:
> *"The decrease in operating income was primarily driven by amortization of intangible assets associated with the Xilinx acquisition."* [Source: AMD_2022_10K.pdf, Page 43]

The "All Other" segment — which pools acquisition-related charges — swung from a **($409M) loss in FY21** to a **($4,979M) loss in FY22**, a **$4,570M deterioration** that single-handedly explains the entire GAAP operating income decline. [Source: AMD_2022_10K.pdf, Page 68]

That $4,979M "All Other" loss consisted of:
| Item | Amount |
|------|--------|
| Amortization of acquisition-related intangibles (COGS) | $1,448M |
| Amortization of acquisition-related intangibles (OpEx) | $2,100M |
| **Total intangible amortization** | **$3,548M** |
| Stock-based compensation | ~

[... truncated, total 4470 chars]
```

### V1 retrieved chunks (top 5 of 7 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 54] Table of Contents
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Advanced Micro Devices, Inc.
Consolidated Statements of Operations
Year Ended
December 31,2022 December 25,2021 December 26,2020
(In millions, except per share amounts)
Net revenue $ 23,601 $ 16,434 $ 9,763 Cost of sales 11,550 8,505 5,416
Amortization of acquisition-related intangibles 1,448 — —
Total cost of sales 12,998 8,505 5,416
Gross profit 10,603 7,929 4,347
Research and development 5,005 2,845 1,983 Marketing, general and administrative 2,336 1,448 995
Amortization of acquisition-related intangibles 2,100 — —
Licensing gain (102) (12) —
Operating income 1,264 3,648 1,369
Interest expense (88) (34) (47)
Other income (expense), net 8 55 (47)
Income before income taxes and equity income 1,184...
```

**Chunk 2:**
```
[FY2022 10K | Page 68] Table of Contents
The following table provides a summary of net revenue and operating income (loss) by segment for 2022, 2021 and 2020.
Year Ended
December 31,2022 December 25,2021 December 26,2020
(In millions)
Net revenue:Data Center $ 6,043 $ 3,694 $ 1,685 Client 6,201 6,887 5,189
Gaming 6,805 5,607 2,746 Embedded 4,552 246 143
Total net revenue $ 23,601 $ 16,434 $ 9,763
Operating income (loss):Data Center $ 1,848 $ 991 $ 198 Client 1,190 2,088 1,608
Gaming 953 934 (138)Embedded 2,252 44 (11)
All Other (4,979) (409) (288)
Total operating income (loss) $ 1,264 $ 3,648 $ 1,369
The following table provides items included in All Other category:
Year Ended
December 31,2022 December 25,2021 December 26,2020
(In millions)
Operating loss:
```

**Chunk 3:**
```
[FY2022 10K | Page 49] f $44 million in 2021. The significant increase in operating income wasprimarily driven by the inclusion of Xilinx embedded product revenue.
All Other All Other operating loss of $5.0 billion in 2022 primarily consisted of $3.5 billion of amortization of acquisition-related intangibles, $1.1 billion of stock-basedcompensation expense, and $452 million of acquisition-related costs, which primarily include transaction costs, amortization of Xilinx inventory fair value step-up adjustment, and depreciation related to the Xilinx fixed assets fair value step-up adjustment, certain compensation charges related to the acquisitions ofXilinx and Pensando, and licensing gain. All Other operating loss of $409 million in 2021 primarily consisted of $379 million of stock-based com...
```

**Chunk 4:**
```
[FY2022 10K | Page 48] by higher revenue, partially offset by higher operating expenses. Operating expenses increased for the reasons outlined under “Expenses” below.
Client Client net revenue of $6.2 billion in 2022 decreased by 10%, compared to net revenue of $6.9 billion in 2021, primarily driven by a 24% decrease in unitshipment, partially offset by a 19% increase in average selling price. The decrease in unit shipments was due to challenging PC market conditions andsignificant inventory correction across the PC supply chain experienced during the second half of 2022. The increase in average selling price was primarilydriven by a richer mix of Ryzen mobile processor sales.
Client operating income was $1.2 billion in 2022, compared to operating income of $2.1 billion in 2021. The decrea...
```

**Chunk 5:**
```
[FY2022 10K | Page 49]  higher revenue, partially offset by higher operating expenses. Operating expenses increased for the reasons outlined under “Expenses” below.
Embedded Embedded net revenue of $4.6 billion in 2022 increased significantly, compared to net revenue of $246 million in 2021. The significant increase in net revenuewas primarily driven by the inclusion of Xilinx embedded product revenue as a result of the acquisition of Xilinx in February 2022.
Embedded operating income was $2.3 billion in 2022, compared to operating income of $44 million in 2021. The significant increase in operating income wasprimarily driven by the inclusion of Xilinx embedded product revenue.
All Other
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `amd`  (display: AMD)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=amd; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. AMD FY2022 and FY2021 operating income and net revenue.
2. AMD FY2022 acquisition-related intangible amortization.
3. AMD management discussion of FY2022 operating income or operating-margin drivers.
4. Whether operating margin is a relevant metric for AMD.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 72 of 75  —  `diag_072`  **[PASSING]**

**fb_id:** `financebench_id_01865`
**company:** 3M
**doc:** 3M_2022_10K
**question_type:** novel-generated

### Question

If we exclude the impact of M&A, which segment has dragged down 3M's overall growth in 2022?

### Gold answer

> The consumer segment shrunk by 0.9% organically.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## Answer

**The Consumer segment was the sole drag on 3M's overall organic growth in 2022.**

When M&A effects (acquisitions and divestitures) are stripped out, the organic sales growth by segment was as follows [Source: 3M_2022_10K.pdf, Page 25]:

| Segment | Organic Sales Growth |
|---|---|
| Health Care | +3.2% |
| Transportation and Electronics | +1.2% |
| Safety and Industrial | +1.0% |
| **Consumer** | **-0.9%** |
| **Total Company** | **+1.2%** |

Consumer was the **only segment with negative organic growth (-0.9%)**, while every other segment posted positive organic growth. The 10-K explains why [Source: 3M_2022_10K.pdf, Page 33]:

> *"Growth was impacted by softening trends in the Consumer retail business as consumers pulled back on discretionary spending and retailers took actions to reduce their [inventory]."*

Within Consumer, the drag was concentrated in **home improvement**, which declined organically, while stationery & office and home care grew, and consumer health & safety was flat.

---

**Bottom line:** Excluding M&A, the **Consumer segment (-0.9% organic growth)** was the only segment that dragged down 3M's overall organic growth of +1.2% in 2022, driven by wea

[... truncated, total 1305 chars]
```

### V1 retrieved chunks (top 5 of 10 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2022 10K | Page 60] 2
Advanced Materials
1,205
1,200
1,029
Automotive and Aerospace
1,754
1,756
1,522
Commercial Solutions
1,751
1,717
1,486
Electronics
3,359
3,673
3,497 Transportation Safety
833
907
880
Other Transportation and Electronics
—
9
(
8
)
Total Transportation and Electronics Business Segment
8,902
9,262
8,406
Drug Delivery
—
—
146
Food Safety
244
368
337
Health Information Systems
1,259
1,220
1,140
Medical Solutions
4,581
4,632
4,288
Oral Care
1,353
1,420
1,071
Separation and Purification Sciences
960
956
848
Other Health Care
24
1
2
Total Health Care Business Group
8,421
8,597
7,832
Consumer Health and Safety
569
588
540
Home Care
1,046
1,074
1,043
Home Improvement
2,392
2,548
2,260
Stationery and Office
1,291
1,306
1,132
Other Consumer
—
(
3
)
1
Total Consumer Business Gr...
```

**Chunk 2:**
```
[FY2022 10K | Page 25] and Industrial
$
11,604
33.9
%
$
1,199
$
11,981
33.9
%
$
2,466
(3.2)
%
(51.4)
%
Transportation and Electronics
8,902
26.0
1,012
9,262
26.2
1,880
(3.9) (46.2)
Health Care
8,421
24.6
1,815
8,597
24.3
2,037
(2.0)
(10.9)
Consumer
5,298
15.5
994
5,513
15.6
1,162
(3.9)
(14.4)
Corporate and Unallocated
4
—
1,519
2
—
(176)
Total Company
$
34,229
100.0
%
$
6,539
$
35,355
100.0
%
$
7,369
(3.2)
%
(11.3)
%
Year ended December 31, 2022
Worldwide Sales Change
By Business Segment
Organic sales
Acquisitions
Divestitures
Translation
Total sales change
Safety and Industrial
1.0
%
—
%
—
%
(4.2)
%
(3.2)
%
Transportation and Electronics
1.2
—
(0.5)
(4.6)
(3.9)
Health Care
3.2
—
(1.4)
(3.8)
(2.0)
Consumer
(0.9)
—
(0.4)
(2.6)
(3.9)
Total Company
1.2
—
(0.5)
(3.9)
(3.2)
Sales by geographic ...
```

**Chunk 3:**
```
[FY2022 10K | Page 60] T
able of
Contents
Disaggregated revenue information:
The Company views the following disaggregated disclosures as useful to understanding the composition of revenue recognized during the respective reporting periods:
Year ended December 31,
Net Sales (Millions)
2022
2021
2020
Abrasives
$
1,343
$
1,296
$
1,077
Automotive Aftermarket
1,209
1,164
1,028
Closure and Masking Systems
1,046
1,033
993
Electrical Markets
1,304
1,229
1,093
Industrial Adhesives and Tapes
2,331
2,353
2,000
Personal Safety
3,916
4,470
4,408
Roofing Granules
455
428
389
Other Safety and Industrial
—
8
(
16
)
Total Safety and Industrial Business Segment
11,604
11,981
10,972
Advanced Materials
1,205
1,200
1,029
Automotive and Aerospace
1,754
1,756
1,522
Commercial Solutions
1,751
1,717
1,486
Electro...
```

**Chunk 4:**
```
[FY2022 10K | Page 25]  information compares the years ended December 31, 2022 and 2021 with the same prior year period, unless otherwise indicated. Additional discussion of business segment results is provided in the Performance by Business Segment section.
Year ended December 31, 2022
Americas
Asia Pacific
Europe, Middle East
& Africa
Other Unallocated
Worldwide
Net sales (millions)
$
18,400
$
9,901
$
5,928
$
—
$
34,229
% of worldwide sales
53.8
%
28.9
%
17.3
%
100.0
%
Components of net sales change:
Organic sales
2.6
0.3
(0.6)
1.2
Divestitures
(0.6)
(0.4)
(0.6)
(0.5)
Translation
(0.3)
(6.5)
(9.8)
(3.9)
Total sales change
1.7
%
(6.6)
%
(11.0)
%
(3.2)
%
Year ended December 31, 2021
Americas
Asia Pacific
Europe, Middle East
& Africa
Other Unallocated
Worldwide
Net sales (millions)
$
18,097...
```

**Chunk 5:**
```
[FY2022 10K | Page 25] T
able of
Contents
Sales and operating income (loss) by business segment:
The following tables contain sales and operating income (loss) results by business segment for the years ended December 31, 2022 and 2021. Refer to the section entitled
“Performance by Business Segment” later in MD&A for additional discussion concerning 2022 versus 2021 results, including Corporate and Unallocated. Refer to Note 19 for
additional information on business segments.
2022
2021
% change
(Dollars in millions)
Net Sales
% of Total
Operating
Income (Loss)
Net Sales
% of Total
Operating
Income (Loss)
Net Sales
Operating Income
(Loss)
Business Segments
Safety and Industrial
$
11,604
33.9
%
$
1,199
$
11,981
33.9
%
$
2,466
(3.2)
%
(51.4)
%
Transportation and Electronics
8,902
26.0
1,012
9,...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `3m`  (display: 3M)
- **Auto target_fiscal_year:** `2022`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=3m; override if wrong)

**TARGET_YEAR:** `OK` (auto=2022; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. 3M FY2022 organic sales growth by segment.
2. 3M FY2022 M&A/divestiture impact by segment.
3. 3M management discussion of Consumer segment sales decline.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Organic-growth table is grounded; consumer-driver and product-line details cite chunks not shown.

---
## Record 73 of 75  —  `diag_073`  **[FAILING]**  audit=REFUSAL

**fb_id:** `financebench_id_00746`
**company:** Ulta Beauty
**doc:** ULTABEAUTY_2023_10K
**question_type:** domain-relevant

### Question

Which debt securities are registered to trade on a national securities exchange under Ulta Beauty's name as of FY2023?

### Gold answer

> There are none

### V1 system answer (for HALLU_GROUNDED labeling)

```
I couldn't find relevant information in the available documents to answer your question.
This could mean the information isn't in the documents I have access to, or the question
may need to be rephrased. Could you try asking in a different way?
```

### V1 retrieved chunks (top 1 of 1 — for HALLU_GROUNDED)

**Chunk 1:**
```

```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `ulta_beauty`  (display: Ulta Beauty)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `simple_lookup`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=ulta_beauty; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
`N/A`

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** Empty retrieval; refusal is grounded.

---
## Record 74 of 75  —  `diag_074`  **[PASSING]**

**fb_id:** `financebench_id_02049`
**company:** JPMorgan
**doc:** JPMORGAN_2023Q2_10Q
**question_type:** novel-generated

### Question

Looking at VaR, did the risk that JPM faced in the second fiscal quarter of 2023 decrease compared to the same period in the prior year?

### Gold answer

> Yes. It decreased.

### V1 system answer (for HALLU_GROUNDED labeling)

```
## JPMorgan Chase VaR: Q2 2023 vs. Q2 2022

**Yes, JPM's risk as measured by Value-at-Risk (VaR) decreased year-over-year.**

According to the 10-Q filing, *"Average total VaR decreased by $7 million for the three months ended June 30, 2023, compared with the same period in the prior year"* [Source: JPMORGAN_2023Q2_10Q.pdf, Page 85].

### Key Drivers of the Decrease:
1. **Credit Portfolio VaR reductions** — risk reduction measures specifically impacting the credit portfolio
2. **Fixed income VaR reductions** — lower risk exposure in fixed income markets

### Additional Context:
- On a **quarter-over-quarter** basis (Q2 2023 vs. Q1 2023), Average total VaR was **flat**, with increases in fixed income offset by commodities market volatility rolling out of the one-year historical look-back period [Source: JPMORGAN_2023Q2_10Q.pdf, Page 85].

---

**Bottom line:** JPM's Average total VaR in Q2 2023 was **$7 million lower** than in Q2 2022, confirming a year-over-year reduction in measured market risk, primarily driven by credit portfolio and fixed income risk reductions [Source: JPMORGAN_2023Q2_10Q.pdf, Page 85].
```

### V1 retrieved chunks (top 3 of 3 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2023 10Q | Page 172] otes 2 and 15 of JPMorgan Chase’s 2022 Form 10-K for a further description of the
MSR asset, interest rate risk management, and the valuation of MSRs. The following table summarizes MSR activity for the three and six months ended J u n e  3 0 ,  2 0 2 3 and 2022.
As of or for the three months
ended June 30,
As of or for the six months
ended June 30,
(in millions, except where otherwise noted) 2023 2022 2023 2022
Fair value at beginning of period $ 7,755 $ 7,294 $ 7,973 $ 5,494
MSR activity:
Originations of MSRs  78  181  110  596
Purchase of MSRs(a)  468  160  467  875
Disposition of MSRs(b)  (92)  (614)  (90)  (671)
Net additions/(dispositions)  454  (273)  487  800
Changes due to collection/realization of expected cash flows  (255)  (236)  (495)  (468)
Changes in ...
```

**Chunk 2:**
```
[FY2023 10Q | Page 135] es
as of J u n e  3 0 ,  2 0 2 3, and D e c e m b e r  3 1 ,  2 0 2 2, where JPMorgan Chase is the seller of protection. The maturity profile is based on the remaining contractual maturity of the credit derivative contracts. The ratings profile is based on the rating of the
reference entity on which the credit derivative contract is based. The ratings and maturity profile of credit derivatives where
JPMorgan Chase is the purchaser of protection are comparable to the profile reflected below.
Protection sold — credit derivatives ratings(a)/maturity profile
June 30, 2023
(in millions) <1 year 1–5 years >5 years
Total
notional amount
Fair value of
receivables(b) Fair value of
payables(b) Net fair
value
Risk rating of reference entity
Investment-grade $ (103,323) $ (412,...
```

**Chunk 3:**
```
[FY2023 10Q | Page 85]  the nickel market which occurred during the first quarter of 2022.
Quarter over quarter results
Average total VaR was flat for the three months ended J u n e  3 0 ,  2 0 2 3, when compared with March 31, 2023,
reflecting increases in fixed income offset by market volatility
relating to commodities rolling out of the one-year historical
look-back period.
Year over year results
Average total VaR decreased by $7 million for the three
months ended J u n e  3 0 ,  2 0 2 3, compared with the same
period in the prior year predominantly driven by risk
reductions impacting Credit Portfolio VaR as well as fixed
income.
The following graph presents daily Risk Management VaR for the five trailing quarters.
Daily Risk Management VaR
$ millions
0
50
100
Second  Quarter
2022
Third...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `jpmorgan`  (display: JPMorgan)
- **Auto target_fiscal_year:** `2023`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=jpmorgan; override if wrong)

**TARGET_YEAR:** `OK` (auto=2023; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. JPMorgan average total VaR for Q2 2023 versus Q2 2022.
2. JPMorgan management explanation of year-over-year VaR change.

**HALLU_GROUNDED:** `Y`  (one of: Y, N, PARTIAL)

**NOTES:** 

---
## Record 75 of 75  —  `diag_075`  **[FAILING]**  audit=WRONG_NUMBER

**fb_id:** `financebench_id_02119`
**company:** JPMorgan
**doc:** JPMORGAN_2021Q1_10Q
**question_type:** novel-generated

### Question

If JPM went bankrupted by the end by 2021 Q1 and liquidated all of its assets to pay its shareholders, how much could each shareholder get?

### Gold answer

> They could receive $66.56 per share.

### V1 system answer (for HALLU_GROUNDED labeling)

```
**Note:** This answer could not be fully verified against source documents. Please verify the information independently.

## JPM Hypothetical Liquidation Value Per Share — End of Q1 2021

### What the Retrieved Chunks Show

The consolidated balance sheet [Source 1: JPMORGAN_2021Q1_10Q.pdf, Page 81] provides **partial asset line items** as of March 31, 2021, but the chunk is truncated before the "Total Assets" and "Total Liabilities" summary lines. The VIE sub-table [Source 2: JPMORGAN_2021Q1_10Q.pdf, Page 81] shows only a subset of consolidated liabilities ($15,910M), not the full picture.

### Calculation (Book Value Basis)

Using the figures from the same 10-Q filing (balance sheet totals that appear beyond the truncated chunk):

| Item | Amount |
|---|---|
| Total Assets (Mar 31, 2021) | ~$3,689,336M |
| Total Liabilities (Mar 31, 2021) | ~$3,409,982M |
| **Net Book Equity** | **~$279,354M** |
| Common Shares Outstanding | ~3,051M shares |
| **Book Value Per Share** | **~$91.56/share** |

### Critical Caveats

1. **Shareholders are last in line.** In a real bankruptcy, creditors (depositors, bondholders, counterparties) are paid *first*. Shareholders only receive what remains — 

[... truncated, total 2489 chars]
```

### V1 retrieved chunks (top 3 of 3 — for HALLU_GROUNDED)

**Chunk 1:**
```
[FY2021 10Q | Page 81] JPMorgan Chase & Co.
Consolidated balance sheets (unaudited)
(in millions, except share data)
March 31,
2021
December 31,
2020
Assets
Cash and due from banks $ 25,397 $ 24,874
Deposits with banks  685,675  502,735
Federal funds sold and securities purchased under resale agreements (included $267,613 and $238,015 at fair
value)  272,481  296,284
Securities borrowed (included $66,277 and $52,983 at fair value)  179,516  160,635
Trading assets (included assets pledged of $117,020 and $130,645)  544,052  503,126
Available-for-sale securities (amortized cost of $378,756 and $381,729; included assets pledged of $64,540
and $32,227)  379,942  388,178
Held-to-maturity securities (net of allowance for credit losses of $94 and $78)  217,452  201,821
```

**Chunk 2:**
```
[FY2021 10Q | Page 81] he assets of the consolidated VIEs are used to settle the liabilities of those entities. The holders of the beneficial interests generally do not have recourse to the general credit of JPMorgan Chase. The assets and liabilities in the table below include third-party assets and liabilities of consolidated VIEs
and exclude intercompany balances that eliminate in consolidation. Refer to Note 13 for a further discussion
(in millions)
March 31,
2021
December 31,
2020
Assets
Trading assets $ 1,994 $ 1,934
Loans  33,509  37,619
All other assets  701  681
Total assets $ 36,204 $ 40,234
Liabilities
Beneficial interests issued by consolidated VIEs $ 15,671 $ 17,578
All other liabilities  239  233
Total liabilities $ 15,910 $ 17,811
The Notes to Consolidated Financial Statement...
```

**Chunk 3:**
```
[FY2021 10Q | Page 29] 6  (12)
Selected balance sheet data
(average)
Total assets $ 225,574 $ 226,071  —
Loans:
Loans retained  204,164  209,988  (3)
Loans held-for-sale and loans at fair value  2,578  1,831  41
Total loans $ 206,742 $ 211,819  (2)
Average loans by client
segment
Middle Market Banking $ 60,011 $ 56,045  7
Corporate Client Banking  45,719  53,032  (14)
Commercial Real Estate
Banking  100,661  101,526  (1)
Other  351  1,216  (71)
Total Commercial Banking
loans $ 206,742 $ 211,819  (2)
Client deposits and other
third-party liabilities $ 290,992 $ 188,808  54
Equity  24,000  22,000  9
Headcount  11,748  11,779  — %
(a) At March 31, 2021, total loans included $7.4 billion of loans under the
PPP, of which $7.2 billion were in Middle Market Banking. Refer to
Credit Portfolio on p...
```

### Auto-prefilled fields (verify or correct)

- **Auto target_company_slug:** `jpmorgan`  (display: JPMorgan)
- **Auto target_fiscal_year:** `2021`

### ➤ Your labels

**INTENT:** `retrieval`  (one of: retrieval, clarification, out_of_scope)

**COMPLEXITY:** `research_required`  (one of: simple_lookup, research_required)

**TARGET_COMPANY:** `OK` (auto=jpmorgan; override if wrong)

**TARGET_YEAR:** `OK` (auto=2021; override if wrong)

**EXPECTED_SUB_QUERIES:**
1. JPMorgan Q1 2021 total assets.
2. JPMorgan Q1 2021 total liabilities.
3. JPMorgan Q1 2021 common shares outstanding.

**HALLU_GROUNDED:** `PARTIAL`  (one of: Y, N, PARTIAL)

**NOTES:** Retrieved chunks only show partial balance-sheet lines; total assets/liabilities, shares, and final per-share value are unsupported.

---
